Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
53 "Risk"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Original Article
Impact of Tumor Bilaterality and Multifocality in Predicting Recurrence of Papillary Thyroid Carcinoma: A Retrospective Cohort Study
Eunji Kim, Jun Hyun Park, Ji-Young Park, Jin Hyang Jung, Sang-Woo Lee
Received August 14, 2025  Accepted November 26, 2025  Published online March 4, 2026  
DOI: https://doi.org/10.3803/EnM.2025.2607    [Epub ahead of print]
  • 111 View
  • 10 Download
AbstractAbstract PDF
Background
This study investigated the prognostic value of bilaterality and multifocality in papillary thyroid carcinoma (PTC) recurrence, aiming to inform optimal surgical strategies.
Methods
In this retrospective cohort, 1,966 patients who underwent total thyroidectomy for PTC (2011–2014) were categorized into four groups according to tumor multifocality and bilaterality confirmed by postoperative histopathology: group 1, unilateral solitary; group 2, unilateral multifocal; group 3, bilateral solitary; group 4, bilateral multifocal. Clinicopathologic features and clinical outcomes were compared across these groups.
Results
Group 4 exhibited the highest prevalence of BRAFV600E positivity, nodal metastases, and recurrence. Both bilaterality and multifocality were associated with more aggressive clinicopathologic characteristics. Recurrence risk increased with the number of tumor foci, with the odds ratio (OR) significantly elevated for more than five foci. Satellite pattern was strongly linked to recurrence (OR, 19.49; P<0.001). While tumor multifocality (≥5 foci) and bilaterality were associated with recurrence in univariate analyses, these associations were not independent after adjustment. Kaplan-Meier analysis demonstrated the lowest recurrence-free survival (RFS) in group 4. Patients with bilateral disease had significantly lower RFS than those with unilateral disease (P=0.003), whereas multifocality did not significantly affect RFS compared to solitary disease (P=0.095).
Conclusion
Tumor bilaterality, multifocality (≥5 foci), and satellite pattern were associated with aggressive features and higher recurrence risk. Although not independent predictors, these factors may serve as useful surrogate markers of aggressive disease biology and help guide personalized surgical strategies in patients with PTC.
Close layer
Namgok Lecture 2025
Mineral, bone & muscle
Current Knowledge on Atypical Parathyroid Tumors and Emerging Strategies for Risk Stratification
Hye-Sun Park, Milim Kim, Jong Ju Jeong, Namki Hong, Yumie Rhee
Endocrinol Metab. 2026;41(1):14-25.   Published online January 7, 2026
DOI: https://doi.org/10.3803/EnM.2025.2846
  • 668 View
  • 41 Download
AbstractAbstract PDFPubReader   ePub   
Atypical parathyroid tumors (APTs) are an uncommon subset of parathyroid neoplasms that carry substantial clinical relevance because of their histological and clinical resemblance to parathyroid cancer. Despite this importance, the diagnosis of APTs remains persistently challenging, even for experienced pathologists. Their histopathological features overlap extensively with those of parathyroid cancer, and at present, no specific immunohistochemical markers are available that can reliably distinguish between these entities. Moreover, the clinical manifestations of APTs are indistinguishable from those of parathyroid adenomas or true parathyroid cancer. A major concern is the uncertain malignant potential of APTs, which contributes to difficulties in prognostic prediction and the absence of standardized surveillance guidelines. Although most published studies suggest a benign clinical course for the majority of APTs, these conclusions are frequently limited by relatively short follow-up durations. This limitation is underscored by several case reports describing recurrence or metastatic disease in patients initially diagnosed with APTs, subsequently prompting reclassification as parathyroid cancer. Recent advances in molecular technologies, particularly RNA sequencing and genomic profiling, have facilitated novel approaches to risk assessment and prognostic evaluation in APTs. This review aims to provide a comprehensive overview of the diagnosis, clinical manifestations, and current molecular strategies used to assess the malignant potential of APTs.
Close layer
Original Article
Global Burden of Early-Onset Cancers Attributable to Metabolic Risk Factors from 1990 to 2021 and Projections to 2040
Wenmei Qiao, Kaijian Zhou, Liang He, Jiahui Guo, Qiqiang Guo, Jing Zhang, Yongze Li
Received July 24, 2025  Accepted October 21, 2025  Published online January 5, 2026  
DOI: https://doi.org/10.3803/EnM.2025.2577    [Epub ahead of print]
  • 537 View
  • 20 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Early-onset cancers (diagnosed in individuals under 50 years of age) are increasingly contributing to the global cancer burden. Among the known contributors, specific metabolic risk factors—namely high body mass index (BMI) and high fasting plasma glucose (FPG)—have emerged as significant determinants. This study assessed the global burden of early-onset cancers attributable to these two metabolic risk factors and projected their trends through 2040.
Methods
Using data from the Global Burden of Disease 2021 study, we analyzed mortality, disability-adjusted life years (DALYs), and estimated annual percentage changes for early-onset cancers linked to metabolic risk factors, stratified by age, sex, and sociodemographic index (SDI). Future trends were projected based on these data.
Results
In 2021, the two metabolic risk factors (high FPG and high BMI) together accounted for 34,112 (95% uncertainty interval [UI], 15,037 to 54,888) deaths and 1,691,418 (95% UI, 762,923 to 2,698,657) DALYs from early-onset cancers, corresponding to mortality and DALY rates of 0.9 (95% UI, 0.4 to 1.4) and 42.8 (95% UI, 19.3 to 68.3) per 100,000 population, respectively. Between 1990 and 2021, both mortality and DALY rates rose significantly, with the greatest increases observed in individuals aged 30–34 years and in low-middle SDI regions. High FPG and high BMI were the leading contributors, with colorectal cancer showing the highest burden and liver cancer the most rapid growth. While high BMI predominated in most SDI regions, high FPG was more prominent in low-SDI countries, particularly among females. Projections indicate a continued rise in mortality and DALY rates through 2040.
Conclusion
High BMI and high FPG are major contributors to the global burden of early-onset cancers, with marked sex and socioeconomic disparities necessitating targeted interventions. Urgent strategies are required to mitigate metabolic risks and enhance early cancer detection, especially among vulnerable populations.
Close layer
Review Article
Thyroid
Diagnostic Challenges, Prognostic Assessment, and Treatment Strategies in High-Grade Differentiated Thyroid Carcinoma
Chan Kwon Jung, Agnes Stephanie Harahap
Endocrinol Metab. 2025;40(6):830-850.   Published online December 11, 2025
DOI: https://doi.org/10.3803/EnM.2025.2725
  • 1,382 View
  • 85 Download
AbstractAbstract PDFPubReader   ePub   
High-grade differentiated thyroid carcinoma (HGDTC) is a recently codified entity in the 2022 World Health Organization Classification of Endocrine Tumors, defined by a mitotic count of ≥5 mitoses per 2 mm² and/or tumor necrosis in a carcinoma that retains papillary, follicular, or oncocytic differentiation without anaplastic morphology. Although uncommon, HGDTC presents significant diagnostic and therapeutic challenges. This review summarizes current evidence regarding histopathologic recognition, molecular features, prognostic determinants, and evolving treatment paradigms. Particular attention is given to pattern-specific pitfalls such as high-grade papillary thyroid carcinoma, the diffuse sclerosing subtype, and the prognostic influence of the invasion phenotype (encapsulated versus infiltrative). Subcentimeter papillary carcinomas exhibiting increased mitotic activity alone should not be overinterpreted as HGDTC. An integrated, stepwise approach is proposed to enhance diagnostic reproducibility, refine risk stratification, and optimize multidisciplinary management in clinical practice.
Close layer
Original Articles
Diabetes, obesity and metabolism
Big Data Articles (National Health Insurance Service Database)
Joint Associations of the Geriatric Nutrition Risk Index and Frailty with All-Cause and Cause-Specific Mortality in Diabetes Patients: A Prospective Cohort Study
Chenke Gu, Qiuyue Jia, Youxiang Wang, Weikang Li, Suying Ding, Jingfeng Chen
Endocrinol Metab. 2025;40(6):916-927.   Published online November 17, 2025
DOI: https://doi.org/10.3803/EnM.2025.2441
  • 850 View
  • 46 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
This study investigated the independent and joint impacts of the geriatric nutritional risk index (GNRI) and frailty index (FI) on all-cause and cause-specific mortality in patients with diabetes.
Methods
This study included 1,790 National Health and Nutrition Examination Survey participants between 1999 and 2018. GNRI and FI were used to assess patients with diabetes, who were categorized into low GNRI and high GNRI groups, as well as low FI and high FI groups, to evaluate older adults’ nutritional status. These groups were combined into four categories. Weighted Cox proportional hazards models, Kaplan-Meier survival curves, and restricted cubic spline regression models were applied to assess the independent and joint associations of GNRI and FI with all-cause and cause-specific mortality in patients with diabetes.
Results
The median follow-up period was 100 months, during which 720 deaths occurred. An independent linear dose-response relationship between GNRI, FI, and all-cause mortality risk was observed. The combination of low GNRI and high FI was significantly associated with increased risk of all-cause mortality (hazard ratio, 1.65; 95% confidence interval [CI], 1.02 to 2.68) for the low GNRI+low FI group, 2.03 (95% CI, 1.61 to 2.55) for the high GNRI+high FI group, and 3.65 (95% CI, 2.38 to 5.58) for the low GNRI+high FI group. Stratified analysis (reference: high GNRI+low FI group) showed an increased mortality risk among men in the low GNRI+high FI group.
Conclusion
The combination of low GNRI and high FI was independently and jointly associated with increased risk of all-cause, cardiovascular disease, diabetes, and hypertension mortality, particularly among men.
Close layer
A Nomogram for End-Stage Renal Disease Prediction in Patients with Type 2 Diabetes Mellitus: A Nationwide Cohort Study in Korea
Inha Jung, Bong-Seong Kim, So Young Park, Da Young Lee, Ji Hee Yu, Ji A Seo, Kyung-Do Han, Nan Hee Kim
Received July 22, 2025  Accepted September 18, 2025  Published online November 12, 2025  
DOI: https://doi.org/10.3803/EnM.2025.2570    [Epub ahead of print]
  • 737 View
  • 38 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Despite the rising incidence of end-stage renal disease (ESRD) among individuals with type 2 diabetes mellitus (T2DM) in Korea, no predictive model or nomogram has been developed using a nationwide cohort. In this study, we developed a nomogram to predict the long-term risk of ESRD in patients with T2DM using a large-scale, population-based Korean database.
Methods
Using the Korean National Health Insurance Database, patients with T2DM who underwent health examinations between 2015 and 2016 were assigned as development (n=1,744,277) and validation (n=747,407) cohorts. New ESRD cases were identified using codes for renal replacement therapy. A Cox proportional hazards regression model was used to derive a risk-scoring system, and 13 variables were selected. A risk score nomogram was then created to estimate the risk of ESRD.
Results
In the development cohort, 8,631 patients with T2DM developed ESRD during a follow-up period of 4.8±0.9 years. After multivariable adjustment, significant predictors of ESRD included male sex, current smoking, physical inactivity, low income, low body mass index, hypertension, low-density lipoprotein cholesterol ≥160 mg/dL, chronic kidney disease, insulin use, and longer duration of T2DM. A final nomogram incorporating 13 variables was developed to estimate the individual probability of ESRD. The concordance index for ESRD prediction in the validation cohort was 0.906 (95% confidence interval, 0.9 to 0.912).
Conclusion
This 13-variable nomogram provides a simple tool for identifying patients with T2DM at high risk of ESRD and may aid in early intervention.
Close layer
Diabetes, obesity and metabolism
Big Data Articles (National Health Insurance Service Database)
Impact of Glucose Metabolism Status on the Association between Apolipoprotein A-I and Ischemic Risk in Patients with Coronary Artery Disease: A Large-Sample Cohort Study
Kailun Yan, Jiawen Li, Kexin Zhang, Menglu Liu, Pei Zhu, Xiaofang Tang, Deshan Yuan, Yuejin Yang, Runlin Gao, Jinqing Yuan, Xueyan Zhao
Endocrinol Metab. 2025;40(6):904-915.   Published online November 7, 2025
DOI: https://doi.org/10.3803/EnM.2025.2407
  • 827 View
  • 35 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Apolipoprotein A-I (ApoA-I) is a key cardioprotective lipoprotein. Nevertheless, it remains unclear how ApoA-I relates to ischemic risk across glucose metabolism statuses in patients with coronary artery disease (CAD). This study investigated whether glucose metabolism status influences the association between ApoA-I and ischemic risk in CAD patients.
Methods
This cohort study included 10,724 consecutive CAD patients undergoing percutaneous coronary intervention, who were classified into diabetes mellitus (DM), pre-DM, and normal glucose regulation (NGR) groups. The primary clinical endpoint was major adverse cardiac and cerebrovascular event (MACCE), defined as a composite of all-cause death, myocardial infarction, revascularization, and stroke.
Results
Of the 10,232 patients ultimately included, 2,139 (20.9%) experienced MACCE over 5 years. A significant interaction was observed between ApoA-I levels and glucose metabolism status (P for interaction=0.041). In the DM group, an L-shaped association between ApoA-I and MACCE was found, with lower ApoA-I levels linked to a higher risk of MACCE (P for non-linearity= 0.044). Multivariate Cox regression analysis showed that patients in the lowest quintile of ApoA-I had a 1.327-fold increased risk of MACCE compared to those at the lowest risk (hazard ratio, 1.327; 95% confidence interval, 1.097 to 1.604). However, no significant association was observed in the pre-DM or NGR groups (both P>0.05).
Conclusion
This large-scale, 5-year follow-up study is the first to demonstrate that lower ApoA-I levels are associated with increased MACCE risk in CAD patients with DM, highlighting the potential value of ApoA-I in risk stratification and as a therapeutic target.
Close layer
Review Articles
Mineral, bone & muscle
Incorporating Artificial Intelligence into Fracture Risk Assessment: Using Clinical Imaging to Predict the Unpredictable
Sung Hye Kong
Endocrinol Metab. 2025;40(4):499-507.   Published online August 4, 2025
DOI: https://doi.org/10.3803/EnM.2025.2518
  • 4,676 View
  • 112 Download
  • 1 Web of Science
  • 3 Crossref
AbstractAbstract PDFPubReader   ePub   
Artificial intelligence (AI) is increasingly being explored as a complementary tool to traditional fracture risk assessment methods. Conventional approaches, such as bone mineral density measurement and established clinical risk calculators, provide populationlevel stratification but often fail to capture the structural nuances of bone fragility. Recent advances in AI—particularly deep learning techniques applied to imaging—enable opportunistic screening and individualized risk estimation using routinely acquired radiographs and computed tomography (CT) data. These models demonstrate improved discrimination for osteoporotic fracture detection and risk prediction, supporting applications such as time-to-event modeling and short-term prognosis. CT- and radiograph-based models have shown superiority over conventional metrics in diverse cohorts, while innovations like multitask learning and survival plots contribute to enhanced interpretability and patient-centered communication. Nevertheless, challenges related to model generalizability, data bias, and automation bias persist. Successful clinical integration will require rigorous external validation, transparent reporting, and seamless embedding into electronic medical systems. This review summarizes recent advances in AI-driven fracture assessment, critically evaluates their clinical promise, and outlines a roadmap for translation into real-world practice.

Citations

Citations to this article as recorded by  
  • Quantitative CT Analysis for Predicting Hip Fragility Fracture Risk in Postmenopausal Women: A Value Assessment
    昭春 杜
    Advances in Clinical Medicine.2026; 16(01): 2897.     CrossRef
  • Advancements in ex vivo bone biomechanics: multimodal technologies and their integration with artificial intelligence
    Safa Unal, Mustafa Unal
    Methods.2026; 249: 48.     CrossRef
  • Diagnostic Value of Opportunistic CT-Based Bone Density Assessment in Patients with and Without Sacral Insufficiency Fractures
    Julian Ramin Andresen, Guido Schröder, Thomas Haider, Hans-Christof Schober, Reimer Andresen
    Diagnostics.2025; 15(22): 2926.     CrossRef
Close layer
Thyroid
The Initial Risk Stratification System for Differentiated Thyroid Cancer: Key Updates in the 2024 Korean Thyroid Association Guideline
Shinje Moon, Young Shin Song, Kyong Yeun Jung, Eun Kyung Lee, Jeongmin Lee, Dong-Jun Lim, Chan Kwon Jung, Young Joo Park, on Behalf of the Korean Thyroid Association Clinical Guideline Committee
Endocrinol Metab. 2025;40(3):357-384.   Published online June 24, 2025
DOI: https://doi.org/10.3803/EnM.2025.2465
  • 6,975 View
  • 222 Download
  • 3 Web of Science
  • 4 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
In 2024, the Korean Thyroid Association (KTA) introduced a revised Risk Stratification System (K-RSS) for differentiated thyroid cancer, building upon the modified RSS (M-RSS) proposed by the American Thyroid Association in 2015. The K-RSS emphasizes the cumulative impact of coexisting clinical and pathological features, acknowledging that multiple intermediate-risk factors collectively indicate a higher recurrence risk. Histologic classification follows the 2022 World Health Organization classification, consolidating encapsulated follicular-patterned thyroid carcinomas, including invasive encapsulated follicular variant papillary thyroid carcinoma, follicular thyroid carcinoma, and oncocytic carcinoma of the thyroid gland, and stratifying them by the extent of capsular and vascular invasion. High-grade thyroid carcinoma is newly included. Updated criteria for tumor size and extrathyroidal extension (ETE) represent another significant change. BRAFV600E-mutated papillary thyroid carcinomas measuring 1 to 2 cm are now considered lower risk than previously classified in the M-RSS, while encapsulated follicular-patterned tumors larger than 4 cm are considered higher risk. Both minimal ETE and gross ETE confined to the strap muscles have been downgraded to low and intermediate risk, respectively. These changes are accompanied by updates regarding molecular profiling and surgical margin status. Collectively, these updates aim to minimize overtreatment in low-risk patients, while ensuring intensified management for those at higher risk.

Citations

Citations to this article as recorded by  
  • Who Really Needs RAI Ablation Therapy for Low-to-Intermediate Risk Differentiated Thyroid Cancer? Insights from the IoN Trial
    Young Joo Park
    Clinical Thyroidology®.2025; 37(9): 323.     CrossRef
  • From Classification to Personalization: Advances in Thyroid Cancer Risk Stratification Systems
    Mijin Kim, Bo Hyun Kim
    Endocrinology and Metabolism.2025; 40(5): 689.     CrossRef
  • Thyroglobulin Cutoffs after Total Thyroidectomy Without Radioiodine in Low- to Intermediate-Risk Thyroid Cancer: A Multicenter Cohort Study
    Mijin Kim, Eun Kyung Lee, Kyeong Jin Kim, Soo Myoung Shin, Jinsun Jang, Je Yoon Shin, Meihua Jin, Ja Seong Bae, Kwangsoon Kim, Won Gu Kim, Min Ji Jeon, Seung Heon Kang, Hee Kyung Kim, Jee Hee Yoon, Yea Eun Kang, Hwa Young Ahn, Young Joo Park, Bo Hyun Kim
    Thyroid®.2025;[Epub]     CrossRef
  • Diagnostic Challenges, Prognostic Assessment, and Treatment Strategies in High-Grade Differentiated Thyroid Carcinoma
    Chan Kwon Jung, Agnes Stephanie Harahap
    Endocrinology and Metabolism.2025; 40(6): 830.     CrossRef
Close layer
Original Article
Diabetes, obesity and metabolism
Fatty Liver Index Dynamics as a Predictor of Hepatocellular Carcinoma in Patients with Type 2 Diabetes Mellitus and Non-Cirrhotic Livers
Eun-Hee Cho, Min Gu Kang, Chang Hun Lee, Shinyoung Oh, Chen Shen, Ha Ram Oh, Young Ran Park, Hyun Lee, Jong Seung Kim, Ji Hyun Park
Endocrinol Metab. 2025;40(6):883-892.   Published online May 29, 2025
DOI: https://doi.org/10.3803/EnM.2024.2286
  • 2,479 View
  • 107 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Type 2 diabetes mellitus (T2DM) is a significant risk factor for hepatocellular carcinoma (HCC) in patients with nonalcoholic fatty liver disease; however, surveillance strategies for patients with T2DM, especially without cirrhosis, are inadequate. This study examined whether the fatty liver index (FLI) and its dynamic changes can effectively identify patients with T2DM at increased risk for HCC.
Methods
Data from 92,761 individuals with T2DM aged 40 to 79 who underwent two health screenings (2012 to 2015) were analyzed. The FLI, calculated using waist circumference, body mass index, triglycerides, and gamma-glutamyl transferase, was used to stratify patients by baseline FLI and FLI changes between screenings. HCC cases were identified via International Classification of Diseases codes and reimbursement records (2016 to 2020).
Results
Patients with baseline FLI of 30 to 59.9 had a 1.90-fold higher risk (P<0.01) and those with FLI ≥60 had a 2.94-fold higher risk (P<0.01) of developing HCC compared to those with FLI <30. An increase in FLI from <30 to ≥30 resulted in a 2.10-fold higher risk of HCC (P<0.01), while a reduction in FLI from ≥30 to <30 led to a 0.64-fold lower risk (P=0.03). Protective benefits of FLI reduction took approximately 3 years to manifest.
Conclusion
Baseline and dynamic monitoring of FLI effectively identified HCC risk in T2DM patients with non-cirrhotic livers, supporting early detection and intervention.
Close layer
Review Article
Diabetes, obesity and metabolism
Prevalence and Current Status of Cardiometabolic Risk Factors in Korean Adults Based on Fact Sheets 2024
Eun-Jung Rhee
Endocrinol Metab. 2025;40(2):174-184.   Published online April 24, 2025
DOI: https://doi.org/10.3803/EnM.2025.2398
  • 4,375 View
  • 97 Download
  • 6 Web of Science
  • 7 Crossref
AbstractAbstract PDFPubReader   ePub   
Korea has entered ‘super-aged’ society in 2025 with the proportion of people 65 years or older exceeding 20% as of the end of the year 2024. The health burden of cardiovascular diseases increases with age, and the increasing prevalence of cardiovascular risk factors, such as obesity, hypertension, diabetes mellitus, and dyslipidemia, may be linked to increased population-level cardiovascular risk. According to data from 2022, the overall prevalence of obesity reached 38.4%, marking a continued upward trend, based on National Health Insurance medical checkup data. In the combined data of 2021 to 2022, the prevalence of diabetes was 15.5% in Koreans older than 30 years according to the Diabetes Fact Sheet 2024 published by the Korean Diabetes Association, based on data from the Korean National Health and Nutrition Examination Survey. The prevalence of hypertension in the total population of Korea in 2022 was 30% according to the Korean Hypertension Fact Sheet produced by the Korean Society of Hypertension. Lastly, the prevalence of dyslipidemia in 2022 was 40.9% according to the Dyslipidemia Fact Sheet published by the Korean Society of Lipid and Atherosclerosis. In this article, I would like to review the prevalence and current management of cardiovascular risk factors in Korea according to the fact sheets released by various associations in 2024.

Citations

Citations to this article as recorded by  
  • High incidence of eating disorders in individuals with type 2 diabetes and their association with cardiovascular and mortality risks
    So Hyun Cho, Seohyun Kim, Rosa Oh, Ji Yoon Kim, Myunghwa Jang, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Gyuri Kim, Jae Hyeon Kim
    Diabetologia.2026; 69(3): 653.     CrossRef
  • Epidemiology and characteristics of obesity in Koreans based on the 2024 Obesity Fact Sheet
    Eun-Jung Rhee
    Journal of the Korean Medical Association.2026; 69(1): 4.     CrossRef
  • 2024 Cardio-cerebrovascular disease fact sheet in Korea
    Kyungdo Han, Jin-Hyung Jung, Sang-Suk Choi, Seung-Hyun Ko
    Cardiovascular Prevention and Pharmacotherapy.2025; 7(3): 85.     CrossRef
  • Study of diastolic dysfunction in diabetic patients and its correlation with microalbuminuria
    Rishibha Kaushik, B. P. Priyadarshi, Lalit Kumar, Yuvraj Gulati, Madhuri Priyadarshi, S. K. Sinha
    International Journal of Advances in Medicine.2025; 12(5): 462.     CrossRef
  • Relationship Between Oral Function and Social Participation Among Community-Dwelling Older Adults: An Observational Cross-Sectional Study
    Mayu Takeda, Yuhei Matsuda, Takafumi Abe, Kazumichi Tominaga, Hisaaki Saito, Jun Shimizu, Norikuni Maeda, Ryouji Matsuura, Yukio Inoue, Yuichi Ando, Shozo Yano, Minoru Isomura, Takahiro Kanno
    Healthcare.2025; 13(18): 2271.     CrossRef
  • Cardiometabolic Risk Factors Among Adults in a Rural Amazonian Peruvian Population
    Miguel A. Arce-Huamani, Gustavo A. Caceres-Cuellar, Anyela Y. Guevara-Paz, Cleofe R. Lopez-Quispe, Abhely K. Barzola-Blancas, Valeria A. Cespedes-Atto, Catherine G. Acosta-Celis, Katherine Pérez-Acuña, Williams Carrascal-Astola, J. Smith Torres-Roman
    Medicina.2025; 61(12): 2206.     CrossRef
  • Longitudinal associations of serum Irisin and adiponectin with incident metabolic syndrome in middle-aged and older adults over three years
    Yejin Kim, Hong Ji Song, Dong-Hyun Kim, Jin-Young Jeong, Kyung Hee Park, Jwa-Kyung Kim, Hye-Mi Noh
    Scientific Reports.2025;[Epub]     CrossRef
Close layer
Original Articles
Thyroid
Prognostic Indicators and Comparative Treatment Outcomes in High-Risk Thyroid Cancer with Laryngotracheal Invasion
Eman A. Toraih, Jessan A. Jishu, Mohammad H. Hussein, Aly A. M. Shaalan, Manal S. Fawzy, Emad Kandil
Endocrinol Metab. 2025;40(2):201-215.   Published online January 22, 2025
DOI: https://doi.org/10.3803/EnM.2024.2033
  • 3,185 View
  • 104 Download
  • 1 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Laryngotracheal invasion occurs in a subset of patients with well-differentiated thyroid cancer (WDTC) and is associated with a poor prognosis. We aimed to analyze patterns and predictors/outcomes related to this high-risk manifestation.
Methods
This population-based analysis utilized the Surveillance, Epidemiology, and End Results (SEER) registry (2000 to 2015) to identify WDTC patients. Temporal trends and geographic variation in invasion rates were assessed. Logistic regression and propensity score matching were employed to identify predictors of secondary malignancy, mortality, and treatment impact on overall and thyroid cancer (TC)-specific survival.
Results
Of 131,721 WDTC patients, 1,662 (1.3%) had tracheal invasion and 976 (0.7%) had laryngeal invasion at diagnosis. Tracheal and laryngeal invasion rates declined from 3.7%–0.7% and 1.5%–0.6%, respectively, from 2000 to 2015. Compared to 98,835 noninvasive cases, patients with laryngotracheal invasion were older and more often male, Asian, and Hispanic (all P<0.001). This group had larger tumors with higher rates of nodal (N1: 61.8% vs. 15.1%) and distant metastases (M1: 9.3% vs. 0.4%). Age ≥55 years (hazard ratio [HR], 1.19; P=0.004) and metastases (HR, 1.75; P<0.001) increased TC-specific mortality, whereas the converse pattern was found for Asian race (HR, 0.63; P=0.002) and surgery (HR, 0.35; P<0.001). In rigorously matched groups to control confounding, adding radioactive iodine to surgery reduced mortality by 30% (P<0.001). However, external beam radiation and systemic therapy did not improve survival over surgery alone.
Conclusion
Laryngotracheal invasion is present in 0.7% to 1.3% of cases, conferring over double the mortality risk. Radioactive iodine with surgery improves outcomes in this aggressive WDTC subset.

Citations

Citations to this article as recorded by  
  • Thyroid cancer in Chinese military flight personnel: Characteristics and management advances
    Yan Wang, Jing Liu, Chun-Xia Zhang, Guo-Li Gu
    World Journal of Clinical Oncology.2026;[Epub]     CrossRef
Close layer
Thyroid
Big Data Articles (National Health Insurance Service Database)
Unveiling Risk Factors for Treatment Failure in Patients with Graves’ Disease: A Nationwide Cohort Study in Korea
Jung A Kim, Kyeong Jin Kim, Jimi Choi, Kyoung Jin Kim, Eyun Song, Ji Hee Yu, Nam Hoon Kim, Hye Jin Yoo, Ji A Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim
Endocrinol Metab. 2025;40(1):125-134.   Published online January 13, 2025
DOI: https://doi.org/10.3803/EnM.2024.2093
  • 4,378 View
  • 142 Download
  • 2 Web of Science
  • 2 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Antithyroid drug (ATD) treatment is the preferred initial treatment for Graves’ disease (GD) in South Korea, despite higher treatment failure rates than radioactive iodine (RAI) therapy or thyroidectomy. This study aimed to evaluate the incidence of treatment failure associated with the primary modalities for GD treatment in real-world practice.
Methods
We included 452,001 patients diagnosed with GD between 2004 and 2020 from the Korean National Health Insurance Service-National Health Information Database. Treatment failure was defined as switching from ATD, RAI, or thyroidectomy treatments, and for ATD specifically, inability to discontinue medication for over 2 years.
Results
Mean age was 46.2 years, with females constituting 70.8%. Initial treatments for GD included ATDs (98.0%), thyroidectomy (1.3%), and RAI (0.7%), with a noted increment in ATD application from 96.2% in 2004 to 98.8% in 2020. During a median follow- up of 8.5 years, the treatment failure rates were 58.5% for ATDs, 21.3% for RAI, and 2.1% for thyroidectomy. Multivariate analysis indicated that the hazard ratio for treatment failure with ATD was 2.81 times higher than RAI. RAI treatments ≥10 mCi had 37% lower failure rates than doses <10 mCi.
Conclusion
ATDs are the most commonly used for GD in South Korea, followed by thyroidectomy and RAI. Although the risk of treatment failure for ATD is higher than that of RAI therapy, initial RAI treatment in South Korea is relatively limited compared to that in Western countries. Further studies are required to evaluate the cause of low initial RAI treatment rates in South Korea.

Citations

Citations to this article as recorded by  
  • Treatment of Graves’ Disease: Faster Remission or Longer but Safe, That Is the Question
    Chan-Hee Jung
    Endocrinology and Metabolism.2025; 40(1): 70.     CrossRef
  • Process to radioactive iodine treatment for Graves’ hyperthyroidism: condemned or absolved?
    Luigi Bartalena, Daniela Gallo, George J. Kahaly, Eliana Piantanida, Maria Laura Tanda
    Journal of Endocrinological Investigation.2025; 48(9): 1927.     CrossRef
Close layer
Thyroid
Prevalence of Subclinical Hypothyroidism in a Non-Diabetic Young Female Population and Its Impact on Diabetes and Cardiometabolic Risk
Nawoda Hewage, Udaya Wijesekara, Rasika Perera
Endocrinol Metab. 2024;39(6):864-876.   Published online November 5, 2024
DOI: https://doi.org/10.3803/EnM.2024.2015
  • 3,867 View
  • 96 Download
  • 2 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
We evaluated the influence of subclinical hypothyroidism (SCH) on insulin resistance (IR), cardiometabolic risk, and obesity in childbearing-age women without diabetes.
Methods
This cross-sectional investigation included 282 women, aged 18 to 35 years, from rural and suburban Sri Lanka. Anthropometric and biochemical parameters, including IR and lipid/thyroid profiles, were recorded. Data were compared between SCH and euthyroidism (EU) for controls (normal weight) and cases (overweight/obese).
Results
The overall rates of SCH, EU, IR, and metabolic syndrome (MetS) were 40.42%, 59.57%, 73.40%, and 24.46%, respectively. Both controls and cases included individuals with SCH; overall, 168 participants (59.57%) had EU, while 114 (40.42%) exhibited SCH. IR was significantly associated with SCH in both weight groups (P<0.05). Among those with SCH, the odds ratios (ORs) for IR were >2 (95% confidence interval [CI], 0.45 to 3.87) in controls and >6 (95% CI, 3.52 to 8.41) in cases. Similarly, the ORs for MetS were >1 (95% CI, 0.38 to 4.16) in controls and >11 (95% CI, 8.73 to 15.01) in cases. Dyslipidemia and hypertriglyceridemia were significantly more prevalent in the SCH group (P<0.05). Women with SCH exhibited higher mean values for all obesity indices compared to their EU counterparts, surpassing normal thresholds (P<0.05). Among obesity measures, visceral adiposity index (VAI) demonstrated the highest area under the curve and sensitivity for assessing SCH and cardiovascular disease (CVD) risk.
Conclusion
SCH must be identified and managed in young women to help prevent diabetes and cardiometabolic disorders. VAI may aid in precisely detecting SCH and CVD.

Citations

Citations to this article as recorded by  
  • Increased Serum Lipopolysaccharide Levels are Related to a Higher Prevalent Risk of Subclinical Hypothyroidism
    Xuan An, Xiaoyi Wang, Jin Zhang, Mingtong Xu, Muchao Wu, Suraiya Saleem
    International Journal of Endocrinology.2025;[Epub]     CrossRef
  • Incidence of Subclinical Hypothyroidism in Obese Adults and Its Metabolic Implications: A Prospective Cohort Study
    Umer Jameel, Obaidullah Durrani, Ahmad Munib, Amanullah Khan
    Cureus.2025;[Epub]     CrossRef
Close layer
Thyroid
Small Multi-Gene DNA Panel Can Aid in Reducing the Surgical Resection Rate and Predicting the Malignancy Risk of Thyroid Nodules
Moon Young Oh, Hye-Mi Choi, Jinsun Jang, Heejun Son, Seung Shin Park, Minchul Song, Yoo Hyung Kim, Sun Wook Cho, Young Jun Chai, Woosung Chung, Young Joo Park
Endocrinol Metab. 2024;39(5):777-792.   Published online October 14, 2024
DOI: https://doi.org/10.3803/EnM.2024.2034
  • 4,226 View
  • 110 Download
  • 3 Web of Science
  • 4 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
We explored the utility of a small multi-gene DNA panel for assessing molecular profiles of thyroid nodules and influencing clinical decisions by comparing outcomes between tested and untested nodules.
Methods
Between April 2022 and May 2023, we prospectively performed fine-needle aspiration (FNA) with gene testing via DNA panel of 11 genes (BRAF, RAS [NRAS, HRAS, KRAS], EZH1, DICER1, EIF1AX, PTEN, TP53, PIK3CA, TERT promoter) in 278 consecutive nodules (panel group). Propensity score-matching (1:1) was performed with 475 nodules that consecutively underwent FNA without gene testing between January 2021 and December 2021 (control group).
Results
In the panel group, positive call rate for mutations was 41.7% (BRAF 16.2%, RAS 12.6%, others 11.5%, double mutation 1.4%) for all nodules, and 40.0% (BRAF 4.3%, RAS 19.1%, others 15.7%, double mutation 0.9%) for indeterminate nodules. Benign call rate was 69.8% for all nodules, and 75.7% for indeterminate nodules. In four nodules, additional TP53 (in addition to BRAF or EZH1) or PIK3CA (in addition to BRAF or TERT) mutations were co-detected. Sensitivity, specificity, positive predictive value, and negative predictive value were 80.0%, 53.3%, 88.1%, 38.1% for all nodules, and 78.6%, 45.5%, 64.7%, 62.5% for indeterminate nodules, respectively. Panel group exhibited lower surgical resection rates than the control group for all nodules (27.0% vs. 52.5%, P<0.001), and indeterminate nodules (23.5% vs. 68.2%, P<0.001). Malignancy risk was significantly different between the panel and control groups (81.5% vs. 63.9%, P=0.008) for all nodules.
Conclusion
Our panel aids in managing thyroid nodules by providing information on malignancy risk based on mutations, potentially reducing unnecessary surgery in benign nodules or patients with less aggressive malignancies.

Citations

Citations to this article as recorded by  
  • Integrative multi-omics refines the molecular subtypes of thyroid cancers and enhances cancer-progression prediction: a retrospective cohort study
    Yoo Hyung Kim, Joseph Wang, Jae-Kyung Won, Youngsoo Kim, Sun Wook Cho, Dohyun Han, Young Joo Park
    International Journal of Surgery.2026;[Epub]     CrossRef
  • Great Debate: Molecular Testing and Extent of Surgery in Well-Differentiated Thyroid Cancer
    Cord Sturgeon, Ashok R. Shaha, Linwah Yip
    Annals of Surgical Oncology.2025; 32(7): 4597.     CrossRef
  • Prediction of malignancy risk in Bethesda III nodules: development and validation of multiple machine learning models
    Wentian Li, Jiayu Zhu, Ying Wang, Jingxiu Li, Zhonghui Li, Cuicui Wang, Jingli Xue, Peng Zhou, Qingqing He
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Inside the Matrix: Integrated Cytology and Molecular Testing of Thyroid FNAC Samples Using a Commercial Synthetic 3D Scaffold
    Diana Raluca Streinu, Dana Liana Stoian, Octavian Constantin Neagoe, Mihnea Derban, Paula Diana Ciordas, Catalin Marian
    International Journal of Molecular Sciences.2025; 26(22): 11100.     CrossRef
Close layer
Thyroid
Dynamic Risk Model for the Medical Treatment of Graves’ Hyperthyroidism according to Treatment Duration
Meihua Jin, Chae A Kim, Min Ji Jeon, Won Bae Kim, Tae Yong Kim, Won Gu Kim
Endocrinol Metab. 2024;39(4):579-589.   Published online May 23, 2024
DOI: https://doi.org/10.3803/EnM.2024.1918
  • 6,061 View
  • 191 Download
  • 3 Web of Science
  • 3 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Changes in thyrotropin receptor antibody (TRAb) levels are associated with the clinical outcomes of Graves’ hyperthyroidism. However, the effects of the patterns of TRAb changes on patient prognosis according to the treatment duration of antithyroid drugs (ATDs) are not well established.
Methods
In this retrospective cohort study, 1,235 patients with Graves’ hyperthyroidism who were treated with ATDs for more than 12 months were included. Patients were divided into two groups according to treatment duration: group 1 (12–24 months) and group 2 (>24 months). Risk prediction models comprising age, sex, and either TRAb levels at ATD withdrawal (model A) or patterns of TRAb changes (model B) were compared.
Results
The median treatment duration in groups 1 (n=667, 54%) and 2 (n=568, 46%) was 17.3 and 37.1 months, respectively. The recurrence rate was significantly higher in group 2 (47.9%) than in group 1 (41.4%, P=0.025). Group 2 had significantly more goiter, thyroid eye disease, and fluctuating and smoldering type of TRAb pattern compared with group 1 (all P<0.001). The patterns of TRAb changes were an independent risk factor for recurrence after adjusting for other confounding factors in all patients, except in group 1. Integrated discrimination improvement and net reclassification improvement analyses showed that model B performed better than model A in all patients, except in group 1.
Conclusion
The dynamic risk model, including the patterns of TRAb changes, was more suitable for predicting prognosis in patients with Graves’ hyperthyroidism who underwent longer ATD treatment duration.

Citations

Citations to this article as recorded by  
  • Integrating shear wave elastography into clinical prediction of Graves’ disease recurrence: a novel risk scoring system
    Xiao-Yun Zha, Ze-Hong Xu, Jia-Jia Dong, Liang-Xiao Xie, Peng-Bin Lai, Chang-Shun Wei, Hua-Qiang Zheng, Duo-Bin Huang, Jin-Zhi Wu
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Risk factors and outcomes of Graves’ orbitopathy after radioactive iodine therapy
    Hwa Young Ahn, Jooyoung Lee, Mina Kim, Jeong Kyu Lee
    Endocrine.2025; 90(1): 248.     CrossRef
  • High TRAb Titer at Diagnosis Predicts Persistent Positivity and Relapse in Graves’ Disease after Prolonged Antithyroid Therapy
    Zimiao Chen, Jinglu Xu, Wenrui Kang, Yang Zhang, Rujun Chen, Xiaohua Gong
    Endocrinology and Metabolism.2025; 40(6): 950.     CrossRef
Close layer
Thyroid
Active Surveillance for Low-Risk Papillary Thyroid Carcinoma as an Acceptable Management Option with Additional Benefits: A Comprehensive Systematic Review
Jee Hee Yoon, Wonsuk Choi, Ji Yong Park, A Ram Hong, Hee Kyung Kim, Ho-Cheol Kang
Endocrinol Metab. 2024;39(1):152-163.   Published online January 22, 2024
DOI: https://doi.org/10.3803/EnM.2023.1794
  • 9,253 View
  • 241 Download
  • 10 Web of Science
  • 11 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Active surveillance (AS) has been introduced as a management strategy for low-risk papillary thyroid carcinoma (PTC) due to its typically indolent nature. Despite this, the widespread adoption of AS has encountered several challenges. The aim of this systematic review was to evaluate the safety of AS related to disease progression and its benefits compared with immediate surgery (IS).
Methods
Studies related to AS in patients with low-risk PTC were searched through the Ovid MEDLINE, Embase, Cochrane Library, and KoreaMed databases. Studies on disease progression, surgical complication, quality of life (QoL), and cost-effectiveness were separately analyzed and narratively synthesized.
Results
In the evaluation of disease progression, the proportions of cases with tumor growth ≥3 mm and a volume increase >50% were 2.2%–10.8% and 16.0%–25.5%, respectively. Newly detected lymph node metastasis was identified in 0.0%–1.4% of patients. No significant difference was found between IS and delayed surgery in surgical complications, including vocal cord paralysis and postoperative hypoparathyroidism. AS was associated with better QoL than IS. Studies on the cost-effectiveness of AS reported inconsistent data, but AS was more cost-effective when quality-adjusted life years were considered.
Conclusion
AS is an acceptable management option for patients with low-risk PTC based on the low rate of disease progression and the absence of an increased mortality risk. AS has additional benefits, including improved QoL and greater QoL-based cost-effectiveness.

Citations

Citations to this article as recorded by  
  • Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer: Protocol of a Multicenter Cluster-Randomized Trial (MAeSTro-SDM)
    Eun Kyung Lee, Min Joo Kim, Yul Hwangbo, Jae Hoon Moon, Sun Wook Cho, Young Jun Chai, June Young Choi, Yuh-Seog Jung, Kyu Eun Lee, Eun-Jae Chung, Kyungsik Kim, Su-jin Kim, Woochul Kim, Yoo Hyung Kim, Young Ki Lee, Jinsun Jang, Young Shin Song, Ka Hee Yi,
    Journal of Korean Medical Science.2026;[Epub]     CrossRef
  • Thyroid Nodules: Past, Present, and Future
    Alan A. Parsa, Hossein Gharib
    Endocrine Practice.2025; 31(1): 114.     CrossRef
  • Approach to the Patient With Thyroid Cancer: Selection and Management of Candidates for Lobectomy
    Eyal Robenshtok, Gideon Bachar, Amit Ritter
    The Journal of Clinical Endocrinology & Metabolism.2025; 110(7): e2327.     CrossRef
  • Navigating Active Surveillance for Low-Risk PTMC by Standardizing Ultrasound Evaluation: Key Takeaways from the Latest Korean Society of Thyroid Radiology Consensus Statements
    Young Joo Park
    Clinical Thyroidology®.2025; 37(1): 27.     CrossRef
  • 2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma
    Eun Kyung Lee, Min Joo Kim, Seung Heon Kang, Bon Seok Koo, Kyungsik Kim, Mijin Kim, Bo Hyun Kim, Ji-hoon Kim, Shin Je Moon, Kyorim Back, Young Shin Song, Jong-hyuk Ahn, Hwa Young Ahn, Ho-Ryun Won, Won Sang Yoo, Min Kyoung Lee, Jeongmin Lee, Ji Ye Lee, Kyo
    International Journal of Thyroidology.2025; 18(1): 30.     CrossRef
  • Global research landscape on active surveillance for papillary thyroid microcarcinoma: a bibliometric analysis
    Dong-Shu Kang, Yu-Hao Lin, Jian-Qing Tian
    Discover Oncology.2025;[Epub]     CrossRef
  • Novel Technologies and Treatment Strategies in Thyroid Cancer Surgery
    David Z. Allen, Mark Zafereo
    Endocrinology and Metabolism Clinics of North America.2025; 54(3): 377.     CrossRef
  • 2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma
    Eun Kyung Lee, Min Joo Kim, Seung Heon Kang, Bon Seok Koo, Kyungsik Kim, Mijin Kim, Bo Hyun Kim, Ji-hoon Kim, Shinje Moon, Kyorim Back, Young Shin Song, Jong-hyuk Ahn, Hwa Young Ahn, Ho-Ryun Won, Won Sang Yoo, Min Kyoung Lee, Jeongmin Lee, Ji Ye Lee, Kyon
    Endocrinology and Metabolism.2025; 40(3): 307.     CrossRef
  • Risk factors for lateral neck lymph node metastasis in papillary thyroid ultra micro carcinoma with implications for active surveillance
    Hyeung Kyoo Kim, Ho Jung Jeong, Jin Seok Lee, Soo Young Kim, Yong Sang Lee, Hang-Seok Chang
    Scientific Reports.2025;[Epub]     CrossRef
  • From screening to follow-up: a review of quality of life and psychological status across the clinical care continuum in patients with differentiated thyroid cancer
    Zifeng Kuang, Hao Zhao, Chenjia Zhang, Xiaoyi Li
    Frontiers in Psychology.2025;[Epub]     CrossRef
  • It Is Time to Understand the Additional Benefits of Active Surveillance for Low-Risk Papillary Thyroid Carcinoma
    Kyeong Jin Kim
    Endocrinology and Metabolism.2024; 39(1): 95.     CrossRef
Close layer
Diabetes, obesity and metabolism
Triglyceride-Glucose Index Predicts Future Atherosclerotic Cardiovascular Diseases: A 16-Year Follow-up in a Prospective, Community-Dwelling Cohort Study
Joon Ho Moon, Yongkang Kim, Tae Jung Oh, Jae Hoon Moon, Soo Heon Kwak, Kyong Soo Park, Hak Chul Jang, Sung Hee Choi, Nam H. Cho
Endocrinol Metab. 2023;38(4):406-417.   Published online August 3, 2023
DOI: https://doi.org/10.3803/EnM.2023.1703
  • 19,296 View
  • 346 Download
  • 34 Web of Science
  • 29 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
While the triglyceride-glucose (TyG) index is a measure of insulin resistance, its association with cardiovascular disease (CVD) has not been well elucidated. We evaluated the TyG index for prediction of CVDs in a prospective large communitybased cohort.
Methods
Individuals 40 to 70 years old were prospectively followed for a median 15.6 years. The TyG index was calculated as the Ln [fasting triglycerides (mg/dL)×fasting glucose (mg/dL)/2]. CVDs included any acute myocardial infarction, coronary artery disease or cerebrovascular disease. We used a Cox proportional hazards model to estimate CVD risks according to quartiles of the TyG index and plotted the receiver operating characteristics curve for the incident CVD.
Results
Among 8,511 subjects (age 51.9±8.8 years; 47.5% males), 931 (10.9%) had incident CVDs during the follow-up. After adjustment for age, sex, body mass index, diabetes mellitus, hypertension, total cholesterol, smoking, alcohol, exercise, and C-reactive protein, subjects in the highest TyG quartile had 36% increased risk of incident CVD compared with the lowest TyG quartile (hazard ratio, 1.36; 95% confidence interval, 1.10 to 1.68). Carotid plaque, assessed by ultrasonography was more frequent in subjects in the higher quartile of TyG index (P for trend=0.049 in men and P for trend <0.001 in women). The TyG index had a higher predictive power for CVDs than the homeostasis model assessment of insulin resistance (HOMA-IR) (area under the curve, 0.578 for TyG and 0.543 for HOMA-IR). Adding TyG index on diabetes or hypertension alone gave sounder predictability for CVDs.
Conclusion
The TyG index is independently associated with future CVDs in 16 years of follow-up in large, prospective Korean cohort.

Citations

Citations to this article as recorded by  
  • Elevated triglyceride-glucose index as a predictor of carotid plaque incidence: Insights from a comprehensive meta-analysis
    Arankesh Mahadevan, Bhavin A. Patel, Sashwath Srikanth, Raja Godasi, Rupak Desai
    The American Journal of the Medical Sciences.2025; 369(2): 197.     CrossRef
  • Analysis of the correlation between the serum triglyceride glucose index and the risk of death in patients on maintenance hemodialysis: a retrospective cohort study
    Xiaokeng Chi, Shuxin Chen, Zhe Huang, Rong Zhou, Zhicheng Su, Qiujun Mai, Yilin Xu, Jianxin Wan
    PeerJ.2025; 13: e18781.     CrossRef
  • Assessing the predictive value of elevated triglycerides, triglyceride-glucose index (TyG), and TG/HDL ratios for cardiovascular disease and mortality during 20 years of follow-up: Tehran lipid and glucose study
    Shayesteh Khalili, Atieh Amouzegar, Seyed Sattar Dorost, Fereidoun Azizi, Aryan Salahi-Niri
    Clinical Biochemistry.2025; 136: 110891.     CrossRef
  • Association between triglyceride-glucose index and carotid atherosclerosis in Chinese steelworkers: a cross-sectional study
    Haoyue Cao, Qinglin Li, Juxiang Yuan
    Scientific Reports.2025;[Epub]     CrossRef
  • Association between the triglyceride-glucose index and silent myocardial infarction in the general population
    Min Dai, Dongze Li, Jing Yu, Yi Liu, Qin Zhang, Wei Zhang, Yan Zhong, Zhi Wan, Menglin Tang, Yongli Gao, Li Rao
    Scientific Reports.2025;[Epub]     CrossRef
  • Integrative Multi‐Omics and Routine Blood Analysis Using Deep Learning: Cost‐Effective Early Prediction of Chronic Disease Risks
    Zhibin Dong, Pei Li, Yi Jiang, Zhihan Wang, Shihui Fu, Hebin Che, Meng Liu, Xiaojing Zhao, Chunlei Liu, Chenghui Zhao, Qin Zhong, Chongyou Rao, Siwei Wang, Suyuan Liu, Dayu Hu, Dongjin Wang, Juntao Gao, Kai Guo, Xinwang Liu, En Zhu, Kunlun He
    Advanced Science.2025;[Epub]     CrossRef
  • Impact of steatotic liver disease categories on atrial fibrillation in type 2 diabetes: a nationwide study
    So Hyun Cho, Gyuri Kim, Kyu-na Lee, Rosa Oh, Ji Yoon Kim, Myunghwa Jang, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Kyungdo Han, Jae Hyeon Kim
    Scientific Reports.2025;[Epub]     CrossRef
  • The Triglyceride-Glucose Index and Risk of End-Stage Renal Disease across Different Durations of Type 2 Diabetes Mellitus: A Longitudinal Cohort Study
    Mi-sook Kim, Kyu-Na Lee, Jeongmin Lee, Jeongeun Kwak, Seung-Hwan Lee, Hyuk-Sang Kwon, Jing Hughes, Kyung-Do Han, Eun Young Lee
    Endocrinology and Metabolism.2025; 40(5): 718.     CrossRef
  • Associations Between Novel Lipid Indicators and the Risk of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes
    Yazhi Wang, Mingkang Zhang, Peng Wang
    Lipids.2025; 60(6): 407.     CrossRef
  • The triglyceride-glucose index, a marker of insulin resistance, as a predictor of thrombotic risk in atrial fibrillation
    José Miguel Rivera-Caravaca, Eva Soler-Espejo, María Pilar Ramos-Bratos, Raquel López-Gálvez, Eduardo González-Lozano, Gregory Y. H. Lip, Francisco Marín, Vanessa Roldán
    Cardiovascular Diabetology.2025;[Epub]     CrossRef
  • The Impact of Triglyceride-Glucose Index Trajectories on Incidence and Recurrent Cardiovascular Events: Evidence from a Retrospective Cohort Study
    Yuan Xu, Gonglong Wu, Long Jiang, Xinlei Yang, Chengjin Wen, Yulan Yang, Hui Hu
    Vascular Health and Risk Management.2025; Volume 21: 557.     CrossRef
  • Association between the Triglyceride-Glucose Index and Cardiovascular Risk and Mortality across Different Diabetes Durations: A Nationwide Cohort Study
    Jeongeun Kwak, Kyung-Do Han, Eun Young Lee, Seung-Hwan Lee, Dong-Jun Lim, Hyuk-Sang Kwon, Jeongmin Lee
    Endocrinology and Metabolism.2025; 40(4): 548.     CrossRef
  • Does diabetes status modify the association between the triglyceride-glucose index and major adverse cardiovascular events in patients with coronary heart disease? A systematic review and meta-analysis of longitudinal cohort studies
    Shicong Xu, Zhihui Zhang, Jing Li, Yiyan Ding, Yuanguo Chen, Yunxia Zhou, Shenglin Hu
    Cardiovascular Diabetology.2025;[Epub]     CrossRef
  • Predictive performance of traditional and novel anthropometric indices for diabetes and hypertension
    Mozhgan Pezeshki, Shirin Esmaeili, Armita Mahdavi‐Gorabi, Tahereh Sadegi, Zahra Farhad Kiaee, Omid Assar, Kiavash Semnani, Mostafa Qorbani
    Journal of Diabetes Investigation.2025; 16(12): 2213.     CrossRef
  • Asociación del Índice de triglicéridos-glucosa (Índice TyG) y el riesgo cardiovascular en docentes de educación superior.
    Luiggi Oscar Solano-Maza, Jhon Bryan Mina-Ortiz, Anita María Murillo-Zavala, Karina Maricela Merchán-Villafuerte
    Innova Science Journal.2025; 3(4): 397.     CrossRef
  • Association of the triglyceride-glucose index with cardiovascular outcomes across cardiovascular-kidney-metabolic syndrome stages
    Byung Sik Kim, Hyun-Jin Kim, Shinje Moon, Hasung Kim, Jungkuk Lee, Jeong-Hun Shin
    The Korean Journal of Internal Medicine.2025; 40(6): 961.     CrossRef
  • Association between the triglyceride-glucose index and carotid plaque progression in patients with type 2 diabetes mellitus: a retrospective cohort study
    Zhangxiang Zhu, Xuan Xu, Guojuan Wang, Qianqian Zhang, Ying Li, Jun Zhu, Li Chen, Qibao Ye, Mingwei Chen
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Associations Between Serum Selenium, Zinc, and Copper Levels and Cognitive Function in the Elderly
    Piangporn Charernwat, Sirintorn Chansirikarnjana, Pachara Panpunuan, Piyamitr Sritara, Jintana Sirivarasai
    Nutrients.2025; 17(24): 3872.     CrossRef
  • Construction and validation of a nomogram for predicting diabetes remission at 3 months after bariatric surgery in patients with obesity combined with type 2 diabetes mellitus
    Kaisheng Yuan, Bing Wu, Ruiqi Zeng, Fuqing Zhou, Ruixiang Hu, Cunchuan Wang
    Diabetes, Obesity and Metabolism.2024; 26(1): 169.     CrossRef
  • Association between the triglyceride glucose index and chronic total coronary occlusion: A cross-sectional study from southwest China
    Kaiyong Xiao, Huili Cao, Bin Yang, Zhe Xv, Lian Xiao, Jianping Wang, Shuiqing Ni, Hui Feng, Zhongwei He, Lei Xv, Juan Li, Dongmei Xv
    Nutrition, Metabolism and Cardiovascular Diseases.2024; 34(4): 850.     CrossRef
  • The association between TyG and all-cause/non-cardiovascular mortality in general patients with type 2 diabetes mellitus is modified by age: results from the cohort study of NHANES 1999–2018
    Younan Yao, Bo Wang, Tian Geng, Jiyan Chen, Wan Chen, Liwen Li
    Cardiovascular Diabetology.2024;[Epub]     CrossRef
  • Comparison of triglyceride glucose index and modified triglyceride glucose indices in prediction of cardiovascular diseases in middle aged and older Chinese adults
    Cancan Cui, Yitian Qi, Jiayin Song, Xinyun Shang, Tianjiao Han, Ning Han, Siqi Yue, Yining Zha, Zhonghang Xu, Jiannan Li, Lin Liu
    Cardiovascular Diabetology.2024;[Epub]     CrossRef
  • Triglyceride-glucose index predicts type 2 diabetes mellitus more effectively than oral glucose tolerance test-derived insulin sensitivity and secretion markers
    Min Jin Lee, Ji Hyun Bae, Ah Reum Khang, Dongwon Yi, Mi Sook Yun, Yang Ho Kang
    Diabetes Research and Clinical Practice.2024; 210: 111640.     CrossRef
  • Prognostic value of triglyceride-glucose index for left ventricular remodeling in nondiabetic ST-elevation myocardial infarction patients
    Tolga Han Efe, Engin Algül
    Biomarkers in Medicine.2024; 18(6): 243.     CrossRef
  • Triglyceride-Glucose Index as Predictor for Hypertension, CHD and STROKE Risk among Non-Diabetic Patients: A NHANES Cross-Sectional Study 2001–2020
    Bisher Sawaf, Sarya Swed, Hidar Alibrahim, Haidara Bohsas, Tirth Dave, Mohamad Nour Nasif, Wael Hafez, Fatema Ali Asgar Tashrifwala, Yazan Khair Eldien Jabban, Safwan Al-Rassas, Heba haj Saleh, Abdul Rehman Zia Zaidi, Baraa Alghalyini, Shaymaa Abdelmaboud
    Journal of Epidemiology and Global Health.2024; 14(3): 1152.     CrossRef
  • An Increasing Triglyceride–Glucose Index Is Associated with a Pro-Inflammatory and Pro-Oxidant Phenotype
    Beverley Adams-Huet, Ishwarlal Jialal
    Journal of Clinical Medicine.2024; 13(13): 3941.     CrossRef
  • Inflammatory and Metabolic Predictors of Mortality in Pulmonary Thromboembolism: A Focus on the Triglyceride–Glucose Index and Pan-Immune Inflammation Value
    Murat Bilgin, Emre Akkaya, Recep Dokuyucu
    Journal of Clinical Medicine.2024; 13(19): 6008.     CrossRef
  • The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes
    Verena Gounden, Sridevi Devaraj, Ishwarlal Jialal
    Lipids in Health and Disease.2024;[Epub]     CrossRef
  • Evaluation of the novel three lipid indices for predicting five- and ten-year incidence of cardiovascular disease: findings from Kerman coronary artery disease risk factors study (KERCADRS)
    Alireza Jafari, Hamid Najafipour, Mitra Shadkam, Sina Aminizadeh
    Lipids in Health and Disease.2023;[Epub]     CrossRef
Close layer
Diabetes, Obesity and Metabolism
Big Data Articles (National Health Insurance Service Database)
Predicting the Risk of Insulin-Requiring Gestational Diabetes before Pregnancy: A Model Generated from a Nationwide Population-Based Cohort Study in Korea
Seung-Hwan Lee, Jin Yu, Kyungdo Han, Seung Woo Lee, Sang Youn You, Hun-Sung Kim, Jae-Hyoung Cho, Kun-Ho Yoon, Mee Kyoung Kim
Endocrinol Metab. 2023;38(1):129-138.   Published online January 27, 2023
DOI: https://doi.org/10.3803/EnM.2022.1609
  • 6,456 View
  • 205 Download
  • 6 Web of Science
  • 7 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
The severity of gestational diabetes mellitus (GDM) is associated with adverse pregnancy outcomes. We aimed to generate a risk model for predicting insulin-requiring GDM before pregnancy in Korean women.
Methods
A total of 417,210 women who received a health examination within 52 weeks before pregnancy and delivered between 2011 and 2015 were recruited from the Korean National Health Insurance database. The risk prediction model was created using a sample of 70% of the participants, while the remaining 30% were used for internal validation. Risk scores were assigned based on the hazard ratios for each risk factor in the multivariable Cox proportional hazards regression model. Six risk variables were selected, and a risk nomogram was created to estimate the risk of insulin-requiring GDM.
Results
A total of 2,891 (0.69%) women developed insulin-requiring GDM. Age, body mass index (BMI), current smoking, fasting blood glucose (FBG), total cholesterol, and γ-glutamyl transferase were significant risk factors for insulin-requiring GDM and were incorporated into the risk model. Among the variables, old age, high BMI, and high FBG level were the main contributors to an increased risk of insulin-requiring GDM. The concordance index of the risk model for predicting insulin-requiring GDM was 0.783 (95% confidence interval, 0.766 to 0.799). The validation cohort’s incidence rates for insulin-requiring GDM were consistent with the risk model’s predictions.
Conclusion
A novel risk engine was generated to predict insulin-requiring GDM among Korean women. This model may provide helpful information for identifying high-risk women and enhancing prepregnancy care.

Citations

Citations to this article as recorded by  
  • Developing a Risk Stratification Tool to Predict Patients with Gestational Diabetes Mellitus at Risk of Insulin Treatment: A Cohort Study
    Xi Yang, Hannah L. Nathan, Ebruba E. Oyekan, Tim I. M. Korevaar, Doaa Ahmed, Katherine Pacifico, Aisha Hameed, Manju Chandiramani, Anita Banerjee, Caroline Ovadia
    Journal of Personalized Medicine.2025; 15(6): 223.     CrossRef
  • Individual Prediction of Insulin Therapy in Gestational Diabetes: Development of a Risk Calculator Based on Real-World Data from the GestDiab Registry
    Friederike Weschenfelder, Barbara Dusek, Heinke Adamczewski, Dietmar Weber, Matthias Kaltheuner, Yvonne Heimann, Tanja Groten
    Geburtshilfe und Frauenheilkunde.2025; 85(12): 1334.     CrossRef
  • Establishment and validation of a nomogram to predict the neck contracture after skin grafting in burn patients: A multicentre cohort study
    Rui Li, Yangyang Zheng, Xijuan Fan, Zilong Cao, Qiang Yue, Jincai Fan, Cheng Gan, Hu Jiao, Liqiang Liu
    International Wound Journal.2023; 20(9): 3648.     CrossRef
  • Predicting the Need for Insulin Treatment: A Risk-Based Approach to the Management of Women with Gestational Diabetes Mellitus
    Anna S. Koefoed, H. David McIntyre, Kristen S. Gibbons, Charlotte W. Poulsen, Jens Fuglsang, Per G. Ovesen
    Reproductive Medicine.2023; 4(3): 133.     CrossRef
  • Prepregnancy Glucose Levels Within Normal Range and Its Impact on Obstetric Complications in Subsequent Pregnancy: A Population Cohort Study
    Ho Yeon Kim, Ki Hoon Ahn, Geum Joon Cho, Soon-Cheol Hong, Min-Jeong Oh, Hai-Joong Kim
    Journal of Korean Medical Science.2023;[Epub]     CrossRef
  • Risk of Cause-Specific Mortality across Glucose Spectrum in Elderly People: A Nationwide Population-Based Cohort Study
    Joonyub Lee, Hun-Sung Kim, Kee-Ho Song, Soon Jib Yoo, Kyungdo Han, Seung-Hwan Lee
    Endocrinology and Metabolism.2023; 38(5): 525.     CrossRef
  • The CHANGED Score—A New Tool for the Prediction of Insulin Dependency in Gestational Diabetes
    Paul Rostin, Selina Balke, Dorota Sroka, Laura Fangmann, Petra Weid, Wolfgang Henrich, Josefine Theresia Königbauer
    Journal of Clinical Medicine.2023; 12(22): 7169.     CrossRef
Close layer
Diabetes, Obesity and Metabolism
Big Data Articles (National Health Insurance Service Database)
Association among Current Smoking, Alcohol Consumption, Regular Exercise, and Lower Extremity Amputation in Patients with Diabetic Foot: Nationwide Population-Based Study
Yoon Jae Lee, Kyung-Do Han, Jun Hyeok Kim
Endocrinol Metab. 2022;37(5):770-780.   Published online October 12, 2022
DOI: https://doi.org/10.3803/EnM.2022.1519
  • 9,424 View
  • 259 Download
  • 13 Web of Science
  • 14 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
The present study investigates whether modifiable behavioral factors of current cigarette smoking, heavy alcohol consumption, and regular exercise are associated with risk of lower extremity amputation (LEA) in diabetic patients.
Methods
A total of 2,644,440 diabetic patients (aged ≥20 years) was analyzed using the database of the Korean National Health Insurance Service. Cox proportional hazard regression was used to assess adjusted hazard ratios (HRs) for the behavioral factors with risk of LEA under adjustment for potential confounders.
Results
The risk of LEA was significantly increased by current cigarette smoking and heavy alcohol consumption (HR, 1.436; 95% confidence interval [CI], 1.367 to 1.508 and HR, 1.082; 95% CI, 1.011 to 1.158) but significantly decreased with regular exercise (HR, 0.745; 95% CI, 0.706 to 0.786) after adjusting for age, sex, smoking, alcohol consumption, exercise, low income, hypertension, dyslipidemia, body mass index, using insulin or oral antidiabetic drugs, and diabetic duration. A synergistically increased risk of LEA was observed with larger number of risky behaviors.
Conclusion
Modification of behaviors of current smoking, heavy alcohol intake, and exercise prevents LEA and can improve physical, emotional, and social quality of life in diabetic patients.

Citations

Citations to this article as recorded by  
  • Fatores associados à amputação de membros inferiores em pacientes diabéticos: uma abordagem epidemiológica
    Edimar Chaves Junior, Ana Clara Paulino Queiroz, Arthur Felipe Vieira Bastos, Isadora Borges Toledo, Jessica Coelho Costa, Julien Barbosa, Lilian Nunes de Assis Lacerda, Marcos Bruno Couto Garcia, Maria Eduarda Avelina Bontempo, Maria Eduarda Mendes Reis,
    Caderno Pedagógico.2025; 22(1): e13493.     CrossRef
  • Are There Sex Differences in the Association of Alcohol Consumption With the Risk of Soft Tissue Sarcoma? A Nationwide Population-based Study in Korea
    Min Wook Joo, Kyungdo Han, Yoon Joo Cho, Nicholas Matthew Bernthal, Ye Bin Park
    Clinical Orthopaedics & Related Research.2025; 483(9): 1583.     CrossRef
  • Knowledge, attitudes, and practices among patients with diabetic foot ulcers towards disease management
    Liangxiao Xie, Changshun Wei, Liqun Chen, Huaqiang Zheng, Jiajia Dong, Jinzhi Wu
    Scientific Reports.2025;[Epub]     CrossRef
  • Diabetes‐Associated Major Limb Amputation in Solomon Islands: A National, 5‐Year Retrospective Study
    Dylan M. Bush, Adrian Garcia Hernandez, Anita Pickard, Thomas H. Fitzpatrick, Rooney Jagilly, Micky Olangi, Michael Buin, Johanna Roth, Hendrick Kaniki, Jones Ghabu, Tony Quity, Alexandra L. Martiniuk
    World Journal of Surgery.2025; 49(8): 2266.     CrossRef
  • The Severity of Diabetes and the Risk of Diabetic Foot Amputation: A National Cohort Study
    Jin Yu, Ji-Hyun Kim, Bongseong Kim, Kyungdo Han, Seung Hwan Lee, Mee Kyoung Kim
    Endocrinology and Metabolism.2025; 40(4): 574.     CrossRef
  • Nationwide study of income-based disparities in diabetic limb preservation in South Korea
    Yoon Jae Lee, Kyung-Do Han, Jun Hyeok Kim
    Scientific Reports.2025;[Epub]     CrossRef
  • Adjuvant effect of antimicrobial photodynamic therapy (aPDT) in the treatment of diabetic foot ulcers: A case series
    Rita de Cassia Ferreira, Rebeca Boltes Cecatto, Silvana Torres Perez, Raquel Agnelli Mesquita‐Ferrari, Sandra Kalil Bussadori, Cinthya Cosme Duran, Anna Carolina Tempestini Horliana, Kristianne Porta Santos Fernandes
    Journal of Biophotonics.2024;[Epub]     CrossRef
  • Factors associated with diabetic foot ulcers and lower limb amputations in type 1 and type 2 diabetes supported by real‐world data from the German/Austrian DPV registry
    Alexander J. Eckert, Stefan Zimny, Marcus Altmeier, Ana Dugic, Anton Gillessen, Latife Bozkurt, Gabriele Götz, Wolfram Karges, Frank J. Wosch, Stephan Kress, Reinhard W. Holl
    Journal of Diabetes.2024;[Epub]     CrossRef
  • Patients with diabetic foot ulcers: A qualitative study of patient knowledge, experience, and encountered obstacles
    Vahide Semerci Çakmak, Serap Çetinkaya Özdemir
    Journal of Tissue Viability.2024; 33(4): 571.     CrossRef
  • A randomized controlled trial of an app-based intervention on physical activity and glycemic control in people with type 2 diabetes
    Gyuri Kim, Seohyun Kim, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim
    BMC Medicine.2024;[Epub]     CrossRef
  • Influence of quitting smoking on diabetes-related complications: A scoping review with a systematic search strategy
    Magdalena Walicka, Arkadiusz Krysiński, Giusy Rita Maria La Rosa, Ang Sun, Davide Campagna, Agostino Di Ciaula, Tabinda Dugal, Andre Kengne, Phuong Le Dinh, Anoop Misra, Riccardo Polosa, Syed Abbas Raza, Cristina Russo, Roberta Sammut, Noel Somasundaram
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2024; 18(5): 103044.     CrossRef
  • Visceral Adiposity as an Independent Risk Factor for Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus: A Retrospective Study
    Rui-Ling Wu, Niyao Chen, Yanni Chen, Xiaohong Wu, Chih-Yuan Ko, Xiao-Yu Chen, Takayuki Masaki
    Journal of Diabetes Research.2024;[Epub]     CrossRef
  • Age Characteristics of Patients With Type 2 Diabetic Foot Ulcers and Predictive Risk Factors for Lower Limb Amputation: A Population‐Based Retrospective Study
    Yuanying Yao, Lei Chen, Yu Qian, Munmun Chattopadhyay
    Journal of Diabetes Research.2024;[Epub]     CrossRef
  • Investigating Diabetic Foot Pathophysiology and Amputation Prevention Strategies through Behavioral Modification
    Jun Hyeok Kim
    Journal of Wound Management and Research.2023; 19(3): 167.     CrossRef
Close layer
Mineral, Bone & Muscle
Development of a Spine X-Ray-Based Fracture Prediction Model Using a Deep Learning Algorithm
Sung Hye Kong, Jae-Won Lee, Byeong Uk Bae, Jin Kyeong Sung, Kyu Hwan Jung, Jung Hee Kim, Chan Soo Shin
Endocrinol Metab. 2022;37(4):674-683.   Published online August 5, 2022
DOI: https://doi.org/10.3803/EnM.2022.1461
  • 10,256 View
  • 313 Download
  • 34 Web of Science
  • 34 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Since image-based fracture prediction models using deep learning are lacking, we aimed to develop an X-ray-based fracture prediction model using deep learning with longitudinal data.
Methods
This study included 1,595 participants aged 50 to 75 years with at least two lumbosacral radiographs without baseline fractures from 2010 to 2015 at Seoul National University Hospital. Positive and negative cases were defined according to whether vertebral fractures developed during follow-up. The cases were divided into training (n=1,416) and test (n=179) sets. A convolutional neural network (CNN)-based prediction algorithm, DeepSurv, was trained with images and baseline clinical information (age, sex, body mass index, glucocorticoid use, and secondary osteoporosis). The concordance index (C-index) was used to compare performance between DeepSurv and the Fracture Risk Assessment Tool (FRAX) and Cox proportional hazard (CoxPH) models.
Results
Of the total participants, 1,188 (74.4%) were women, and the mean age was 60.5 years. During a mean follow-up period of 40.7 months, vertebral fractures occurred in 7.5% (120/1,595) of participants. In the test set, when DeepSurv learned with images and clinical features, it showed higher performance than FRAX and CoxPH in terms of C-index values (DeepSurv, 0.612; 95% confidence interval [CI], 0.571 to 0.653; FRAX, 0.547; CoxPH, 0.594; 95% CI, 0.552 to 0.555). Notably, the DeepSurv method without clinical features had a higher C-index (0.614; 95% CI, 0.572 to 0.656) than that of FRAX in women.
Conclusion
DeepSurv, a CNN-based prediction algorithm using baseline image and clinical information, outperformed the FRAX and CoxPH models in predicting osteoporotic fracture from spine radiographs in a longitudinal cohort.

Citations

Citations to this article as recorded by  
  • Hotspots and Trends in the Application of Artificial Intelligence in Spine Medicine from 2005 to 2024: A Bibliometric and Visualization Analysis
    Tianyu Liu, Hanlin Zou, Haibo Zou
    Indian Journal of Orthopaedics.2026; 60(2): 473.     CrossRef
  • Artificial intelligence and multimodal imaging in orthopaedics: from technological advances to clinical translation
    Guangan Luo, Shuanglong Tan, Lincong Luo, Konghe Hu
    Frontiers in Medicine.2026;[Epub]     CrossRef
  • Artificial Intelligence in Rheumatology: From Algorithms to Clinical Impact in Osteoporosis and Chronic Inflammatory Rheumatic Diseases
    Marie Doussiere, Ahlem Aboud, Gilles Dequen, Vincent Goëb
    Journal of Clinical Medicine.2026; 15(2): 491.     CrossRef
  • Deep learning for hepatocellular carcinoma recurrence before and after liver transplantation: a multicenter cohort study
    Shuang Cao, Sihan Yu, Liangbin Huang, Samuel Seery, Yu Xia, Yongwei Zhao, Zhongzhou Si, Xinxue Zhang, Jiqiao Zhu, Ren Lang, Jiantao Kou, Haiming Zhang, Lin Wei, Guangpeng Zhou, Liying Sun, Lei Wang, Ting Li, Qiang He, Zhijun Zhu
    Scientific Reports.2025;[Epub]     CrossRef
  • Accuracy of artificial intelligence in prediction of osteoporotic fractures in comparison with dual-energy X-ray absorptiometry and the Fracture Risk Assessment Tool: A systematic review
    Mir Sadat-Ali, Bandar A Alzahrani, Turki S Alqahtani, Musaad A Alotaibi, Abdallah M Alhalafi, Ahmed A Alsousi, Abdullah M Alasiri
    World Journal of Orthopedics.2025;[Epub]     CrossRef
  • Deep learning-based identification of vertebral fracture and osteoporosis in lateral spine radiographs and DXA vertebral fracture assessment to predict incident fracture
    Namki Hong, Sang Wouk Cho, Young Han Lee, Chang Oh Kim, Hyeon Chang Kim, Yumie Rhee, William D Leslie, Steven R Cummings, Kyoung Min Kim
    Journal of Bone and Mineral Research.2025; 40(5): 628.     CrossRef
  • Aplicaciones de aprendizaje profundo en ortopedia: una revisión sistemática y futuras direcciones
    R González-Pola, A Herrera-Lozano, LF Graham-Nieto, G Zermeño-García
    Acta Ortopédica Mexicana.2025; 39(3): 152.     CrossRef
  • A Federated Graph-Based Multimodal AI Framework for Privacy-Preserving and Explainable Osteoporosis Detection
    O. Venkata Siva, M. S. Anbarasi
    International Journal on Artificial Intelligence Tools.2025;[Epub]     CrossRef
  • Artificial Intelligence for Bone: Theory, Methods, and Applications
    Dongfeng Yuan, Haicang Zhang, Liping Tong, Di Chen
    Advanced Intelligent Discovery.2025;[Epub]     CrossRef
  • Incorporating Artificial Intelligence into Fracture Risk Assessment: Using Clinical Imaging to Predict the Unpredictable
    Sung Hye Kong
    Endocrinology and Metabolism.2025; 40(4): 499.     CrossRef
  • Enhancing vertebral fracture prediction using multitask deep learning computed tomography imaging of bone and muscle
    Sung Hye Kong, Saemee Choi, Wonwoo Cho, Sung Bae Park, Seung Shin Park, Jaegul Choo, Jung Hee Kim, Sang Wan Kim, Chan Soo Shin
    European Radiology.2025;[Epub]     CrossRef
  • Artificial Intelligence Applications in Osteoporosis: A Comprehensive Review of Screening, Diagnosis, and Risk Prediction
    Alireza Keshtkar, Alireza Karimi, Farnaz Atighi, Parsa Yazdanpanahi, Arzhang Naseri, Amirhossein Khajepour, Mohammad Salehi, Yaser Sarikhani, Mohammad Hossein Dabbaghmanesh
    Shiraz E-Medical Journal.2025;[Epub]     CrossRef
  • Automated detection of vertebral fractures from X-ray images: A novel machine learning model and survey of the field
    Li-Wei Cheng, Hsin-Hung Chou, Yu-Xuan Cai, Kuo-Yuan Huang, Chin-Chiang Hsieh, Po-Lun Chu, I-Szu Cheng, Sun-Yuan Hsieh
    Neurocomputing.2024; 566: 126946.     CrossRef
  • Application of radiomics model based on lumbar computed tomography in diagnosis of elderly osteoporosis
    Baisen Chen, Jiaming Cui, Chaochen Li, Pengjun Xu, Guanhua Xu, Jiawei Jiang, Pengfei Xue, Yuyu Sun, Zhiming Cui
    Journal of Orthopaedic Research.2024; 42(6): 1356.     CrossRef
  • Machine Learning and Deep Learning in Spinal Injury: A Narrative Review of Algorithms in Diagnosis and Prognosis
    Satoshi Maki, Takeo Furuya, Masahiro Inoue, Yasuhiro Shiga, Kazuhide Inage, Yawara Eguchi, Sumihisa Orita, Seiji Ohtori
    Journal of Clinical Medicine.2024; 13(3): 705.     CrossRef
  • A CT-based Deep Learning Model for Predicting Subsequent Fracture Risk in Patients with Hip Fracture
    Yisak Kim, Young-Gon Kim, Jung-Wee Park, Byung Woo Kim, Youmin Shin, Sung Hye Kong, Jung Hee Kim, Young-Kyun Lee, Sang Wan Kim, Chan Soo Shin
    Radiology.2024;[Epub]     CrossRef
  • A Computed Tomography–Based Fracture Prediction Model With Images of Vertebral Bones and Muscles by Employing Deep Learning: Development and Validation Study
    Sung Hye Kong, Wonwoo Cho, Sung Bae Park, Jaegul Choo, Jung Hee Kim, Sang Wan Kim, Chan Soo Shin
    Journal of Medical Internet Research.2024; 26: e48535.     CrossRef
  • A Novel QCT-Based Deep Transfer Learning Approach for Predicting Stiffness Tensor of Trabecular Bone Cubes
    Pengwei Xiao, Tinghe Zhang, Yufei Huang, Xiaodu Wang
    IRBM.2024; 45(2): 100831.     CrossRef
  • Deep learning in the radiologic diagnosis of osteoporosis: a literature review
    Yu He, Jiaxi Lin, Shiqi Zhu, Jinzhou Zhu, Zhonghua Xu
    Journal of International Medical Research.2024;[Epub]     CrossRef
  • Pathological Priors Inspired Network for Vertebral Osteophytes Recognition
    Junzhang Huang, Xiongfeng Zhu, Ziyang Chen, Guoye Lin, Meiyan Huang, Qianjin Feng
    IEEE Transactions on Medical Imaging.2024; 43(7): 2522.     CrossRef
  • Fully Automatic Deep Learning Model for Spine Refracture in Patients with OVCF: A Multi‐Center Study
    Xuetao Zhu, Dejian Liu, Lian Liu, Jingxuan Guo, Zedi Li, Yixiang Zhao, Tianhao Wu, Kaiwen Liu, Xinyu Liu, Xin Pan, Lei Qi, Yuanqiang Zhang, Lei Cheng, Bin Chen
    Orthopaedic Surgery.2024; 16(8): 2052.     CrossRef
  • Artificial Intelligence in Spinal Imaging and Patient Care: A Review of Recent Advances
    Sungwon Lee, Joon-Yong Jung, Akaworn Mahatthanatrakul, Jin-Sung Kim
    Neurospine.2024; 21(2): 474.     CrossRef
  • Machine learning value in the diagnosis of vertebral fractures: A systematic review and meta-analysis
    Yue Li, Zhuang Liang, Yingchun Li, Yang Cao, Hui Zhang, Bo Dong
    European Journal of Radiology.2024; 181: 111714.     CrossRef
  • Development and reporting of artificial intelligence in osteoporosis management
    Guillaume Gatineau, Enisa Shevroja, Colin Vendrami, Elena Gonzalez-Rodriguez, William D Leslie, Olivier Lamy, Didier Hans
    Journal of Bone and Mineral Research.2024; 39(11): 1553.     CrossRef
  • Artificial intelligence in risk prediction and diagnosis of vertebral fractures
    Srikar R. Namireddy, Saran S. Gill, Amaan Peerbhai, Abith G. Kamath, Daniele S. C. Ramsay, Hariharan Subbiah Ponniah, Ahmed Salih, Dragan Jankovic, Darius Kalasauskas, Jonathan Neuhoff, Andreas Kramer, Salvatore Russo, Santhosh G. Thavarajasingam
    Scientific Reports.2024;[Epub]     CrossRef
  • Development and Validation of a Convolutional Neural Network Model to Predict a Pathologic Fracture in the Proximal Femur Using Abdomen and Pelvis CT Images of Patients With Advanced Cancer
    Min Wook Joo, Taehoon Ko, Min Seob Kim, Yong-Suk Lee, Seung Han Shin, Yang-Guk Chung, Hong Kwon Lee
    Clinical Orthopaedics & Related Research.2023; 481(11): 2247.     CrossRef
  • Automated Opportunistic Trabecular Volumetric Bone Mineral Density Extraction Outperforms Manual Measurements for the Prediction of Vertebral Fractures in Routine CT
    Sophia S. Goller, Jon F. Rischewski, Thomas Liebig, Jens Ricke, Sebastian Siller, Vanessa F. Schmidt, Robert Stahl, Julian Kulozik, Thomas Baum, Jan S. Kirschke, Sarah C. Foreman, Alexandra S. Gersing
    Diagnostics.2023; 13(12): 2119.     CrossRef
  • Machine learning‐based prediction of osteoporosis in postmenopausal women with clinical examined features: A quantitative clinical study
    Kainat A. Ullah, Faisal Rehman, Muhammad Anwar, Muhammad Faheem, Naveed Riaz
    Health Science Reports.2023;[Epub]     CrossRef
  • Skeletal Fracture Detection with Deep Learning: A Comprehensive Review
    Zhihao Su, Afzan Adam, Mohammad Faidzul Nasrudin, Masri Ayob, Gauthamen Punganan
    Diagnostics.2023; 13(20): 3245.     CrossRef
  • Deep learning system for automated detection of posterior ligamentous complex injury in patients with thoracolumbar fracture on MRI
    Sang Won Jo, Eun Kyung Khil, Kyoung Yeon Lee, Il Choi, Yu Sung Yoon, Jang Gyu Cha, Jae Hyeok Lee, Hyunggi Kim, Sun Yeop Lee
    Scientific Reports.2023;[Epub]     CrossRef
  • Vertebra Segmentation Based Vertebral Compression Fracture Determination from Reconstructed Spine X-Ray Images
    Srinivasa Rao Gadu, Chandra Sekhar Potala
    International Journal of Electrical and Electronics Research.2023; 11(4): 1225.     CrossRef
  • Computer Vision in Osteoporotic Vertebral Fracture Risk Prediction: A Systematic Review
    Anthony K. Allam, Adrish Anand, Alex R. Flores, Alexander E. Ropper
    Neurospine.2023; 20(4): 1112.     CrossRef
  • A Meaningful Journey to Predict Fractures with Deep Learning
    Jeonghoon Ha
    Endocrinology and Metabolism.2022; 37(4): 617.     CrossRef
  • New Horizons: Artificial Intelligence Tools for Managing Osteoporosis
    Hans Peter Dimai
    The Journal of Clinical Endocrinology & Metabolism.2022;[Epub]     CrossRef
Close layer
Diabetes, Obesity and Metabolism
The Presence of Clonal Hematopoiesis Is Negatively Associated with Diabetic Peripheral Neuropathy in Type 2 Diabetes
Tae Jung Oh, Han Song, Youngil Koh, Sung Hee Choi
Endocrinol Metab. 2022;37(2):243-248.   Published online April 25, 2022
DOI: https://doi.org/10.3803/EnM.2021.1337
  • 6,805 View
  • 147 Download
  • 5 Web of Science
  • 5 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
Clonal hematopoiesis of indeterminate potential (CHIP) has been reported to be associated with increased cardiovascular disease, aging and insulin resistance. Despite the debate of causal contribution of CHIP on metabolic diseases, we want to explore whether CHIP is related to diabetic peripheral neuropathy (DPN).
Methods
This study analyzed the prevalence of CHIP in patients with type 2 diabetes classified according to DPN status. Logistic regression analysis was used to evaluate the association between CHIP and DPN.
Results
CHIP was more prevalent in subjects without DPN than those with DPN (19.9% vs. 8.8%, respectively; P=0.013). Individuals having any CHIP, or DNA methyltransferase 3A (DNMT3A) CHIP were less likely to have any abnormality shown in DPN test; the adjusted odds ratio were 0.85 (95% confidence interval [CI], 0.73 to 1.00) and 0.70 (95% CI, 0.56 to 0.89), respectively. Interestingly, DNMT3A CHIP showed the negative association, but Tet methylcytosine dioxygenase 2 (TET2) CHIP showed the positive association with abnormal feet electrochemical skin conductance level.
Conclusion
On the contrary to expectations, CHIP was negatively associated with DPN. Functional linking between the mutation in hematopoietic cells and DPN, and the opposite role of DNMT3A and TET2 should be investigated.

Citations

Citations to this article as recorded by  
  • Clonal Hematopoiesis of Indeterminate Potential and Risk of Microvascular Complications Among Individuals With Type 2 Diabetes: A Cohort Study
    Jiahe Wei, Yuefeng Yu, Hanzhang Wu, Yingjun Li, Ningjian Wang, Xiao Tan
    Diabetes.2025; 74(4): 585.     CrossRef
  • Clonal hematopoiesis of indeterminate potential: a multisystem hub bridging hematopoietic dysfunction with non-hematopoietic diseases
    Jing-Lei Zhang, Shuo-Lan Tong, Qi-Qi Zhuang, Sheng-Jie Jin, Jia-Qiu Li, Jie Sun
    Military Medical Research.2025;[Epub]     CrossRef
  • Clonal Hematopoiesis of Indeterminate Potential and Cardiometabolic Disease: Challenges, Controversies and Future Perspectives
    Ioanna A. Anastasiou, Dimitris Kounatidis, Natalia G. Vallianou, Eleni Rebelos, Irene Karampela, Maria Dalamaga
    International Journal of Molecular Sciences.2025; 27(1): 233.     CrossRef
  • TET2 mutation as prototypic clonal hematopoiesis lesion
    Luca Guarnera, Babal K. Jha
    Seminars in Hematology.2024; 61(1): 51.     CrossRef
  • Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume
    Woo‐Jin Lee, Keun‐Hwa Jung, Han Song, Heesun Lee, Hyo Eun Park, Youngil Koh, Su‐Yeon Choi, Kyung‐Il Park
    CNS Neuroscience & Therapeutics.2023; 29(5): 1243.     CrossRef
Close layer
Diabetes, Obesity and Metabolism
Big Data Articles (National Health Insurance Service Database)
Cumulative Exposure to High γ-Glutamyl Transferase Level and Risk of Diabetes: A Nationwide Population-Based Study
Ji-Yeon Park, Kyungdo Han, Hun-Sung Kim, Jae-Hyoung Cho, Kun-Ho Yoon, Mee Kyoung Kim, Seung-Hwan Lee
Endocrinol Metab. 2022;37(2):272-280.   Published online April 13, 2022
DOI: https://doi.org/10.3803/EnM.2022.1416
  • 7,419 View
  • 116 Download
  • 10 Web of Science
  • 10 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Elevated γ-glutamyl transferase (γ-GTP) level is associated with metabolic syndrome, impaired glucose tolerance, and insulin resistance, which are risk factors for type 2 diabetes. We aimed to investigate the association of cumulative exposure to high γ-GTP level with risk of diabetes.
Methods
Using nationally representative data from the Korean National Health Insurance system, 346,206 people who were free of diabetes and who underwent 5 consecutive health examinations from 2005 to 2009 were followed to the end of 2018. High γ-GTP level was defined as those in the highest quartile, and the number of exposures to high γ-GTP level ranged from 0 to 5. Hazard ratio (HR) and 95% confidence interval (CI) for diabetes were analyzed using the multivariable Cox proportional-hazards model.
Results
The mean follow-up duration was 9.2±1.0 years, during which 15,183 (4.4%) patients developed diabetes. There was a linear increase in the incidence rate and the risk of diabetes with cumulative exposure to high γ-GTP level. After adjusting for possible confounders, the HR of diabetes in subjects with five consecutive high γ-GTP levels were 2.60 (95% CI, 2.47 to 2.73) in men and 3.05 (95% CI, 2.73 to 3.41) in women compared with those who never had a high γ-GTP level. Similar results were observed in various subgroup and sensitivity analyses.
Conclusion
There was a linear relationship between cumulative exposure to high γ-GTP level and risk of diabetes. Monitoring and lowering γ-GTP level should be considered for prevention of diabetes in the general population.

Citations

Citations to this article as recorded by  
  • Elevated GGT to HDL ratio as a marker for the risk of NAFLD and liver fibrosis
    Yanyan Xuan, Fangfang He, Qing Liu, Dandan Dai, Dingting Wu, Yanmei Shi, Qi Yao
    Scientific Reports.2025;[Epub]     CrossRef
  • Investigating the synergistic effects of gamma-glutamyl transferase with homocysteine, ferritin, and uric acid in patients with type II diabetes mellitus
    Simin Shirvani, Masomeh Halvaeezade, Maryam Avazzade, Morteza Golbashirzadeh, Atousa Moradzadegan
    Endocrine and Metabolic Science.2025; 17: 100211.     CrossRef
  • Association between non-high-density lipoprotein cholesterol-to-high-density lipoprotein cholesterol ratio and the risk of gestational diabetes: a retrospective study
    Guohua Li, Dongxing Su, Wei Huang, Xuehua Wu, Yanzhu Huang
    Frontiers in Nutrition.2025;[Epub]     CrossRef
  • Nonlinear association between gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio and risk of progression from normoglycemia to prediabetes: a 5-year cohort study
    Chuang Gao, Cailing Yu, Peijie Shi, Dehong Liu, Qiming Li, Yong Han
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Sex differences in the association between atherogenic index of plasma and progression from normoglycemia to prediabetes: evidence from a 5-year large-scale retrospective cohort study
    Chufu Yang, Qiying Chen, Weiyan Li, Chuang Gao, Yong Han, Jiaqian Zhu
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Validation of Estimated Small Dense Low-Density Lipoprotein Cholesterol Concentration in a Japanese General Population
    Keisuke Endo, Ryo Kobayashi, Makito Tanaka, Marenao Tanaka, Yukinori Akiyama, Tatsuya Sato, Itaru Hosaka, Kei Nakata, Masayuki Koyama, Hirofumi Ohnishi, Satoshi Takahashi, Masato Furuhashi
    Journal of Atherosclerosis and Thrombosis.2024; 31(6): 931.     CrossRef
  • Risk Factors for Colorectal Adenoma and Cancer in Comprehensive Health Checkups: Usefulness of Gamma-Glutamyltransferase
    Yoko Yamanouchi, Maiko Osawa, Takaaki Senbonmatsu, Yuki Shiko, Yohei Kawasaki, Toshihiro Muramatsu
    Journal of Personalized Medicine.2024; 14(11): 1082.     CrossRef
  • Long-Term Cumulative Exposure to High γ-Glutamyl Transferase Levels and the Risk of Cardiovascular Disease: A Nationwide Population-Based Cohort Study
    Han-Sang Baek, Bongseong Kim, Seung-Hwan Lee, Dong-Jun Lim, Hyuk-Sang Kwon, Sang-Ah Chang, Kyungdo Han, Jae-Seung Yun
    Endocrinology and Metabolism.2023; 38(6): 770.     CrossRef
  • Elevated gamma‐glutamyl transferase to high‐density lipoprotein cholesterol ratio has a non‐linear association with incident diabetes mellitus: A second analysis of a cohort study
    Haofei Hu, Yong Han, Mijie Guan, Ling Wei, Qijun Wan, Yanhua Hu
    Journal of Diabetes Investigation.2022; 13(12): 2027.     CrossRef
  • Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio: A valuable predictor of type 2 diabetes mellitus incidence
    Wangcheng Xie, Bin Liu, Yansong Tang, Tingsong Yang, Zhenshun Song
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
Close layer
Diabetes, Obesity and Metabolism
Big Data Articles (National Health Insurance Service Database)
Frequency of Exposure to Impaired Fasting Glucose and Risk of Mortality and Cardiovascular Outcomes
Seung-Hwan Lee, Kyungdo Han, Hyuk-Sang Kwon, Mee Kyoung Kim
Endocrinol Metab. 2021;36(5):1007-1015.   Published online October 21, 2021
DOI: https://doi.org/10.3803/EnM.2021.1218
  • 8,195 View
  • 153 Download
  • 14 Web of Science
  • 15 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Metabolic abnormalities, such as impaired fasting glucose (IFG), are dynamic phenomena; however, it is unclear whether the timing of IFG exposure and cumulative exposure to IFG are related to cardiovascular disease (CVD) and mortality risk.
Methods
Data were extracted from a nationwide population-based cohort in South Korea for adults (n=2,206,679) who were free of diabetes and had 4 years of consecutive health examination data. Fasting blood glucose levels of 100 to 125 mg/dL were defined as IFG, and the number of IFG diagnoses for each adult in the 4-year period was tabulated as the IFG exposure score (range, 0 to 4). Adults with persistent IFG for the 4-year period received a score of 4.
Results
The median follow-up was 8.2 years. There were 24,820 deaths, 13,502 cases of stroke, and 13,057 cases of myocardial infarction (MI). IFG exposure scores of 1, 2, 3, and 4 were associated with all-cause mortality (multivariable-adjusted hazard ratio [aHR], 1.11; 95% confidence interval [CI], 1.08 to 1.15; aHR, 1.16; 95% CI, 1.12 to 1.20; aHR, 1.20; 95% CI, 1.15 to 1.25; aHR, 1.18; 95% CI, 1.11 to 1.25, respectively) compared with an IFG exposure score of 0. Adjusting for hypertension and dyslipidemia attenuated the slightly increased risk of MI or stroke associated with high IFG exposure scores, but significant associations for allcause mortality remained.
Conclusion
The intensity of IFG exposure was associated with an elevated risk of all-cause mortality, independent of cardiovascular risk factors. The association between IFG exposure and CVD risk was largely mediated by the coexistence of dyslipidemia and hypertension.

Citations

Citations to this article as recorded by  
  • Impact of cumulative exposure to a high TG to HDL-C ratio on type 2 diabetes risk in young adults
    Jung Heo, Byungpyo Kim, Kyungdo Han, Jae-Hyuk Lee, Seo-Young Sohn, Jiyeon Ahn, Whi-An Kwon, Moon Jung Kim, Eun-Young Doo, Min-Kyung Lee
    Journal of Clinical Lipidology.2025; 19(2): 267.     CrossRef
  • Exposure to perfluoroalkyl and polyfluoroalkyl substances and risk of stroke in adults: a meta-analysis
    Min Cheol Chang, Seung Min Chung, Sang Gyu Kwak
    Reviews on Environmental Health.2024; 39(4): 791.     CrossRef
  • Cumulative exposure to impaired fasting glucose and gastrointestinal cancer risk: A nationwide cohort study
    Byeong Yun Ahn, Bokyung Kim, Sanghyun Park, Sang Gyun Kim, Kyungdo Han, Soo‐Jeong Cho
    Cancer.2024; 130(10): 1807.     CrossRef
  • Diabetes severity and the risk of depression: A nationwide population-based study
    Yunjung Cho, Bongsung Kim, Hyuk-Sang Kwon, Kyungdo Han, Mee Kyoung Kim
    Journal of Affective Disorders.2024; 351: 694.     CrossRef
  • Triglyceride-glucose index is associated with the risk of impaired fasting glucose in Chinese elderly individuals
    Jie Liu, Feng Yi, Kai Duan, Haibo Liu
    Scientific Reports.2024;[Epub]     CrossRef
  • A nationwide cohort study on diabetes severity and risk of Parkinson disease
    Kyungdo Han, Bongsung Kim, Seung Hwan Lee, Mee Kyoung Kim
    npj Parkinson's Disease.2023;[Epub]     CrossRef
  • Diabetes severity is strongly associated with the risk of active tuberculosis in people with type 2 diabetes: a nationwide cohort study with a 6-year follow-up
    Ji Young Kang, Kyungdo Han, Seung-Hwan Lee, Mee Kyoung Kim
    Respiratory Research.2023;[Epub]     CrossRef
  • Construction and Validation of a Model for Predicting Impaired Fasting Glucose Based on More Than 4000 General Population
    Cuicui Wang, Xu Zhang, Chenwei Li, Na Li, Xueni Jia, Hui Zhao
    International Journal of General Medicine.2023; Volume 16: 1415.     CrossRef
  • Factors Affecting High Body Weight Variability
    Kyungdo Han, Mee Kyoung Kim
    Journal of Obesity & Metabolic Syndrome.2023; 32(2): 163.     CrossRef
  • Cumulative effect of impaired fasting glucose on the risk of dementia in middle-aged and elderly people: a nationwide cohort study
    Jin Yu, Kyu-Na Lee, Hun-Sung Kim, Kyungdo Han, Seung-Hwan Lee
    Scientific Reports.2023;[Epub]     CrossRef
  • A Longitudinal Retrospective Observational Study on Obesity Indicators and the Risk of Impaired Fasting Glucose in Pre- and Postmenopausal Women
    Myung Ji Nam, Hyunjin Kim, Yeon Joo Choi, Kyung-Hwan Cho, Seon Mee Kim, Yong-Kyun Roh, Kyungdo Han, Jin-Hyung Jung, Yong-Gyu Park, Joo-Hyun Park, Do-Hoon Kim
    Journal of Clinical Medicine.2022; 11(10): 2795.     CrossRef
  • Current Trends of Big Data Research Using the Korean National Health Information Database
    Mee Kyoung Kim, Kyungdo Han, Seung-Hwan Lee
    Diabetes & Metabolism Journal.2022; 46(4): 552.     CrossRef
  • Lipid cutoffs for increased cardiovascular disease risk in non-diabetic young people
    Mee Kyoung Kim, Kyungdo Han, Hun-Sung Kim, Kun-Ho Yoon, Seung-Hwan Lee
    European Journal of Preventive Cardiology.2022; 29(14): 1866.     CrossRef
  • Low-Density Lipoprotein Cholesterol Level, Statin Use and Myocardial Infarction Risk in Young Adults
    Heekyoung Jeong, Kyungdo Han, Soon Jib Yoo, Mee Kyoung Kim
    Journal of Lipid and Atherosclerosis.2022; 11(3): 288.     CrossRef
  • Additive interaction of diabetes mellitus and chronic kidney disease in cancer patient mortality risk
    Seohyun Kim, Gyuri Kim, Jae Hyeon Kim
    Scientific Reports.2022;[Epub]     CrossRef
Close layer
Review Articles
Mineral, Bone & Muscle
Review and Update of the Risk Factors and Prevention of Antiresorptive-Related Osteonecrosis of the Jaw
Ha Young Kim
Endocrinol Metab. 2021;36(5):917-927.   Published online October 21, 2021
DOI: https://doi.org/10.3803/EnM.2021.1170
  • 13,801 View
  • 380 Download
  • 23 Web of Science
  • 26 Crossref
AbstractAbstract PDFPubReader   ePub   
Antiresorptive-related osteonecrosis of the jaw (ARONJ) is a rare but serious adverse event of bisphosphonate or denosumab administration; it is associated with severe pain and a deteriorated quality of life. Since its first report in 2003, there have been many studies on its definition, epidemiology, pathophysiology, diagnosis, and treatment. Nevertheless, the epidemiology and mechanisms underlying this condition have not yet been fully delineated and several risk factors are known. Moreover, as there is no effective treatment currently available for osteonecrosis of the jaw, prevention is essential. Furthermore, close cooperation between prescribing physicians and dentists is important. The aim of this review was to provide up-to-date information regarding the risk factors and prevention of ARONJ from a physician’s perspective.

Citations

Citations to this article as recorded by  
  • Prevention of medication-related osteonecrosis of the jaw after tooth extraction by local administration of antibiotics and atelocollagen sponge: A preliminary study
    Natsumi Nakamura, Sakiko Soutome, Akira Imakiire, Satoshi Rokutanda, Seigo Ohba, Shunsuke Sawada, Yuka Kojima, Yuki Sakamoto, Yoshiko Yamamura, Madoka Funahara, Mitsunobu Otsuru, Masahiro Umeda
    Journal of Dental Sciences.2026; 21(1): 579.     CrossRef
  • Mandibular osteomyelitis induced by denosumab administration: Case report
    Chongyuan Liu, Lidi Cheng, Ting Jiang, Jian Fang, Ling Zhang
    Medicine.2026; 105(3): e47148.     CrossRef
  • Prevalence of MRONJ in patients treated with antiresorptive agents for glucocorticoid-induced osteoporosis
    Hidenobu Sakuma, Hiroko Kanemaru, Akira Kurokawa, Marie Soga, Moe Yamashita, Mai Nozawa-Kobayashi, Kanae Niimi, Tadaharu Kobayashi
    Oral and Maxillofacial Surgery.2025;[Epub]     CrossRef
  • Dental Implant Failure and Medication-Related Osteonecrosis of the Jaw Related to Dental Implants in Patients Taking Antiresorptive Therapy for Osteoporosis: A Systematic Review and Meta-Analysis
    Reza Mirza, Mohamed El Rabbany, Dalal S. Ali, Sotirios Tetradis, Archibald Morrison, Salvatore Ruggiero, Rasha Alnajimi, Aliya A. Khan, Gordon Guyatt
    Endocrine Practice.2025; 31(9): 1189.     CrossRef
  • Risk of bisphosphonate-related osteonecrosis of the jaw in implants vs. extractions: a nationwide population-based study
    Jin-Joo Yoo, Jaeyeon Kim, Min Jin Kang, Wonse Park, Joon-Ho Yoon
    Clinical Oral Investigations.2025;[Epub]     CrossRef
  • What is the appropriate antibiotic administration to prevent MRONJ development after tooth extraction?
    Eiji Iwata, Hiroaki Ohori, Yuriko Susukida, Nanae Yatagai, Masahiko Kashin, Taiki Matsui, Naoki Takata, Masaki Kobayashi, Daisuke Miyai, Akira Tachibana, Masaya Akashi
    Journal of Bone and Mineral Metabolism.2025; 43(5): 525.     CrossRef
  • Effectiveness of Pharmacists’ Recommendations for Dental Examinations for Prevention of Medication-Related Osteonecrosis of the Jaw
    Shinichi Watanabe, Satomi Sumikawa, Satoshi Watanabe, Takaaki Yano, Yukiro Kurokawa, Noriaki Hidaka, Satoshi Hino, Takumi Yamaguchi, Mamoru Tanaka
    Biological and Pharmaceutical Bulletin.2025; 48(9): 1399.     CrossRef
  • Medication-Related Osteonecrosis of the Jaw: An Evidence-Based 2025 Position Statement from a Korean Multidisciplinary Task Force
    Jin-Woo Kim, Sung-Hye Kong, Jae-Young Kim, Mi Kyung Kwak, Jun-Young Kim, Ji-Hyeon Oh, Hyung-Youl Park, BeomTaek Kim, Young-Kyun Lee, Jeong Joon Han, Moon-Young Kim, Yong Jun Choi, Yong-Dae Kwon, Kwang-Sup Song, Beom-Jun Kim, Sun-Jong Kim, Seung-Hoon Baek,
    Endocrinology and Metabolism.2025; 40(6): 787.     CrossRef
  • Osteoporosis Management after the Occurrence of Medication-Related Osteonecrosis of the Jaw: A 13-Year Experience at a Tertiary Center
    Chun Ho Wong, Kimberly Hang Tsoi, Jingya Jane Pu, Nancy Su Jiang, Stacey Sheung Yi Chan, Connie Hong Nin Loong, Xincheng Zou, Carol Ho Yi Fong, Eunice Ka Hong Leung, Alan Chun Hong Lee, Chi Ho Lee, Kathryn Choon Beng Tan, Yu Cho Woo, Yu-xiong Su, David Ta
    Endocrinology and Metabolism.2025; 40(6): 974.     CrossRef
  • Medication-related osteonecrosis of the jaw: an evidence-based 2025 position statement from a Korean multidisciplinary task force
    Jin-Woo Kim, Sung-Hye Kong, Jae-Young Kim, Mi Kyung Kwak, Jun-Young Kim, Ji-Hyeon Oh, Hyung-Youl Park, BeomTaek Kim, Young-Kyun Lee, Jeong Joon Han, Moon-Young Kim, Yong Jun Choi, Yong-Dae Kwon, Kwang-Sup Song, Beom-Jun Kim, Sun-Jong Kim, Seung-Hoon Baek,
    Journal of the Korean Association of Oral and Maxillofacial Surgeons.2025; 51(6): 333.     CrossRef
  • Risk factors for dental findings of the development of medication-related osteonecrosis of the jaw: Investigation of 3734 teeth in cancer patients receiving high dose antiresorptive agents
    Mitsunobu Otsuru, Yoshinari Fujiki, Sakiko Soutome, Norio Nakamura, Taro Miyoshi, Tomofumi Naruse, Mizuho Ohnuma, Yuka Hotokezaka, Satoshi Rokutanda, Masahiro Umeda
    Journal of Dental Sciences.2024; 19(1): 203.     CrossRef
  • Editorial: Immunological processes in maxillofacial bone pathology
    Matthias Tröltzsch
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Polysacharide of Agaricus blazei gel mitigates bone necrosis in model of the jaws related to bisphosphonate via Wnt signaling
    Vanessa Costa de Sousa, Fátima Regina Nunes Sousa, Raquel Felipe Vasconcelos, Gisele Angelino Barreto, Conceição S. Martins, Nilson Romero Dias, Sislana Costa, Maria Jennifer Chaves Bernardino, George de Almeida Silva, Nadine Linhares, Delane Gondim, Mirn
    Scientific Reports.2024;[Epub]     CrossRef
  • A Systematic Review of Laser Photobiomodulation Dosimetry and Treatment Protocols in the Management of Medications-Related Osteonecrosis of the Jaws: A Rationalised Consensus for Future Randomised Controlled Clinical Trials
    Reem Hanna, Ioana Cristina Miron, Snehal Dalvi, Praveen Arany, René Jean Bensadoun, Stefano Benedicenti
    Pharmaceuticals.2024; 17(8): 1011.     CrossRef
  • Perfil Odontológico dos Pacientes em Uso de Bisfosfonatos em um Hospital Oncológico
    Jade Fontenele Tagliabue, Lísia Daltro Borges Alves, Héliton Spíndola Antunes
    Revista Brasileira de Cancerologia.2024;[Epub]     CrossRef
  • Position Paper on Medication-Related Osteonecrosis of the Jaw 2023 update -Key Points for Revision-
    Hiromitsu KISHIMOTO, Kuniyasu MORIDERA
    Japanese Journal of Oral and Maxillofacial Surgery.2024; 70(7): 278.     CrossRef
  • Annual review of selected scientific literature: A report of the Committee on Scientific Investigation of the American Academy of Restorative Dentistry
    David R. Cagna, Terence E. Donovan, James R. McKee, James E. Metz, Riccardo Marzola, Kevin G. Murphy, Matthias Troeltzsch
    The Journal of Prosthetic Dentistry.2024; 132(6): 1133.     CrossRef
  • Effectiveness of Local Use of Green Propolis-Loaded Lipid Nanoparticles as Adjuvant Therapy to Scaling and Root Planing in the Management of Periodontitis in Rats Treated with Zoledronate
    Glauco Rodrigues Carmo Silveira, Vinícius Franzão Ganzaroli, Luan Felipe Toro, Estevão Lopes-Pereira, Leandro Lemes da Costa, João Martins de Mello-Neto, Rogério Leone Buchaim, Valdir Gouveia Garcia, Leticia Helena Theodoro, José Maurício Sforcin, Priscyl
    International Journal of Molecular Sciences.2024; 25(22): 12443.     CrossRef
  • Prevention of bone fractures for people with dementia
    浩太郎 東
    Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics.2024; 61(4): 436.     CrossRef
  • When and how to stop denosumab therapy in a patient with osteoporosis
    Eirena L. Goulden, Rachel K. Crowley
    Clinical Endocrinology.2023; 98(5): 649.     CrossRef
  • Clinical and Histopathological Aspects of MRONJ in Cancer Patients
    George Adrian Ciobanu, Laurențiu Mogoantă, Adrian Camen, Mihaela Ionescu, Daniel Vlad, Ionela Elisabeta Staicu, Cristina Maria Munteanu, Mircea Ionuț Gheorghiță, Răzvan Mercuț, Elena Claudia Sin, Sanda Mihaela Popescu
    Journal of Clinical Medicine.2023; 12(10): 3383.     CrossRef
  • Bisphosphonates and osteonecrosis of the jaws: Clinical and forensic aspects
    Diana Nogueira, Inês Morais Caldas, Ricardo Jorge Dinis-Oliveira
    Archives of Oral Biology.2023; 155: 105792.     CrossRef
  • Correlations between Immune Response and Etiopathogenic Factors of Medication-Related Osteonecrosis of the Jaw in Cancer Patients Treated with Zoledronic Acid
    George Adrian Ciobanu, Laurențiu Mogoantă, Sanda Mihaela Popescu, Mihaela Ionescu, Cristina Maria Munteanu, Ionela Elisabeta Staicu, Răzvan Mercuț, Cristian Corneliu Georgescu, Monica Scrieciu, Daniel Vlad, Adrian Camen
    International Journal of Molecular Sciences.2023; 24(18): 14345.     CrossRef
  • Analysis of the Degree of Information of Dental Surgeons about Antiresorptive Drugs According to the Time Since Graduation in Dentistry
    Flávia Godinho Costa Wanderley Rocha, Roberto Paulo Correia de Araújo
    Pesquisa Brasileira em Odontopediatria e Clínica Integrada.2023;[Epub]     CrossRef
  • Safety and Efficacy of Pamidronate in Neonatal Hypercalcemia Caused by Subcutaneous Fat Necrosis: A Case Report
    Stefano Martinelli, Marco Pitea, Italo Francesco Gatelli, Tara Raouf, Graziano Barera, Ottavio Vitelli
    Frontiers in Pediatrics.2022;[Epub]     CrossRef
  • Zoledronic acid for osteoporosis and associated low-energy fractures
    S. S. Rodionova, A. F. Kolondaev, A. N. Torgashin, I. A. Solomyannik
    Meditsinskiy sovet = Medical Council.2022; (21): 163.     CrossRef
Close layer
Obesity and Metabolism
An Update on Contraception in Polycystic Ovary Syndrome
Seda Hanife Oguz, Bulent Okan Yildiz
Endocrinol Metab. 2021;36(2):296-311.   Published online April 15, 2021
DOI: https://doi.org/10.3803/EnM.2021.958
  • 35,241 View
  • 1,170 Download
  • 46 Web of Science
  • 52 Crossref
AbstractAbstract PDFPubReader   ePub   
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in reproductive-aged women, characterized by hyperandrogenism, oligo/anovulation, and polycystic ovarian morphology. Combined oral contraceptives (COCs), along with lifestyle modifications, represent the first-line medical treatment for the long-term management of PCOS. Containing low doses of estrogen and different types of progestin, COCs restore menstrual cyclicity, improve hyperandrogenism, and provide additional benefits such as reducing the risk of endometrial cancer. However, potential cardiometabolic risk associated with these agents has been a concern. COCs increase the risk of venous thromboembolism (VTE), related both to the dose of estrogen and the type of progestin involved. Arterial thrombotic events related to COC use occur much less frequently, and usually not a concern for young patients. All patients diagnosed with PCOS should be carefully evaluated for cardiometabolic risk factors at baseline, before initiating a COC. Age, smoking, obesity, glucose intolerance or diabetes, hypertension, dyslipidemia, thrombophilia, and family history of VTE should be recorded. Patients should be re-assessed at consecutive visits, more closely if any baseline cardiometabolic risk factor is present. Individual risk assessment is the key in order to avoid unfavorable outcomes related to COC use in women with PCOS.

Citations

Citations to this article as recorded by  
  • Therapeutic effects of Angelica gigas Nakai in experimental rat model of polycystic ovary syndrome with network pharmacology
    Bomee Lee, Go Woon Lee, La Yoon Choi, Sujin Kwon, Yong-Deok Jeon, Mi Hye Kim, Sae Hun Kim
    Food Science and Biotechnology.2026; 35(1): 285.     CrossRef
  • Injectable contraceptives differentially affect the hypothalamic–pituitary-gonadal axis and amenorrhea incidence
    Alexis J Bick, Chanel Avenant, Carole-Keza Capitaine, Sharoné van Eck, Mu-Tien Lee, Johnson M Moliki, Sigcinile Dlamini, David W Erikson, Jenni Smit, Mags Beksinska, G Justus Hofmeyr, Donita J Africander, Pai-Lien Chen, Janet P Hapgood
    Biology of Reproduction.2026;[Epub]     CrossRef
  • Pain in polycystic ovary syndrome: a comprehensive bedside to bench perspective on an underrecognized symptom
    Lida Khodavirdilou, Jenny L. Wilkerson
    Frontiers in Pharmacology.2026;[Epub]     CrossRef
  • Onecut2, negatively regulated by methyltransferase METTL3, inhibits polycystic ovary syndrome by transcriptionally modulating SIRT3 expression
    Mingxing Sui, Shuying Wu, Qingqing Song, Siyao Chen, Yingli Lu
    Biochemical Pharmacology.2026; 246: 117712.     CrossRef
  • Combined Oral Contraceptive Pills Versus Progestin-Only Pills for Heavy Menstrual Bleeding: A Systematic Review
    Gehad S Mohamed, Ebtihag M Abdalla, Suhila Karamalla, Tuhama I Osman, Hafsa Mohamed Hamid Musa, Huda Mohamed, Ozaz K Ahmed, Suheir I Elshaikh, Muhammad Muddassar Shafiq
    Cureus.2026;[Epub]     CrossRef
  • Ocimum tenuiflorum L. for the management of metabolic and hormonal disturbances in letrozole induced PCOS rat models
    Safeena Rashid, Waseem Younis Khan, Farhat Jabeen, Sana Hafiz, Nuzhat Khursheed, Showkat Ahmad Ganie, Shajrul Amin
    Endocrine and Metabolic Science.2026; 20: 100292.     CrossRef
  • Skin deep: dermatologic challenges in PCOS through the female lifespan
    Seda Hanife Oğuz, Başak Yalici Armagan, Bulent Okan Yildiz
    Expert Review of Endocrinology & Metabolism.2026;[Epub]     CrossRef
  • Impact of short‐term ketogenic diet on sex hormones and glucose‐lipid metabolism in overweight or obese patients with polycystic ovary syndrome
    Meng Li, Lisong Zhang, Xiaoyu Li, Yanzhong Zhao
    Journal of Obstetrics and Gynaecology Research.2025;[Epub]     CrossRef
  • Exploring the efficacy of Wenshentiaojing decoction in PCOS: Network pharmacology and mouse model insights
    Mingming Wang, Jing Huang, Yue Shi, Richard Mprah, Huanhuan Ding, Shanshan Zhang, Cui Li
    Bioorganic Chemistry.2025; 154: 108089.     CrossRef
  • Targeting UGT2B15 and NR1H4 interaction: a novel therapeutic strategy for polycystic ovary syndrome using naftopidil enantiomers
    Xiufen Zheng, Zikai Chen, Miao Liang, Liting Zhou, Miaoru Wang, Silin Zhang, Shuyun Zhang, Lei Ma, Wei Yi, Xiawen Liu
    Journal of Ovarian Research.2025;[Epub]     CrossRef
  • Postpartum hormonal contraceptive use in Denmark during 1997–2021
    Søren Vinther Larsen, Anders Pretzmann Mikkelsen, Kathrine Bang Madsen, Xiaoqin Liu, Trine Munk-Olsen, Vibe Gedso Frokjaer, Øjvind Lidegaard
    Sexual & Reproductive Healthcare.2025; 43: 101075.     CrossRef
  • Association of Polycystic Ovary Syndrome with Clinical, Physical, and Reproductive Factors: A Data-Driven Analysis
    Ismat Ara Begum, A. S. M. Sanwar Hosen, Deepak Ghimire, Mi Jin Park
    Diagnostics.2025; 15(6): 711.     CrossRef
  • Association of Different Formulation with Oral Contraceptive Agents in Lipid and Carbohydrates Metabolism in Women
    Syeda Masooma Hussain, Sikandar Ali Khan, Somaya Noor, Najma Fida, Syed Muhammad Sajid Ali Bukhari, Jahangir Zeb
    Pakistan Journal of Health Sciences.2025; : 66.     CrossRef
  • Development of a Long-Acting Follicle-Stimulating Hormone Using Serum Albumin Fab-Associated Technology for Female Infertility
    Daham Kim, Yoon Hee Cho, Min Jeong Kang, So Jeong Lee, Soohyun Lee, Bo Hyon Yun, Hyunjin Chi, Jeongsuk An, Kyungsun Lee, Jaekyu Han, Susan Chi, Moo Young Song, Sang-Hoon Cha, Eun Jig Lee
    Endocrinology and Metabolism.2025; 40(1): 146.     CrossRef
  • Recurrent Giant Ovarian Cysts in Biological Sisters: 2 Case Reports and Literature Review—Giant Ovarian Cysts in 2 Sisters
    Shuaibin Liu, Qianru Zeng, Lina Hu, Biao Zeng, Yi Wu, Chenxi Wang, Min Zhou, Xiaoling Gan
    Healthcare.2025; 13(6): 656.     CrossRef
  • ‘Ovariostasis’ as the main preventive and therapeutic strategy for gynecological pathologies in women of reproductive age
    Antonio La Marca, Chiara Selmi
    Human Reproduction.2025; 40(6): 983.     CrossRef
  • Association of Polycystic Ovarian Syndrome Features and Metabolic Syndrome Among Reproductive-Aged Women in the United States
    Deepali K. Ernest, Asha Collier, Aparajita Chandrasekhar, Luyu Xie, Shaghayegh Darraji, Jenil Patel, Jaime P. Almandoz, Sarah E. Messiah
    Women's Health Reports.2025;[Epub]     CrossRef
  • Extracellular fluid miRNAs in PCOS
    Saba Hadi, Seyed Hossein Khoshraftar, Amir Hossein Kiani Darabi, Anahita Soleimani, Hamid Reza Nejabati
    Clinica Chimica Acta.2025; 576: 120404.     CrossRef
  • Impact of oral contraceptive use on muscle mass and strength in women with PCOS
    Seren Aksun, Levend Karaçoban, Ilkay Idilman, Bulent O. Yildiz
    Endocrine.2025; 89(2): 647.     CrossRef
  • Recognizing the Role of Insulin Resistance in Polycystic Ovary Syndrome: A Paradigm Shift from a Glucose-Centric Approach to an Insulin-Centric Model
    Jim Parker, Lara Briden, Felice L. Gersh
    Journal of Clinical Medicine.2025; 14(12): 4021.     CrossRef
  • Pharmacological management of PCOS: trends and insights from a 10-year bibliometric analysis
    Rohit Gautam, Anshu Jyoti, Asmitha Bhateja, Neena Malhotra, Taruna Arora
    Expert Opinion on Pharmacotherapy.2025; 26(11-12): 1351.     CrossRef
  • Statins for polycystic ovary syndrome in varying resource settings: a phenome-wide association study and evidence synthesis
    Laura A. Zahn, Taylor D. Budine, Jana K. Shirey-Rice, Meghan M. Joly, Robert S. Wallis, Gordon R. Bernard, Kenneth J. Holroyd, Jill M. Pulley, Rebecca N. Jerome
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Oral contraceptive treatment improves cognitive performance in polycystic ovarian syndrome (PCOS) patients
    Saloni Kumari, Soumen Manna, Sheeba Marwah, Himani Ahluwalia, Shweta Panwar
    Archives of Women's Mental Health.2025; 28(6): 1527.     CrossRef
  • Effects of endocrine disruptive chemicals (EDCs) and therapeutic approaches to the polycystic ovary syndrome (PCOS): A current state-of-the-art
    Adèle Lemogne Robert, Edite Oliveira Torres, Catarina Jota Baptista
    Environmental Toxicology and Pharmacology.2025; 120: 104842.     CrossRef
  • Oral prolonged-release dienogest 2 mg and ethinylestradiol 0.02 mg in a 24/4-day regimen for polycystic ovary syndrome-associated hirsutism: a double-blind, randomised, placebo-controlled trial
    Roger Lobo, Alicyoy Angulo, Alejandro Muñoz, Enrico Colli, Héctor F. Escobar-Morreale, Manuel Luque-Ramírez, Janos Zatik, Pedro-Antonio Regidor
    eClinicalMedicine.2025; 90: 103594.     CrossRef
  • An apology to my body: Mapping the changing relationship with my fat body, a reflection on childhood & PCOS
    Sarah McLean-Orsborn
    Fat Studies.2025; : 1.     CrossRef
  • Evaluation and Management of Polycystic Ovarian Syndrome (PCOS) in Adolescents With Obesity: A Scoping Review of National and International Obesity and PCOS Management Guidelines
    Carey Yun Shan Lim, Kah Yin Loke, Sajini Mary Varughese, Yung Seng Lee, Nicholas Beng Hui Ng
    Obesity Reviews.2025;[Epub]     CrossRef
  • Clinical management of androgen excess and defect in women
    Elena Rosato, Francesca Sciarra, Marianna Minnetti, Anisa Degjoni, Mary Anna Venneri
    Expert Review of Endocrinology & Metabolism.2024; 19(1): 21.     CrossRef
  • Il rischio tromboembolico nella sindrome dell’ovaio policistico
    Davide Ceccato, Francesca Dassie, Pietro Maffei, Roberto Mioni
    L'Endocrinologo.2024; 25(2): 151.     CrossRef
  • Systematic exploration of network pharmacology, in silico modeling and pharmacokinetic profiling for vitamin E in polycystic ovarian syndrome
    Rukaiah Fatma Begum, Sumithra Mohan
    Future Science OA.2024;[Epub]     CrossRef
  • The ameliorating effects of apigenin and chrysin alone and in combination on polycystic ovary syndrome induced by dehydroepiandrosterone in rats
    Buket Berk, Nevin İlhan, Solmaz Susam, Fatma Tedik, Nalan Kaya Tektemur
    Marmara Medical Journal.2024; 37(2): 198.     CrossRef
  • Changes in the serum metabolomics of polycystic ovary syndrome before and after compound oral contraceptive treatment
    Ting Zhao, Xiao Xiao, Lingchuan Li, Jing Zhu, Wenli He, Qiong Zhang, Jiaqi Wu, Xiaomei Wu, Tao Yuan
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Association Between Intrauterine System Hormone Dosage and Depression Risk
    Søren Vinther Larsen, Anders Pretzmann Mikkelsen, Brice Ozenne, Trine Munk-Olsen, Øjvind Lidegaard, Vibe Gedso Frokjaer
    American Journal of Psychiatry.2024; 181(9): 834.     CrossRef
  • Combined oral contraceptive use and obesity in women with polycystic ovary syndrome. A meta-analysis of randomized clinical trials
    Sebastião Freitas de Medeiros, José Maria Soares Junior, Matheus Antonio Souto de Medeiros, Ana Karine Lin Winck Yamamoto, Cindy Lin Winck de Medeiros, Anna Bethany da Silva Carvalho, Márcia Marly Winck Yamamoto, Edmund Chada Baracat
    Archives of Gynecology and Obstetrics.2024; 310(4): 2223.     CrossRef
  • Dietary supplements in polycystic ovary syndrome–current evidence
    Ya Han, Ye Hou, Qimao Han, Xingxing Yuan, Lu Chen
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Oxidative Stress in Polycystic Ovary Syndrome: Impact of Combined Oral Contraceptives
    Nicolás Santander, Esteban G. Figueroa, Alejandro González-Candia, Manuel Maliqueo, Bárbara Echiburú, Nicolás Crisosto, Francisca Salas-Pérez
    Antioxidants.2024; 13(10): 1168.     CrossRef
  • miRNAs in ovarian disorders: Small but strong cast
    Parsa Tafazoli, Hanieh Motahari Rad, Mehri Mashayekhi, Seyedeh Fatemeh Siadat, Rouhollah Fathi
    Pathology - Research and Practice.2024; 264: 155709.     CrossRef
  • Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
    Chandrani Dutta, Srivarshini Maddukuri
    Cureus.2024;[Epub]     CrossRef
  • Review of current therapeutic approaches for polycystic ovary syndrome
    Teodora Mitrovic, Artur Bjelica, Djordje Petrovic, Dragan Stajic
    Medicinski pregled.2024; 77(9-12): 309.     CrossRef
  • Current and emerging drug treatment strategies for polycystic ovary syndrome
    Nafiye Helvaci, Bulent Okan Yildiz
    Expert Opinion on Pharmacotherapy.2023; 24(1): 105.     CrossRef
  • Weighted Gene Co-Expression Network Analysis (WGCNA) Discovered Novel Long Non-Coding RNAs for Polycystic Ovary Syndrome
    Roozbeh Heidarzadehpilehrood, Maryam Pirhoushiaran, Malina Binti Osman, Habibah Abdul Hamid, King-Hwa Ling
    Biomedicines.2023; 11(2): 518.     CrossRef
  • The mechanism of Leonuri Herba in improving polycystic ovary syndrome was analyzed based on network pharmacology and molecular docking
    Mali Wu, Hua Liu, Jie Zhang, Fangfang Dai, Yiping Gong, Yanxiang Cheng
    Journal of Pharmacy & Pharmaceutical Sciences.2023;[Epub]     CrossRef
  • Evaluation of the efficacy of an antioxidant combination for the modulation of metabolic, endocrine, and clinical parameters in patients with polycystic ovary syndrome
    Carmen Pingarrón Santofímia, Silvia Poyo Torcal, Helena López Verdú, Alexandra Henríquez Linares, Virginia Calvente Aguilar, Pablo Terol Sánchez, María Sol Martínez García, Pilar Lafuente González
    Gynecological Endocrinology.2023;[Epub]     CrossRef
  • Contemporary Management of the Patient with Polycystic Ovary Syndrome
    Nicolás Omar Francone, Tia Ramirez, Christina E. Boots
    Obstetrics and Gynecology Clinics of North America.2023; 50(4): 695.     CrossRef
  • Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care
    Beate C. Sydora, Michaelann S. Wilke, Maggie McPherson, Sarah Chambers, Mahua Ghosh, Donna F. Vine
    BMC Women's Health.2023;[Epub]     CrossRef
  • Effect of Berberine Phytosome on reproductive, dermatologic, and metabolic characteristics in women with polycystic ovary syndrome: a controlled, randomized, multi-centric, open-label clinical trial
    Francesco Di Pierro, Ruqqia Sultana, Amna Zia Eusaph, Saida Abrar, Mahroo Bugti, Fauzia Afridi, Umer Farooq, Somia Iqtadar, Fareeha Ghauri, Syeda Makhduma, Shazia Nourin, Ayesha Kanwal, Aasiya Bano, Ali Akbar Bugti, Shah Mureed, Ayesha Ghazal, Romana Irsh
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • Investigation of taste function and eating behavior in women with polycystic ovary syndrome
    Sila Cetik, Aylin Acikgoz, Bulent Okan Yildiz
    Appetite.2022; 168: 105776.     CrossRef
  • microRNAs and long non‐coding RNAs as biomarkers for polycystic ovary syndrome
    Mona Tamaddon, Mostafa Azimzadeh, Seyed Mohammad Tavangar
    Journal of Cellular and Molecular Medicine.2022; 26(3): 654.     CrossRef
  • Effect of orlistat during individualized comprehensive life-style intervention on visceral fat in overweight or obese PCOS patients
    Min Min, Xiangyan Ruan, Husheng Wang, Jiaojiao Cheng, Suiyu Luo, Zhongting Xu, Meng Li, Alfred Otto Mueck
    Gynecological Endocrinology.2022; 38(8): 676.     CrossRef
  • Effect of metformin and exenatide on pregnancy rate and pregnancy outcomes in overweight or obese infertility PCOS women: long-term follow-up of an RCT
    Renyuan Li, Tingting Mai, Siyuan Zheng, Ying Zhang
    Archives of Gynecology and Obstetrics.2022; 306(5): 1711.     CrossRef
  • Oral contraceptives and stroke: Foes or friends
    Varun Reddy, Megan Wurtz, Shahil H. Patel, Micheline McCarthy, Ami P. Raval
    Frontiers in Neuroendocrinology.2022; 67: 101016.     CrossRef
  • Clinical profiling of polycystic ovary syndrome patients in Kashmir population
    Ahila Ashraf, Rajesh Singh, Shahnawaz Mir
    Matrix Science Pharma.2022; 6(1): 23.     CrossRef
Close layer
Original Articles
Clinical Study
Development of a Non-Invasive Liver Fibrosis Score Based on Transient Elastography for Risk Stratification in Patients with Type 2 Diabetes
Chi-Ho Lee, Wai-Kay Seto, Kelly Ieong, David T.W. Lui, Carol H.Y. Fong, Helen Y. Wan, Wing-Sun Chow, Yu-Cho Woo, Man-Fung Yuen, Karen S.L. Lam
Endocrinol Metab. 2021;36(1):134-145.   Published online February 24, 2021
DOI: https://doi.org/10.3803/EnM.2020.887
  • 8,578 View
  • 158 Download
  • 9 Web of Science
  • 9 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
In non-alcoholic fatty liver disease (NAFLD), transient elastography (TE) is an accurate non-invasive method to identify patients at risk of advanced fibrosis (AF). We developed a diabetes-specific, non-invasive liver fibrosis score based on TE to facilitate AF risk stratification, especially for use in diabetes clinics where TE is not readily available.
Methods
Seven hundred sixty-six adults with type 2 diabetes and NAFLD were recruited and randomly divided into a training set (n=534) for the development of diabetes fibrosis score (DFS), and a testing set (n=232) for internal validation. DFS identified patients with AF on TE, defined as liver stiffness (LS) ≥9.6 kPa, based on a clinical model comprising significant determinants of LS with the lowest Akaike information criteria. The performance of DFS was compared with conventional liver fibrosis scores (NFS, FIB-4, and APRI), using area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, positive and negative predictive values (NPV).
Results
DFS comprised body mass index, platelet, aspartate aminotransferase, high-density lipoprotein cholesterol, and albuminuria, five routine measurements in standard diabetes care. Derived low and high DFS cut-offs were 0.1 and 0.3, with 90% sensitivity and 90% specificity, respectively. Both cut-offs provided better NPVs of >90% than conventional fibrosis scores. The AUROC of DFS for AF on TE was also higher (P<0.01) than the conventional fibrosis scores, being 0.85 and 0.81 in the training and testing sets, respectively.
Conclusion
Compared to conventional fibrosis scores, DFS, with a high NPV, more accurately identified diabetes patients at-risk of AF, who need further evaluation by hepatologists.

Citations

Citations to this article as recorded by  
  • Benefits of combining SGLT2 inhibitors and pioglitazone on risk of MASH in type 2 diabetes—A real‐world study
    Chi‐Ho Lee, David Tak‐Wai Lui, Lung‐Yi Mak, Carol Ho‐Yi Fong, Kylie Sze‐Wing Chan, Jimmy Ho‐Cheung Mak, Chloe Yu‐Yan Cheung, Wing‐Sun Chow, Yu‐Cho Woo, Man‐Fung Yuen, Wai‐Kay Seto, Karen Siu‐Ling Lam
    Diabetes, Obesity and Metabolism.2025; 27(2): 574.     CrossRef
  • Moving diagnosis of liver fibrosis into the community
    Elisa Pose, Salvatore Piano, Maja Thiele, Núria Fabrellas, Emmanuel A. Tsochatzis, Pere Ginès
    Journal of Hepatology.2025; 83(1): 258.     CrossRef
  • Implementation of a liver health check in people with type 2 diabetes
    Kushala W M Abeysekera, Luca Valenti, Zobair Younossi, John F Dillon, Alina M Allen, Mazen Noureddin, Mary E Rinella, Frank Tacke, Sven Francque, Pere Ginès, Maja Thiele, Philip N Newsome, Indra Neil Guha, Mohammed Eslam, Jörn M Schattenberg, Saleh A Alqa
    The Lancet Gastroenterology & Hepatology.2024; 9(1): 83.     CrossRef
  • Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective
    Inha Jung, Dae-Jeong Koo, Won-Young Lee
    Diabetes & Metabolism Journal.2024; 48(3): 327.     CrossRef
  • Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease
    Chi-Ho Lee, David Tak-Wai Lui, Raymond Hang-Wun Li, Michele Mae-Ann Yuen, Carol Ho-Yi Fong, Ambrose Pak-Wah Leung, Justin Chiu-Man Chu, Loey Lung-Yi Mak, Tai-Hing Lam, Jean Woo, Yu-Cho Woo, Aimin Xu, Hung-Fat Tse, Kathryn Choon-Beng Tan, Bernard Man-Yung
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review
    Luca Rinaldi, Chiara Giorgione, Andrea Mormone, Francesca Esposito, Michele Rinaldi, Massimiliano Berretta, Raffaele Marfella, Ciro Romano
    Viruses.2023; 15(8): 1730.     CrossRef
  • Metabolic dysfunction-associated fatty liver disease — How relevant is this to primary care physicians and diabetologists?
    Chi-Ho Lee
    Primary Care Diabetes.2022; 16(2): 245.     CrossRef
  • Non‐alcoholic fatty liver disease and type 2 diabetes: An update
    Chi‐H Lee, David TW Lui, Karen SL Lam
    Journal of Diabetes Investigation.2022; 13(6): 930.     CrossRef
  • Ultrasound-Based Hepatic Elastography in Non-Alcoholic Fatty Liver Disease: Focus on Patients with Type 2 Diabetes
    Georgiana-Diana Cazac, Cristina-Mihaela Lăcătușu, Cătălina Mihai, Elena-Daniela Grigorescu, Alina Onofriescu, Bogdan-Mircea Mihai
    Biomedicines.2022; 10(10): 2375.     CrossRef
Close layer
Clinical Study
Predicting the Development of Myocardial Infarction in Middle-Aged Adults with Type 2 Diabetes: A Risk Model Generated from a Nationwide Population-Based Cohort Study in Korea
Seung-Hwan Lee, Kyungdo Han, Hun-Sung Kim, Jae-Hyoung Cho, Kun-Ho Yoon, Mee Kyoung Kim
Endocrinol Metab. 2020;35(3):636-646.   Published online September 22, 2020
DOI: https://doi.org/10.3803/EnM.2020.704
  • 8,691 View
  • 136 Download
  • 13 Web of Science
  • 16 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
Most of the widely used prediction models for cardiovascular disease are known to overestimate the risk of this disease in Asians. We aimed to generate a risk model for predicting myocardial infarction (MI) in middle-aged Korean subjects with type 2 diabetes.
Methods
A total of 1,272,992 subjects with type 2 diabetes aged 40 to 64 who received health examinations from 2009 to 2012 were recruited from the Korean National Health Insurance database. Seventy percent of the subjects (n=891,095) were sampled to develop the risk prediction model, and the remaining 30% (n=381,897) were used for internal validation. A Cox proportional hazards regression model and Cox coefficients were used to derive a risk scoring system. Twelve risk variables were selected, and a risk nomogram was created to estimate the 5-year risk of MI.
Results
During 7.1 years of follow-up, 24,809 cases of MI (1.9%) were observed. Age, sex, smoking status, regular exercise, body mass index, chronic kidney disease, duration of diabetes, number of anti-diabetic medications, fasting blood glucose, systolic blood pressure, total cholesterol, and atrial fibrillation were significant risk factors for the development of MI and were incorporated into the risk model. The concordance index for MI prediction was 0.682 (95% confidence interval [CI], 0.678 to 0.686) in the development cohort and 0.669 (95% CI, 0.663 to 0.675) in the validation cohort.
Conclusion
A novel risk engine was generated for predicting the development of MI among middle-aged Korean adults with type 2 diabetes. This model may provide useful information for identifying high-risk patients and improving quality of care.

Citations

Citations to this article as recorded by  
  • Global, regional, and national burden of major diabetes-related complications attributable to physical inactivity
    Jayne Feter, Natan Feter, Rodrigo Leal-Menezes, Pedro C. Hallal, Daniel Umpierre
    Journal of Sport and Health Science.2026; : 101123.     CrossRef
  • Overcoming Missing Data: Accurately Predicting Cardiovascular Risk in Type 2 Diabetes, A Systematic Review
    Wenhui Ren, Keyu Fan, Zheng Liu, Yanqiu Wu, Haiyan An, Huixin Liu
    Journal of Diabetes.2025;[Epub]     CrossRef
  • Development and validation of prediction models for stroke and myocardial infarction in type 2 diabetes based on health insurance claims: does machine learning outperform traditional regression approaches?
    Anna-Janina Stephan, Michael Hanselmann, Medina Bajramovic, Simon Schosser, Michael Laxy
    Cardiovascular Diabetology.2025;[Epub]     CrossRef
  • A literature review of quality assessment and applicability to HTA of risk prediction models of coronary heart disease in patients with diabetes
    Li Jiu, Junfeng Wang, Francisco Javier Somolinos-Simón, Jose Tapia-Galisteo, Gema García-Sáez, Mariaelena Hernando, Xinyu Li, Rick A. Vreman, Aukje K. Mantel-Teeuwisse, Wim G. Goettsch
    Diabetes Research and Clinical Practice.2024; 209: 111574.     CrossRef
  • Investigating the impact of extreme weather events and related indicators on cardiometabolic multimorbidity
    Di Wu, Yu Shi, ChenChen Wang, Cheng Li, Yaoqin Lu, Chunfang Wang, Weidong Zhu, Tingting Sun, Junjie Han, Yanling Zheng, Liping Zhang
    Archives of Public Health.2024;[Epub]     CrossRef
  • Predicting the Risk of Insulin-Requiring Gestational Diabetes before Pregnancy: A Model Generated from a Nationwide Population-Based Cohort Study in Korea
    Seung-Hwan Lee, Jin Yu, Kyungdo Han, Seung Woo Lee, Sang Youn You, Hun-Sung Kim, Jae-Hyoung Cho, Kun-Ho Yoon, Mee Kyoung Kim
    Endocrinology and Metabolism.2023; 38(1): 129.     CrossRef
  • Factors Affecting High Body Weight Variability
    Kyungdo Han, Mee Kyoung Kim
    Journal of Obesity & Metabolic Syndrome.2023; 32(2): 163.     CrossRef
  • Coronary Artery Calcium Score as a Sensitive Indicator of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus: A Long-Term Cohort Study
    Dae-Jeong Koo, Mi Yeon Lee, Sun Joon Moon, Hyemi Kwon, Sang Min Lee, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki Won Oh, Sung Rae Cho, Young-Hoon Jeong, Eun-Jung Rhee
    Endocrinology and Metabolism.2023; 38(5): 568.     CrossRef
  • Serum/plasma biomarkers and the progression of cardiometabolic multimorbidity: a systematic review and meta-analysis
    Yichen Jin, Ziyuan Xu, Yuting Zhang, Yue Zhang, Danyang Wang, Yangyang Cheng, Yaguan Zhou, Muhammad Fawad, Xiaolin Xu
    Frontiers in Public Health.2023;[Epub]     CrossRef
  • Assessing the Validity of the Criteria for the Extreme Risk Category of Atherosclerotic Cardiovascular Disease: A Nationwide Population-Based Study
    Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park
    Journal of Lipid and Atherosclerosis.2022; 11(1): 73.     CrossRef
  • Evaluating Triglyceride and Glucose Index as a Simple and Easy-to-Calculate Marker for All-Cause and Cardiovascular Mortality
    Kyung-Soo Kim, Sangmo Hong, You-Cheol Hwang, Hong-Yup Ahn, Cheol-Young Park
    Journal of General Internal Medicine.2022; 37(16): 4153.     CrossRef
  • Effects of exercise initiation and smoking cessation after new-onset type 2 diabetes mellitus on risk of mortality and cardiovascular outcomes
    Mee Kyoung Kim, Kyungdo Han, Bongsung Kim, Jinyoung Kim, Hyuk-Sang Kwon
    Scientific Reports.2022;[Epub]     CrossRef
  • Current Trends of Big Data Research Using the Korean National Health Information Database
    Mee Kyoung Kim, Kyungdo Han, Seung-Hwan Lee
    Diabetes & Metabolism Journal.2022; 46(4): 552.     CrossRef
  • Lipid cutoffs for increased cardiovascular disease risk in non-diabetic young people
    Mee Kyoung Kim, Kyungdo Han, Hun-Sung Kim, Kun-Ho Yoon, Seung-Hwan Lee
    European Journal of Preventive Cardiology.2022; 29(14): 1866.     CrossRef
  • Low-Density Lipoprotein Cholesterol Level, Statin Use and Myocardial Infarction Risk in Young Adults
    Heekyoung Jeong, Kyungdo Han, Soon Jib Yoo, Mee Kyoung Kim
    Journal of Lipid and Atherosclerosis.2022; 11(3): 288.     CrossRef
  • Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
    Sang Youn You, Kyungdo Han, Seung-Hawn Lee, Mee Kyoung Kim
    Diabetology & Metabolic Syndrome.2021;[Epub]     CrossRef
Close layer
Clinical Study
Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying Treatments
Ye Seul Yang, Seo Young Lee, Jung-Sun Kim, Kyung Mook Choi, Kang Wook Lee, Sang-Chol Lee, Jung Rae Cho, Seung-Jin Oh, Ji-Hyun Kim, Sung Hee Choi
Endocrinol Metab. 2020;35(2):367-376.   Published online June 24, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.2.367
  • 11,970 View
  • 175 Download
  • 9 Web of Science
  • 10 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
This study assessed the proportion of risk-stratified Korean patients with dyslipidemia achieving their low-density lipoprotein cholesterol (LDL-C) targets as defined by the European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) (2011) guidelines while receiving lipid-modifying treatments (LMTs).
Methods
In this multicenter, cross-sectional, observational study, we evaluated data from Korean patients aged ≥19 years who were receiving LMTs for ≥3 months and had an LDL-C value within the previous 12 months on the same LMT. Data were collected for demographics, cardiovascular (CV) risk factors, medical history, and healthcare consumption. Patients were risk-stratified according to the ESC Systematic COronary Risk Evaluation (SCORE) chart and LDL-C target achievement rate was assessed.
Results
Guideline-based risk-stratification of the 1,034 patients showed the majority (72.2%) to be in the very high-risk category. Investigators’ assessment of risk was underestimated in 71.6% compared to ESC/EAS guidelines. Overall LDL-C target achievement rate was 44.3%; target achievement was the highest (66.0%) in moderate-risk patients and the lowest (39.0%) in very high-risk patients. Overall 97.1% patients were receiving statin therapy, mostly as a single-agent (89.2%). High-intensity statins and the highest permissible dose of high-intensity statins had been prescribed to only 9.1% and 7.3% patients in the very high-risk group, respectively. Physician satisfaction with patients’ LDL-C levels was the primary reason for non-intensification of statin therapy.
Conclusion
Achievement of target LDL-C level is suboptimal in Korean patients with dyslipidemia, especially in those at very high-risk of CV events. Current practices in LMTs need to be improved based on precise CV risk evaluation posed by dyslipidemia.

Citations

Citations to this article as recorded by  
  • Effects of statin use on serum creatinine phosphokinase levels in normal thyroid function
    Jeonghoon Ha, Joonyub Lee, Jin Yu, Hakyoung Park, Jiwon Shinn, Seung-Hwan Lee, Jae-Hyoung Cho, Hun-Sung Kim
    The Korean Journal of Internal Medicine.2024; 39(4): 650.     CrossRef
  • Lipid Management in Korean People With Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
    Ye Seul Yang, Hack-Lyoung Kim, Sang-Hyun Kim, Min Kyong Moon
    Journal of Lipid and Atherosclerosis.2023; 12(1): 12.     CrossRef
  • Lipid Management in Korean People with Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
    Ye Seul Yang, Hack-Lyoung Kim, Sang-Hyun Kim, Min Kyong Moon
    Diabetes & Metabolism Journal.2023; 47(1): 1.     CrossRef
  • Bempedoic Acid for Lipid Management in the Indian Population: An Expert Opinion
    Jagdish Hiremath, J C Mohan, Prakash Hazra, JP S Sawhney, Ashwani Mehta, Sadanand Shetty, Abraham Oomman, Mahesh K Shah, Ganapathi Bantwal, Rajeev Agarwal, Rajiv Karnik, Peeyush Jain, Saumitra Ray, Sambit Das, Vibhuti Jadhao, Sachin Suryawanshi, Hanmant B
    Cureus.2023;[Epub]     CrossRef
  • Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI study
    Julia Brandts, Sarah Bray, Guillermo Villa, Alberico L. Catapano, Neil R. Poulter, Antonio J. Vallejo-Vaz, Kausik K. Ray
    The Lancet Regional Health - Europe.2023; 31: 100665.     CrossRef
  • Management of Dyslipidemia in Patients with Diabetes Mellitus
    Kyung Ae Lee
    The Journal of Korean Diabetes.2023; 24(3): 111.     CrossRef
  • Target Low-Density Lipoprotein-Cholesterol and Secondary Prevention for Patients with Acute Myocardial Infarction: A Korean Nationwide Cohort Study
    Ju Hyeon Kim, Jung-Joon Cha, Subin Lim, Jungseok An, Mi-Na Kim, Soon Jun Hong, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu, Do-Sun Lim, Kyeongmin Byeon, Sang-Wook Kim, Eun-Seok Shin, Kwang Soo Cha, Jei Keon Chae, Youngkeun Ahn, Myung Ho Jeong, Tae Hoo
    Journal of Clinical Medicine.2022; 11(9): 2650.     CrossRef
  • Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines
    Soo Jin Yun, In-Kyung Jeong, Jin-Hye Cha, Juneyoung Lee, Ho Chan Cho, Sung Hee Choi, SungWan Chun, Hyun Jeong Jeon, Ho-Cheol Kang, Sang Soo Kim, Seung-Hyun Ko, Gwanpyo Koh, Su Kyoung Kwon, Jae Hyuk Lee, Min Kyong Moon, Junghyun Noh, Cheol-Young Park, Sung
    Diabetes & Metabolism Journal.2022; 46(3): 464.     CrossRef
  • There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness
    Michael E. Makover, Michael D. Shapiro, Peter P. Toth
    American Journal of Preventive Cardiology.2022; 12: 100371.     CrossRef
  • Non-achievement of the Low-Density Lipoprotein Cholesterol Goal in Older Patients with Type 2 Diabetes Mellitus and a Very High Cardiovascular Disease Risk: A Multicenter Study in Vietnam
    Huan Thanh Nguyen, Khang Pham Trong Ha, An Huu Nguyen, Thu Thanh Nguyen, Hang My Lam
    Annals of Geriatric Medicine and Research.2021; 25(4): 278.     CrossRef
Close layer
Clinical Study
Low Predictive Value of FRAX Adjusted by Trabecular Bone Score for Osteoporotic Fractures in Korean Women: A Community-Based Cohort Study
Hana Kim, Jung Hee Kim, Min Joo Kim, A Ram Hong, HyungJin Choi, EuJeong Ku, Ji Hyun Lee, Chan Soo Shin, Nam H. Cho
Endocrinol Metab. 2020;35(2):359-366.   Published online June 24, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.2.359
  • 9,508 View
  • 152 Download
  • 12 Web of Science
  • 13 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
The value of the Fracture Risk Assessment Tool (FRAX) and the trabecular bone score (TBS) for assessing osteoporotic fracture risk has not been fully elucidated in Koreans. We conducted this study to clarify the predictive value of FRAX adjusted by TBS for osteoporotic fractures in Korean women.
Methods
After screening 7,192 eligible subjects from the Ansung cohort, 1,165 women aged 45 to 76 years with available bone mineral density (BMD) and TBS data were enrolled in this study. We assessed their clinical risk factors for osteoporotic fractures and evaluated the predictive value of FRAX with or without BMD and TBS.
Results
During the mean follow-up period of 7.5 years, 99 (8.5%) women suffered major osteoporotic fractures (MOFs) and 28 (2.4%) experienced hip fractures. FRAX without BMD, BMD-adjusted FRAX, and TBS-adjusted FRAX were significantly associated with the risk of MOFs (hazard ratio [HR] per percent increase, 1.08; 95% confidence interval [CI], 1.03 to 1.14; HR, 1.09; 95% CI, 1.03 to 1.15; and HR, 1.07; 95% CI, 1.02 to 1.13, respectively). However, BMD-adjusted FRAX and TBS-adjusted FRAX did not predict MOFs better than FRAX without BMD based on the Harrell’s C statistic. FRAX probabilities showed limited value for predicting hip fractures. The cut-off values of FRAX without BMD, FRAX with BMD, and FRAX with BMD adjusted by TBS for predicting MOFs were 7.2%, 5.0%, and 6.7%, respectively.
Conclusion
FRAX with BMD and TBS adjustment did not show better predictive value for osteoporotic fractures in this study than FRAX without adjustment. Moreover, the cut-off values of FRAX probabilities for treatment might be lower in Korean women than in other countries.

Citations

Citations to this article as recorded by  
  • Trabecular Bone Score in Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-Analysis
    A.B.M. Kamrul-Hasan, Saptarshi Bhattacharya, Vanishri Ganakumar, Lakshmi Nagendra, Deep Dutta, Fatema Tuz Zahura Aalpona, Joseph M. Pappachan
    Journal of Clinical Densitometry.2025; 28(4): 101602.     CrossRef
  • Update on the utility of trabecular bone score (TBS) in clinical practice for the management of osteoporosis: a systematic review by the Egyptian Academy of Bone and Muscle Health
    Yasser El Miedany, Walaa Elwakil, Mohammed Hassan Abu-Zaid, Safaa Mahran
    Egyptian Rheumatology and Rehabilitation.2024;[Epub]     CrossRef
  • Enhancing Osteoporosis Management: A Thorough Examination of Surgical Techniques and Their Effects on Patient Outcomes
    Mihnea Popa, Adrian Cursaru, Bogdan Cretu, Sergiu Iordache, Georgian L Iacobescu, Razvan Spiridonica, Bogdan Serban, Catalin Cirstoiu
    Cureus.2024;[Epub]     CrossRef
  • Imaging bone turnover assessment through volumetric density-adjusted standardized uptake value using quantitative bone SPECT/CT in osteoporosis
    Dong Yun Lee, Jungsu S. Oh, Ji Wan Kim, Seung Hun Lee, Beom-Jun Kim, Jung-Min Koh, Jae Seung Kim, Jin-Sook Ryu
    EJNMMI Research.2024;[Epub]     CrossRef
  • Comparison of predictive value of FRAX, trabecular bone score, and bone mineral density for vertebral fractures in systemic sclerosis: A cross-sectional study
    Kyung-Ann Lee, Hyun-Joo Kim, Hyun-Sook Kim
    Medicine.2023; 102(2): e32580.     CrossRef
  • Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools
    Michelle Gates, Jennifer Pillay, Megan Nuspl, Aireen Wingert, Ben Vandermeer, Lisa Hartling
    Systematic Reviews.2023;[Epub]     CrossRef
  • Chronic airway disease as a major risk factor for fractures in osteopenic women: Nationwide cohort study
    Sung Hye Kong, Ae Jeong Jo, Chan Mi Park, Kyun Ik Park, Ji Eun Yun, Jung Hee Kim
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Disease
    Enisa Shevroja, Jean-Yves Reginster, Olivier Lamy, Nasser Al-Daghri, Manju Chandran, Anne-Laurence Demoux-Baiada, Lynn Kohlmeier, Marie-Paule Lecart, Daniel Messina, Bruno Muzzi Camargos, Juraj Payer, Sansin Tuzun, Nicola Veronese, Cyrus Cooper, Eugene V.
    Osteoporosis International.2023; 34(9): 1501.     CrossRef
  • Comparison of HU histogram analysis and BMD for proximal femoral fragility fracture assessment: a retrospective single-center case–control study
    Sun-Young Park, Hong Il Ha, Injae Lee, Hyun Kyung Lim
    European Radiology.2022; 32(3): 1448.     CrossRef
  • Association of Trabecular Bone Score-Adjusted Fracture Risk Assessment Tool with Coronary Artery Calcification in Women
    Tzyy-Ling Chuang, Yuh-Feng Wang, Malcolm Koo, Mei-Hua Chuang
    Diagnostics.2022; 12(1): 178.     CrossRef
  • Risk of osteoporotic fracture in women using the FRAX tool with and without bone mineral density score in patients followed at a tertiary outpatient clinic ‒ An observational study
    Maria Helena Sampaio Favarato, Maria Flora de Almeida, Arnaldo Lichtenstein, Milton de Arruda Martins, Mario Ferreira Junior
    Clinics.2022; 77: 100015.     CrossRef
  • Comparison of Trabecular Bone Score–Adjusted Fracture Risk Assessment (TBS-FRAX) and FRAX Tools for Identification of High Fracture Risk among Taiwanese Adults Aged 50 to 90 Years with or without Prediabetes and Diabetes
    Tzyy-Ling Chuang, Mei-Hua Chuang, Yuh-Feng Wang, Malcolm Koo
    Medicina.2022; 58(12): 1766.     CrossRef
  • Application of the Trabecular Bone Score in Clinical Practice
    Sung Hye Kong, Namki Hong, Jin-Woo Kim, Deog Yoon Kim, Jung Hee Kim
    Journal of Bone Metabolism.2021; 28(2): 101.     CrossRef
Close layer
Review Articles
Diabetes
Recent Updates on Vascular Complications in Patients with Type 2 Diabetes Mellitus
Chan-Hee Jung, Ji-Oh Mok
Endocrinol Metab. 2020;35(2):260-271.   Published online June 24, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.2.260
  • 11,790 View
  • 305 Download
  • 20 Web of Science
  • 22 Crossref
AbstractAbstract PDFPubReader   ePub   
It is well known that patients with type 2 diabetes mellitus (T2DM) are at an increased risk of morbidity and mortality from atherosclerotic cardiovascular (CV) complications. Previously, the concept that diabetes mellitus (DM) is a “coronary artery disease (CAD) risk equivalent” was widely accepted, implying that all DM patients should receive intensive management. However, considerable evidence exist for wide heterogeneity in the risk of CV events among T2DM patients and the concept of a “CAD risk equivalent” has changed. Recent guidelines recommend further CV risk stratification in T2DM patients, with treatment tailored to the risk level. Although imaging modalities for atherosclerotic cardiovascular disease (ASCVD) have been used to improve risk prediction, there is currently no evidence that imaging-oriented therapy improves clinical outcomes. Therefore, controversy remains whether we should screen for CVD in asymptomatic T2DM. The coexistence of T2DM and heart failure (HF) is common. Based on recent CV outcome trials, sodium glucose cotransporter-2 inhibitors and glucagon like peptide-1 receptor agonists are recommended who have established ASCVD, indicators of high risk, or HF because of their demonstrated benefits for CVD. These circumstances have led to an increasing emphasis on ASCVD and HF in T2DM patients. In this review, we examine the literature published within the last 5 years on the risk assessment of CVD in asymptomatic T2DM patients. In particular, we review recent guidelines regarding screening for CVD and research focusing on the role of coronary artery calcium, coronary computed tomography angiography, and carotid intima-media thickness in asymptomatic T2DM patients.

Citations

Citations to this article as recorded by  
  • Sustained alogliptin elicits superior control of glycemia and related complications in diabetic rats: Effects on vital organs functions, biochemistry, and structure
    Mariam Mohamedy Eladawy, Hany M. El-Bassossy, Shaimaa S. El-Sayed
    European Journal of Pharmacology.2026; 1016: 178614.     CrossRef
  • Progress in Evaluation of Brain Structural Changes in Type 2 Diabetes Mellitus Complicated with Cognitive Impairment by Magnetic
    贤贤 周
    Advances in Clinical Medicine.2025; 15(01): 1281.     CrossRef
  • Predictive value of uric acid to albumin ratio for carotid atherosclerosis in type 2 diabetes mellitus: A retrospective study
    Yao Yin, Liyin Zhang, Jiaoyue Zhang, Si Jin, Aleksandra Klisic
    PLOS ONE.2025; 20(3): e0320738.     CrossRef
  • Predictive Value of Left Atrial Structure and Function Parameters in Left Ventricular Remodeling in Patients With Type 2 Diabetes Mellitus
    Yumeng Xing, Rui Zhao, Xiaoli Zhang, Jiamei Jin, Yiming Yang, Haier Wang, Yan Wang, Chunyan Zhong, Lin Chen, Yinjia Zhang
    Echocardiography.2025;[Epub]     CrossRef
  • The association between liver function tests abnormalities and type 2 diabetes mellitus patients in Saudi Arabia: a cross-sectional study
    Nimer Mehyar, Ziyad Alhajeri, Muath Alosaimi, Ziyad Alanazi, Abdulkarim Alanazi, Raghib Abusaris
    Frontiers in Clinical Diabetes and Healthcare.2025;[Epub]     CrossRef
  • Mechanistic Insights Into the Cardioprotective Effects of Modern Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review
    Mounica Ratnala, Loveleen K Johal, Zulaihat F Galadima, Fatima F Janjua, Katherine S Trejos Guzman, Kirshan Lal, Maryam Fatima, Mashal Khan, Maryem Mallick, Sunil Yadav, Muhammad Usman Sarwar, Riaz Khan
    Cureus.2025;[Epub]     CrossRef
  • Nonlinear association between high-density lipoprotein cholesterol and carotid atherosclerosis risk in patients with type 2 diabetes: a retrospective analysis from China
    Changchun Cao, Yuzhi Zheng, Fubing Zha, Yong Han, Haofei Hu, Meiling Huang
    European Journal of Medical Research.2025;[Epub]     CrossRef
  • Associations between neutrophil-lymphocyte ratio with all-cause mortality, major adverse vascular events and progression of diabetic kidney disease in type 2 diabetes mellitus
    Ying Jie Chee, Xiaoe Doris Zhang, Rinkoo Dalan
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Factors Affecting Arterial Stiffness and Brachial-Ankle Pulse Wave Velocity in Patients With Type 2 Diabetes
    Tomoki Furuya, Shinji Kitahama, Yuma Tamura, Susumu Ogawa, Yuki Nakatani, Takanori Yasu
    Cureus.2024;[Epub]     CrossRef
  • Serum levels of soluble receptor activator for nuclear factor kB ligand play a crucial role in the association of osteoprotegerin with coronary artery disease
    Shaoqiong Zhou, Hui Wen, Bin Wang, Siming Guan, Xin Fang
    Experimental and Therapeutic Medicine.2024;[Epub]     CrossRef
  • Significance of Myocardial Perfusion SPECT (Single-Photon Emission Computed Tomography) Imaging in the Detection of Silent Myocardial Ischemia in Type II Diabetic Patients with Microalbuminuria
    Nayyar Rubab, Muhammad Ijaz Khan, Tania Jabbar, Warda Ahmed, Farkhanda Gillani, Muhammad Shehzad Afzal, Muhammad Iftikhar Khattak, Muhammad Babar Imran
    Pakistan BioMedical Journal.2024; : 17.     CrossRef
  • Pathways of Coagulopathy and Inflammatory Response in SARS-CoV-2 Infection among Type 2 Diabetic Patients
    Orsolya-Zsuzsa Akácsos-Szász, Sándor Pál, Kinga-Ilona Nyulas, Enikő Nemes-Nagy, Ana-Maria Fárr, Lóránd Dénes, Mónika Szilveszter, Erika-Gyöngyi Bán, Mariana Cornelia Tilinca, Zsuzsánna Simon-Szabó
    International Journal of Molecular Sciences.2023; 24(5): 4319.     CrossRef
  • Increased soluble endoglin levels in newly-diagnosed type 2 diabetic patients are associated with endothelial dysfunction
    Xiaobing Dou, Xiujing Wang, Xiuhua Yu, Jiaqi Yao, Huiling Shen, Yao Xu, Bojing Zheng, Zhenying Zhang, Qingying Tan, Tianxiao Hu
    Endocrine Journal.2023; 70(7): 711.     CrossRef
  • Effects of hypertension on subcortical nucleus morphological alternations in patients with type 2 diabetes
    Feng Cui, Zhi-Qiang Ouyang, Yi-Zhen Zeng, Bing-Bing Ling, Li Shi, Yun Zhu, He-Yi Gu, Wan-Lin Jiang, Ting Zhou, Xue-Jin Sun, Dan Han, Yi Lu
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Coronary Artery Calcium Score as a Sensitive Indicator of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus: A Long-Term Cohort Study
    Dae-Jeong Koo, Mi Yeon Lee, Sun Joon Moon, Hyemi Kwon, Sang Min Lee, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki Won Oh, Sung Rae Cho, Young-Hoon Jeong, Eun-Jung Rhee
    Endocrinology and Metabolism.2023; 38(5): 568.     CrossRef
  • Exploring Endothelial Colony-Forming Cells to Better Understand the Pathophysiology of Disease: An Updated Review
    Qiuwang Zhang, Anthony Cannavicci, Michael J. B. Kutryk, Giuseppe Mandraffino
    Stem Cells International.2022; 2022: 1.     CrossRef
  • Recent Insights into the Nutritional Antioxidant Therapy in Prevention and Treatment of Diabetic Vascular Complications: A Comprehensive Review
    Narasimha M. Beeraka, Irina K. Tomilova, Galina A. Batrak, Maria V. Zhaburina, Vladimir N. Nikolenko, Mikhail Y. Sinelnikov, Liudmila M. Mikhaleva
    Current Medicinal Chemistry.2022; 29(11): 1920.     CrossRef
  • Topical Reappraisal of Molecular Pharmacological Approaches to Endothelial Dysfunction in Diabetes Mellitus Angiopathy
    Constantin Munteanu, Mariana Rotariu, Marius-Alexandru Turnea, Aurelian Anghelescu, Irina Albadi, Gabriela Dogaru, Sînziana Calina Silișteanu, Elena Valentina Ionescu, Florentina Carmen Firan, Anca Mirela Ionescu, Carmen Oprea, Gelu Onose
    Current Issues in Molecular Biology.2022; 44(8): 3378.     CrossRef
  • Visfatin is negatively associated with coronary artery lesions in subjects with impaired fasting glucose
    Fei Xu, Xiang Ning, Tong Zhao, Qinghua Lu, Huiqiang Chen
    Open Medicine.2022; 17(1): 1405.     CrossRef
  • Effects of dulaglutide on endothelial progenitor cells and arterial elasticity in patients with type 2 diabetes mellitus
    Dandan Xie, Yutong Li, Murong Xu, Xiaotong Zhao, Mingwei Chen
    Cardiovascular Diabetology.2022;[Epub]     CrossRef
  • Serum netrin and VCAM-1 as biomarker for Egyptian patients with type IΙ diabetes mellitus
    Maher M. Fadel, Faten R. Abdel Ghaffar, Shimaa K. Zwain, Hany M. Ibrahim, Eman AE. badr
    Biochemistry and Biophysics Reports.2021; 27: 101045.     CrossRef
  • Decoding the chemical composition and pharmacological mechanisms of Jiedu Tongluo Tiaogan Formula using high-performance liquid chromatography coupled with network pharmacology-based investigation
    Qi Zhang, Chunli Piao, Wenqi Jin, De Jin, Han Wang, Cheng Tang, Xiaohua Zhao, Naiwen Zhang, Shengnan Gao, Fengmei Lian
    Aging.2021; 13(21): 24290.     CrossRef
Close layer
Diabetes
Prevalence and Current Management of Cardiovascular Risk Factors in Korean Adults Based on Fact Sheets
Eun-Jung Rhee
Endocrinol Metab. 2020;35(1):85-94.   Published online March 19, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.1.85
  • 13,593 View
  • 193 Download
  • 41 Web of Science
  • 49 Crossref
AbstractAbstract PDFPubReader   ePub   

Korea is currently an aged society and is on the cusp of becoming a superaged society in a few years. The health burden of cardiovascular diseases increases with age, and the increasing prevalence of cardiovascular risk factors, such as obesity, hypertension, diabetes mellitus, and dyslipidemia, may be linked to increased population-level cardiovascular risk. In 2018, the prevalence of obesity in Korea was 35.7% (men, 45.4%; women, 26.5%) according to the Obesity Fact Sheet 2019, based on National Health Insurance Corporation medical checkup data. In 2016, the prevalence of diabetes was 14.4% in Koreans older than 30 years according to the Diabetes Fact Sheet published by the Korean Diabetes Association, based on data from the Korean National Health and Nutrition Examination Survey. The prevalence of hypertension in the total population of Korea in 2018 was 28.3% according to the Korean Hypertension Fact Sheet produced by the Korean Society of Hypertension. Lastly, the prevalence of dyslipidemia in 2018 was 40.5% according to the Dyslipidemia Fact Sheet published by the Korean Society of Lipid and Atherosclerosis. In this article, I would like to review the prevalence and current management of cardiovascular risk factors in Korea according to the fact sheets released by various associations.

Citations

Citations to this article as recorded by  
  • Association between cumulative low-income status and cardiovascular event incidence and mediating effect of engagement in health behaviour: a retrospective cohort study
    Sun Young Shim, Hyeonkyeong Lee, Mona Choi, Hyeon Chang Kim, Chang Gi Park, Hyang Yuol Lee
    European Journal of Cardiovascular Nursing.2026;[Epub]     CrossRef
  • Association of gender and metabolic factors with thyroid nodules in T2DM: a retrospective study
    Xi Yuan, Xin Wang, Xinwen Yu, Yuxin Jin, Aili Yang, Xiaorui Jing, Shengru Liang, Chunni Heng, Na Zhang, Lijuan Chao, Langlang Liu, Meiying Wang, Yufei Liu, Guohong Zhao, Bin Gao
    PeerJ.2025; 13: e19068.     CrossRef
  • Prevalence and Current Status of Cardiometabolic Risk Factors in Korean Adults Based on Fact Sheets 2024
    Eun-Jung Rhee
    Endocrinology and Metabolism.2025; 40(2): 174.     CrossRef
  • National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022
    Hyeseung Lee, Seokjun Kim, Yejun Son, Soeun Kim, Hyeon Jin Kim, Hyesu Jo, Jaeyu Park, Kyeongmin Lee, Hayeon Lee, Jiseung Kang, Selin Woo, Sunyoung Kim, Sang Youl Rhee, Jiyoung Hwang, Lee Smith, Dong Keon Yon
    Scientific Reports.2025;[Epub]     CrossRef
  • Obesity Report: Distribution and Pattern by Age and Sex in Heart Failure Cohort over 10 Years in Korea
    Joongmin Kim, Geunhee Park, Haeyong Pak, Hyeongsoo Kim, Ji-Yong Jang, Hancheol Lee, Jong-Kwan Park, Seung-Jin Oh, Se-Jung Yoon
    Journal of Cardiovascular Development and Disease.2025; 12(7): 244.     CrossRef
  • Prognostic Value of Brachial–Ankle Pulse Wave Velocity in the Prediction of Cardiovascular Events: Comparison with Brachial Pulse Pressure
    Bo Kyung Jeon, Hack-Lyoung Kim, Kyung-Jin Kim
    Journal of Clinical Medicine.2025; 14(24): 8724.     CrossRef
  • Continuity of care for patients with hypertension or diabetes mellitus reduced medical utilizations, total medical costs, and cardiovascular events based on the Korean NHIS-HEALS cohort
    Eun-Kyeong Yun, Jae-Yong Shim, Sang-Jun Shin, Hee-Taik Kang
    Nutrition, Metabolism and Cardiovascular Diseases.2025; : 104527.     CrossRef
  • Non-invasive coronary artery disease identification through the iris and bio-demographic health profile features using stacking learning
    Ferdi Özbilgin, Çetin Kurnaz, Ertan Aydın
    Image and Vision Computing.2024; 146: 105046.     CrossRef
  • Integrative Bioinformatics Approaches to Uncover Hub Genes and Pathways Involved in Cardiovascular Diseases
    Awatef Salah, Fériel Bouzid, Wala Dhouib, Riadh Benmarzoug, Nesrine Triki, Ahmed Rebai, Najla Kharrat
    Cell Biochemistry and Biophysics.2024; 82(3): 2107.     CrossRef
  • The association between TSH and thyroid hormones in the normal or subclinical dysfunction range with left ventricular diastolic dysfunction
    Ji Eun Jun, Tae Hyuk Kim, Sun Wook Kim, Jae Hoon Chung, Jae Hyeon Kim, You-Bin Lee, Mira Kang
    Scientific Reports.2024;[Epub]     CrossRef
  • Epidemiological Association of Current Smoking Status with Hypertension and Obesity among Adults Including the Elderly in Korea: Multivariate Analysis of a Nationwide Cross-Sectional Study Excluding Grades 2–3 Hypertension Cases
    Sung-Eun Park, Seyong Jang, Wi-Young So, Junsu Kim
    Journal of Cardiovascular Development and Disease.2024; 11(7): 212.     CrossRef
  • Incidence of metabolic dysfunction‐associated steatotic liver disease and advanced fibrosis and impact of overweight/obesity in elderly population: a nationwide cohort study
    Kunhee Kim, Yaeji Lee, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Inkyung Jung, Hye Won Lee
    Journal of Gastroenterology and Hepatology.2024; 39(12): 2845.     CrossRef
  • A Study on Changes in Nutritional and Blood Conditions Before and After Consumption of Diabetic Soymilk in Elderly Women with Diabetes
    Hyo-Jeong Hwang, Soon-Hee Park, Seon-Young Park, Soo-Rin Ahn, Su-Jin Park, Yoo-Jin Lee, Kwang-Jin Chon, Chung-Hwa Song, Dae-Gyun Moon, Kyung-Ok Shin
    Journal of the Korean Society of Food Science and Nutrition.2023; 52(4): 341.     CrossRef
  • Effect of hemp seed oil on lipid metabolism in rats fed a high-cholesterol diet
    Jin A Lee, Seong-Soo Roh, Woo Rak Lee, Mi-Rae Shin
    Journal of Nutrition and Health.2023; 56(4): 361.     CrossRef
  • The Longitudinal Effect of Ultra‐Processed Food on the Development of Dyslipidemia/Obesity as Assessed by the NOVA System and Food Compass Score
    Li‐Juan Tan, Su Bin Hwang, Sangah Shin
    Molecular Nutrition & Food Research.2023;[Epub]     CrossRef
  • Sex Differences in Coronary Artery Disease: Insights From the KoRean wOmen’S chest pain rEgistry (KoROSE)
    Hack-Lyoung Kim, Myung-A Kim
    Korean Circulation Journal.2023; 53(10): 655.     CrossRef
  • Awareness and Related Factors of Dyslipidemia in Menopausal Women in Korea
    Jeonghee Jeong, Mijin Kim
    Healthcare.2022; 10(1): 112.     CrossRef
  • Genetic Determinants of Visit-to-Visit Lipid Variability: Genome-Wide Association Study in Statin-Naïve Korean Population
    Jun-Bean Park, Eunsoon Shin, Jong-Eun Lee, Seung Jae Lee, Heesun Lee, Su-Yeon Choi, Eun Kyung Choe, Seung Ho Choi, Hyo Eun Park
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • TheIn VitroAntioxidant and Antidiabetic Activity of Various Fractions from Monascus-Fermented Ginger Extract
    Su-Min Yoon, Young-Hee Pyo
    Journal of the Korean Society of Food Science and Nutrition.2022; 51(2): 125.     CrossRef
  • The Influence of Obesity and Metabolic Health on Vascular Health
    Eun-Jung Rhee
    Endocrinology and Metabolism.2022; 37(1): 1.     CrossRef
  • Correlates of Objectively Measured Sitting Time in South Korean Adults: 2014–2015 Korea National Health and Nutrition Examination Survey
    Hyo Lee, Miyoung Lee
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • Association between metabolic syndrome and left ventricular geometric change including diastolic dysfunction
    Seung‐Jae Lee, Hyunah Kim, Byeong Kil Oh, Hyo‐In Choi, Ki‐Chul Sung, Jeonggyu Kang, Mi Yeon Lee, Jong‐Young Lee
    Clinical Cardiology.2022; 45(7): 767.     CrossRef
  • Sex and Gender Determinants of Vascular Disease in the Global Context
    Rubee Dev, Alayne M. Adams, Valeria Raparelli, Colleen M. Norris, Louise Pilote
    Canadian Journal of Cardiology.2022; 38(12): 1799.     CrossRef
  • Effects of exercise initiation and smoking cessation after new-onset type 2 diabetes mellitus on risk of mortality and cardiovascular outcomes
    Mee Kyoung Kim, Kyungdo Han, Bongsung Kim, Jinyoung Kim, Hyuk-Sang Kwon
    Scientific Reports.2022;[Epub]     CrossRef
  • Dyslipidaemia—Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease
    Sung-Bum Lee, Ja-Eun Choi, Byoungjin Park, Mi-Yeon Cha, Kyung-Won Hong, Dong-Hyuk Jung
    Biomedicines.2022; 10(7): 1615.     CrossRef
  • Current status of obesity treatment in Korea: based on the 2020 Korean Society for the Study of Obesity guidelines for obesity management
    Eun-Jung Rhee
    Journal of the Korean Medical Association.2022; 65(7): 388.     CrossRef
  • Association between endocrine-disrupting chemical mixture and metabolic indices among children, adolescents, and adults: A population-based study in Korea
    Byungmi Kim, Bohyun Park, Chung Ho Kim, Seyoung Kim, Bomi Park
    Environmental Pollution.2022; 315: 120399.     CrossRef
  • Genetic variation rs1121980 in the fat mass and obesity-associated gene (FTO) is associated with dietary intake in Koreans
    Young Goh, Jeong-Hwa Choi
    Food & Nutrition Research.2022;[Epub]     CrossRef
  • The association between hyperuricemia and cardiovascular disease history: A cross-sectional study using KoGES HEXA data
    Joo-Hee Kim, Mi Jung Kwon, Hyo Geun Choi, Sang Jun Lee, Sung-Woo Kim, Ji Hee Kim, Bong Cheol Kwon, Jung Woo Lee
    Medicine.2022; 101(51): e32338.     CrossRef
  • Association between Endocrine-Disrupting Chemical Mixture and Metabolic Indices Among Children, Adolescents, And Adults: A Population-Based Study in Korea
    Byungmi Kim, Chung Ho Kim, Bohyun Park, Seyoung Kim, Bomi Park
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • Thirty-six Year Trends in Mortality from Diseases of Circulatory System in Korea
    Jongmin Baek, Hokyou Lee, Hyeok-Hee Lee, Ji Eun Heo, So Mi Jemma Cho, Hyeon Chang Kim
    Korean Circulation Journal.2021; 51(4): 320.     CrossRef
  • Identification of susceptibility loci for cardiovascular disease in adults with hypertension, diabetes, and dyslipidemia
    Youhyun Song, Ja-Eun Choi, Yu-Jin Kwon, Hyuk-Jae Chang, Jung Oh Kim, Da-Hyun Park, Jae-Min Park, Seong-Jin Kim, Ji Won Lee, Kyung-Won Hong
    Journal of Translational Medicine.2021;[Epub]     CrossRef
  • Association of Maintaining Healthy Habits with Clinical Outcomes in Patients with Diabetes, Dyslipidemia or Hypertension
    Jeong Hyeon Kim, Young Ho Yun
    Korean Journal of Family Practice.2021; 11(1): 74.     CrossRef
  • Epidemiology of cardiovascular disease and its risk factors in Korea
    Hyeon Chang Kim
    Global Health & Medicine.2021; 3(3): 134.     CrossRef
  • Cumulative exposure to impaired fasting glucose and future risk of type 2 diabetes mellitus
    Mee Kyoung Kim, Kyungdo Han, Eun Sil Koh, Oak-Kee Hong, Ki-Hyun Baek, Ki-Ho Song, Hyuk-Sang Kwon
    Diabetes Research and Clinical Practice.2021; 175: 108799.     CrossRef
  • Association between Diabetes Mellitus and Oral Health Status in Patients with Cardiovascular Diseases: A Nationwide Population-Based Study
    Su-Jin Han, Youn-Jung Son, Bo-Hwan Kim
    International Journal of Environmental Research and Public Health.2021; 18(9): 4889.     CrossRef
  • Comorbidities and Factors Determining Medical Expenses and Length of Stay for Admitted COVID-19 Patients in Korea
    Su Yeon Jang, Jeong-Yeon Seon, Seok-Jun Yoon, So-Youn Park, Seung Heon Lee, In-Hwan Oh
    Risk Management and Healthcare Policy.2021; Volume 14: 2021.     CrossRef
  • Metabolic Syndrome Fact Sheet 2021: Executive Report
    Ji Hye Huh, Dae Ryong Kang, Jang Young Kim, Kwang Kon Koh
    CardioMetabolic Syndrome Journal.2021; 1(2): 125.     CrossRef
  • Effect of Triticum turgidum ssp. turanicum on serum lipid levels and colonic microbiota of dyslipidemia-induced rats
    Hyeon-Ju Seo, Kyoung-Sik Han
    Toxicology and Environmental Health Sciences.2021; 13(3): 195.     CrossRef
  • The Clinical Characteristics of Gestational Diabetes Mellitus in Korea: A National Health Information Database Study
    Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park
    Endocrinology and Metabolism.2021; 36(3): 628.     CrossRef
  • Comparison of the Efficacy and Safety of Atorvastatin 40 mg/ω-3 Fatty Acids 4 g Fixed-dose Combination and Atorvastatin 40 mg Monotherapy in Hypertriglyceridemic Patients who Poorly Respond to Atorvastatin 40 mg Monotherapy: An 8-week, Multicenter, Random
    Jong Shin Woo, Soon Jun Hong, Dong Hoon Cha, Kee Sik Kim, Moo Hyun Kim, Jun-Won Lee, Myung Ho Jeong, Jin-Ok Jeong, Jun-Hee Lee, Doo Soo Jeon, Eun Joo Cho, Soon Kil Kim, Jun Kwan, Chang Gyu Park, Hae Young Lee, Taek Jong Hong, Jinho Shin, Ho Joong Youn, Do
    Clinical Therapeutics.2021; 43(8): 1419.     CrossRef
  • Differing Nutrient Intake and Dietary Patterns According to the Presence of Hyper-Low-Density Lipoprotein Cholesterolemia or Hypertriglyceridemia
    Yu-Jin Kwon, Sujee Lee, Hye Sun Lee, Ji-Won Lee
    Nutrients.2021; 13(9): 3008.     CrossRef
  • A Century of Progress in Diabetes Care with Insulin: A History of Innovations and Foundation for the Future
    Seung-Hwan Lee, Kun-Ho Yoon
    Diabetes & Metabolism Journal.2021; 45(5): 629.     CrossRef
  • Frequency of Exposure to Impaired Fasting Glucose and Risk of Mortality and Cardiovascular Outcomes
    Seung-Hwan Lee, Kyungdo Han, Hyuk-Sang Kwon, Mee Kyoung Kim
    Endocrinology and Metabolism.2021; 36(5): 1007.     CrossRef
  • Metabolic risks in living kidney donors in South Korea
    Eunjeong Kang, Jina Park, Hyo Jeong Kim, Sehoon Park, Minsu Park, Yaerim Kim, Kwangsoo Kim, Sang Min Park, Dong-Wan Chae, Ho Jun Chin, Jung Pyo Lee, Sik Lee, Soo Wan Kim, Jang-Hee Cho, Miyeun Han, Yong Chul Kim, Yon Su Kim, Insun Choi, Hajeong Lee
    Kidney Research and Clinical Practice.2021; 40(4): 645.     CrossRef
  • Invited commentary on “Prediction of postoperative mortality and morbidity in octogenarians with gastric cancer - Comparison of P-POSSUM, O-POSSUM, and E-POSSUM: A retrospective single-center cohort study”
    Alessandro M. Paganini, Andrea Balla
    International Journal of Surgery.2020; 78: 22.     CrossRef
  • Association of the Healthy Eating Index with Estimated Cardiovascular Age in Adults from the KNHANES 2013–2017
    Sunmin Park, Kyungjin Kim, Byung-Kook Lee, Jaeouk Ahn
    Nutrients.2020; 12(10): 2912.     CrossRef
  • Anti-Obesity and Antidiabetic Effects of Nelumbinis Semen Powder in High-Fat Diet-Induced Obese C57BL/6 Mice
    Su Bin Hwang, Bog-Hieu Lee
    Nutrients.2020; 12(11): 3576.     CrossRef
  • Inhibitory Effect of Jeju Tea Extracts and Vanadate on Postprandial Hyperglycemia and Hypertension, and In Vitro Study
    Shin Young Park
    The Korean Journal of Clinical Laboratory Science.2020; 52(4): 398.     CrossRef
Close layer
Mineral, Bone & Muscle
Potential Biomarkers to Improve the Prediction of Osteoporotic Fractures
Beom-Jun Kim, Seung Hun Lee, Jung-Min Koh
Endocrinol Metab. 2020;35(1):55-63.   Published online March 19, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.1.55
  • 10,420 View
  • 163 Download
  • 29 Web of Science
  • 27 Crossref
AbstractAbstract PDFPubReader   ePub   

Osteoporotic fracture (OF) is associated with high disability and morbidity rates. The burden of OF may be reduced by early identification of subjects who are vulnerable to fracture. Although the current fracture risk assessment model includes clinical risk factors (CRFs) and bone mineral density (BMD), its overall ability to identify individuals at high risk for fracture remains suboptimal. Efforts have therefore been made to identify potential biomarkers that can predict the risk of OF, independent of or combined with CRFs and BMD. This review highlights the emerging biomarkers of bone metabolism, including sphongosine-1-phosphate, leucine-rich repeat-containing 17, macrophage migration inhibitory factor, sclerostin, receptor activator of nuclear factor-κB ligand, and periostin, and the importance of biomarker risk score, generated by combining these markers, in enhancing the accuracy of fracture prediction.

Citations

Citations to this article as recorded by  
  • Advanced lung cancer inflammation index as a diagnostic indicator of bone turnover in osteoporotic fracture patients: a non-linear analysis
    Jiahao Wang, Mengcheng Zhu, Weihong Wang, Chong Li, Ke Lu, Yanming Hao
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Bone mineral density in French adults with early-treated phenylketonuria
    Elisa Dybal, François Maillot, François Feillet, Alain Fouilhoux, Leonardo Astudillo, Christian Lavigne, Jean-Baptiste Arnoux, Sylvie Odent, Claire Gay, Manuel Schiff, Karin Mazodier, Alice Kuster, Vincent Rigalleau, Christel Thauvin-Robinet, Vanessa Legu
    Molecular Genetics and Metabolism.2025; 144(3): 109044.     CrossRef
  • The Impact of Traditional Chinese Medicines on Osteoclastogenesis through NF-κB Signaling Pathway: A Review
    Jiajun Huang, Diyou Wu, Yu Zhao, Yun Xue, Junqing Huang, Bin Yang
    Pharmacognosy Magazine.2025; 21(4): 1153.     CrossRef
  • Global knowledge mapping of receptor activator of nuclear factor kappa-B ligand in osteoporotic fractures: a bibliometric analysis (2001–2024)
    Shuai Lu, Huaishuang Shen, Minjuan Li, Yiming Luo, Hao Sun, Xian Zhao, Jianming Chen, Ruifeng Bai, Pengli Han, Yejun Zha, Xieyuan Jiang
    Frontiers in Molecular Biosciences.2025;[Epub]     CrossRef
  • Bone biomarkers in post-polio clinic patients
    Seyed Pezhman Madani, Richard Kremer, Ami Grunbaum, Shaddam Bagmar, Andrea Benedetti, Daria A. Trojan
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Identification and Validation of Novel Lipids Linked to Bone Mineral Density Change and Fracture Risk
    Canchen Ma, Ziyuan Shen, Jing Tian, Yvette L. Schooneveldt, Corey Giles, Flavia Cicuttini, Graeme Jones, Peter J. Meikle, Feng Pan
    Calcified Tissue International.2025;[Epub]     CrossRef
  • Isorhamnetin ameliorates ovariectomy-induced osteoporosis in female rats by regulating the receptor activator of nuclear factor kappa B ligand, osteoprotegerin, bone morphogenetic protein 2 and runt-related transcription factor 2 signaling pathway
    Haibin JIAO, Kun ZHENG
    Journal of Veterinary Medical Science.2025; 87(7): 826.     CrossRef
  • Systematic Review and Meta-Analysis of Clinical Efficacy of Herbal Medicine on Osteoporosis
    Su Min Hong, Hyun Ju Ha, Sohyeon Park, Chang-Gue Son, Min-Seok Oh, Eun-Jung Lee
    Journal of Korean Medicine Rehabilitation.2025; 35(3): 13.     CrossRef
  • The Association of Bone-related Biomarkers With Incident Hip Fracture: A Nested Case-control Study
    Sara J Cromer, Elaine W Yu, Elisabetta Patorno, Gary C Curhan, Julie M Paik
    Journal of the Endocrine Society.2025;[Epub]     CrossRef
  • Evaluation of osteoporosis in adult patients with beta-thalassemia major and its relation to serum sclerostin level
    Ahmed Abd El Fattah El Bamby, Tamer Abd El Hamid El bedawi, Mohammed Adel Eltomi, Sara Mamdouh Shoeeb, Enji Abd El Wahab Ibrahim
    Clinics and Research in Hepatology and Gastroenterology.2025; 49(9): 102709.     CrossRef
  • Novel aspects of biochemical assessment of bone remodeling and mineralization
    Dorota Leszczyńska, Alicja Szatko, Agata Toboła, Katarzyna Karoń, Waldemar Misiorowski, Piotr Glinicki, Wojciech Zgliczyński
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Application of artificial intelligence in osteoporosis: a review
    Shu-Ting Fan, Min Lu, Jin-Lu Dong, Yi-Lin Li, Li-Na Hao, Ren-Chao Dong, Ming-Dong Hou
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Ångstrom-scale gold particles loaded with alendronate via alpha-lipoic acid alleviate bone loss in osteoporotic mice
    Weihang Gao, Jiao Jiao Li, Jingyu Shi, Hongbing Lan, Yuanyuan Guo, Dehao Fu
    Journal of Nanobiotechnology.2024;[Epub]     CrossRef
  • Changes in bone turnover markers 6–12 months after bariatric surgery
    Per G. Farup
    Scientific Reports.2024;[Epub]     CrossRef
  • Imaging bone turnover assessment through volumetric density-adjusted standardized uptake value using quantitative bone SPECT/CT in osteoporosis
    Dong Yun Lee, Jungsu S. Oh, Ji Wan Kim, Seung Hun Lee, Beom-Jun Kim, Jung-Min Koh, Jae Seung Kim, Jin-Sook Ryu
    EJNMMI Research.2024;[Epub]     CrossRef
  • The administration of bovine hydroxyapatite-alendronate implant accelerates bone defect healing in an osteoporotic rat
    Toetik Aryani, Aniek Setiya Budiatin, Samirah, Aulia Maulidina, Aulia Intan Firdaus, Maria Apriliani Gani, Khoirotin Nisak, Junaidi Khotib, Alvi Jauharotus Syukriya
    Technology and Health Care.2023; 31(5): 1747.     CrossRef
  • Impact of Intravenous Iron Substitution on Serum Phosphate Levels and Bone Turnover Markers—An Open-Label Pilot Study
    Alexandra Struppe, Jakob E. Schanda, Andreas Baierl, Paul Watzl, Christian Muschitz
    Nutrients.2023; 15(12): 2693.     CrossRef
  • Dynamics of Bone Disease Biomarkers Dickkopf-1 and Sclerostin in Patients with Multiple Myeloma
    Vladimir Gerov, Daniela Gerova, Ilina Micheva, Miglena Nikolova, Galya Mihaylova, Bistra Galunska
    Journal of Clinical Medicine.2023; 12(13): 4440.     CrossRef
  • Impact of vitamin D supplementation on markers of bone turnover: Systematic review and meta‐analysis of randomised controlled trials
    Mohammad Hassan Sohouli, Sicong Wang, Faisal Almuqayyid, Mariana Papini Gabiatti, Fateme Mozaffari, Zahra Mohamadian, Nazanin Koushki, Kamar Allayl Alras, Abdullah M. AlHossan, Saud K. Albatati, Aya Alfardous Alazm, Saeed Baradwan, Mihnea‐Alexandru Găman,
    European Journal of Clinical Investigation.2023;[Epub]     CrossRef
  • Night shift work and serum markers of bone turnover in male shift workers
    Margherita Martelli, Gianmaria Salvio, Raffaella Lazzarini, Marijana Milinkovic, Alessandro Ciarloni, Giancarlo Balercia, Lory Santarelli, Massimo Bracci
    Chronobiology International.2023; 40(9): 1270.     CrossRef
  • Circulating sRANKL, Periostin, and Osteopontin as Biomarkers for the Assessment of Activated Osteoclastogenesis in Myeloma Related Bone Disease
    Vladimir Gerov, Daniela Gerova, Ilina Micheva, Miglena Nikolova, Milena Pasheva, Neshe Nazifova, Bistra Galunska
    Cancers.2023; 15(23): 5562.     CrossRef
  • Oral Administration of Isovitexin, a Naturally Occurring Apigenin Derivative Showed Osteoanabolic Effect in Ovariectomized Mice: A Comparative Study with Teriparatide
    Subhashis Pal, Shivani Sharma, Konica Porwal, Mohammed Riyazuddin, Chirag Kulkarni, Sourav Chattopadhyay, Sabyasachi Sanyal, Jiaur R. Gayen, Naibedya Chattopadhyay
    Calcified Tissue International.2022; 111(2): 196.     CrossRef
  • Serum sclerostin levels in osteoporotic fracture patients
    Erwin A. Gorter, Casper R. Reinders, Pieta Krijnen, Natasha M. Appelman-Dijkstra, Inger B. Schipper
    European Journal of Trauma and Emergency Surgery.2022; 48(6): 4857.     CrossRef
  • Elevated gamma-glutamyl transpeptidase level is associated with an increased risk of hip fracture in postmenopausal women
    Kyoung Jin Kim, Namki Hong, Min Heui Yu, Seunghyun Lee, Sungjae Shin, Sin Gon Kim, Yumie Rhee
    Scientific Reports.2022;[Epub]     CrossRef
  • Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis
    Alice Wang, Nishi Karunasinghe, Lindsay D. Plank, Shuotun Zhu, Sue Osborne, Charis Brown, Karen Bishop, Tiffany Schwass, Sofian Tijono, Michael Holmes, Jonathan Masters, Roger Huang, Christine Keven, Lynnette R. Ferguson, Ross Lawrenson
    Scientific Reports.2021;[Epub]     CrossRef
  • Update on Glucocorticoid Induced Osteoporosis
    Soo-Kyung Cho, Yoon-Kyoung Sung
    Endocrinology and Metabolism.2021; 36(3): 536.     CrossRef
  • Nobiletin promotes osteogenic differentiation of human osteoblastic cell line (MG-63) through activating the BMP-2/RUNX-2 signaling pathway
    Ying Pang, Lili Liu, Hong Mu, Vishnu Priya Veeraraghavan
    Saudi Journal of Biological Sciences.2021; 28(9): 4916.     CrossRef
Close layer
Thyroid
Management of Low-Risk Papillary Thyroid Cancer
Nicole M. Iñiguez-Ariza, Juan P. Brito
Endocrinol Metab. 2018;33(2):185-194.   Published online June 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.2.185
  • 13,083 View
  • 166 Download
  • 41 Web of Science
  • 42 Crossref
AbstractAbstract PDFPubReader   ePub   

The incidence of thyroid cancer has increased, mainly due to the incidental finding of low-risk papillary thyroid cancers (PTC). These malignancies grow slowly, and are unlikely to cause morbidity and mortality. New understanding about the prognosis of tumor features has led to reclassification of many tumors within the low-risk thyroid category, and to the development of a new one “very low-risk tumors.” Alternative less aggressive approaches to therapy are now available including active surveillance and minimally invasive interventions. In this narrative review, we have summarized the available evidence for the management of low-risk PTC.

Citations

Citations to this article as recorded by  
  • Radiofrequency Ablation for Primary Thyroid Cancer
    Iram Hussain
    Endocrine Practice.2026;[Epub]     CrossRef
  • Clinical and surgical outcome of hemi thyroidectomy in low-risk papillary carcinoma thyroid
    Muhammad Ali Azad, A. K. M. Mashiul Munir, Mohammad Misbah Al Kabir Sumon, Lailanur, Mohammad Nesar Uddin
    International Surgery Journal.2025; 12(5): 713.     CrossRef
  • Thermal field management in thyroid ablation for papillary thyroid carcinoma: Advancing precision and patient-centered care
    Sivan Sathish
    World Journal of Radiology.2025;[Epub]     CrossRef
  • Risk of malignancy in Thy3 thyroid nodules
    Emad Mofid Nassif Rezkallah, Ragai Sobhi Hanna, Wael Magdy Elsaify
    Endocrine Regulations.2024; 58(1): 19.     CrossRef
  • Adequacy of clinical guideline recommendations for patients with low-risk cancer managed with monitoring: systematic review
    Kiana K. Collins, Claire Friedemann Smith, Tori Ford, Nia Roberts, Brian D. Nicholson, Jason L. Oke
    Journal of Clinical Epidemiology.2024; 169: 111280.     CrossRef
  • Endokrine Onkologie
    Kerstin Lorenz
    Die Innere Medizin.2024; 65(7): 656.     CrossRef
  • Racial–Ethnic Comparison of Treatment for Papillary Thyroid Cancer in the Military Health System
    Yvonne L. Eaglehouse, Sarah Darmon, Craig D. Shriver, Kangmin Zhu
    Annals of Surgical Oncology.2024; 31(12): 8196.     CrossRef
  • A Qualitative Thematic Analysis Exploring Chinese Young Adults’ Experiences in Decision Making on the Management of Low-Risk Papillary Thyroid Cancer
    Xinyue Gu, Pingting Zhu, Hui Zhang, Wen Wang, Yinwen Ding, Meiyan Qian, Guanghui Shi, Qianqian Zhang, Josephine Hegarty
    Thyroid®.2024; 34(12): 1486.     CrossRef
  • Safety and Effectiveness of Percutaneous Ethanol Injection as a Treatment for Locally Recurrent Papillary Thyroid Carcinoma
    Amin Momeni Moghaddam, Mahsa Abbaszadeh, Vajihe Chavoshi, Amir Ebadinejad, Nafiseh Hassanloo, Farhad Hosseinpanah
    International Journal of Endocrinology and Metabolism.2024;[Epub]     CrossRef
  • Integrated metabolic and genetic analysis reveals distinct features of human differentiated thyroid cancer
    Eduardo Cararo Lopes, Akshada Sawant, Dirk Moore, Hua Ke, Fuqian Shi, Saurabh Laddha, Ying Chen, Anchal Sharma, Jake Naumann, Jessie Yanxiang Guo, Maria Gomez, Maria Ibrahim, Tracey L. Smith, Gregory M. Riedlinger, Edmund C. Lattime, Stanley Trooskin, Shr
    Clinical and Translational Medicine.2023;[Epub]     CrossRef
  • Clinical management of low-risk papillary thyroid microcarcinoma
    Chie MASAKI, Kiminori SUGINO, Koichi ITO
    Minerva Endocrinology.2022;[Epub]     CrossRef
  • The circ_FAM53B-miR-183-5p-CCDC6 axis modulates the malignant behaviors of papillary thyroid carcinoma cells
    Chong Zhang, Huxia Gu, Dingrong Liu, Fuyun Tong, Huijie Wei, Dan Zhou, Jing Fang, Xiaolu Dai, Haibo Tian
    Molecular and Cellular Biochemistry.2022; 477(11): 2627.     CrossRef
  • An Appraisal and Update of Fluorodeoxyglucose and Non-Fluorodeoxyglucose-PET Tracers in Thyroid and Non–Thyroid Endocrine Neoplasms
    Aadil Adnan, Shobhana Raju, Rakesh Kumar, Sandip Basu
    PET Clinics.2022; 17(3): 343.     CrossRef
  • A Narrative Review of Preventive Central Lymph Node Dissection in Patients With Papillary Thyroid Cancer - A Necessity or an Excess
    David D. Dolidze, Alexey V. Shabunin, Robert B. Mumladze, Arshak V. Vardanyan, Serghei D. Covantsev, Alexander M. Shulutko, Vasiliy I. Semikov, Khalid M. Isaev, Airazat M. Kazaryan
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Ethanol Ablation as a Treatment in a Low-Risk Follicular Thyroid Cancer: A Case Report
    Juan Pesantez, Carla Lituma, Carla Valencia, Jose Prieto, Marco Cazorla
    Cureus.2022;[Epub]     CrossRef
  • The new T3b category has clinical significance? SEER‐based study
    Jingzhe Xiang, Zhihong Wang, Wei Sun, Hao Zhang
    Clinical Endocrinology.2021; 94(3): 449.     CrossRef
  • Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study
    Xiao-Jing Cao, Juan Liu, Ya-Lin Zhu, Lu Qi, Geng Liu, Hong-Ling Wang, Zhong-Hua Wang, Ying Zhou, Jun-Feng He, Jian-Qin Guo, Li-Li Shi, Mei Jian, Aini Shataer, Guo-Zhen Yan, Zhen-Long Zhao, Ying Wei, Li-Li Peng, Yan Li, Ying Che, Shu-Rong Wang, Ming-An Yu
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(2): e573.     CrossRef
  • A Clinical Audit of Hemithyroidectomy for Differentiated Thyroid Cancer—Experience from a Tertiary Cancer Center
    Nithyanand Chidambaranathan, Shivakumar Thiagarajan, Nandini Menon, Adhara Chakraborthy, Richa Vaish, Devendra Chaukar
    Indian Journal of Surgery.2021; 83(6): 1444.     CrossRef
  • Pros and cons of hemi‐thyroidectomy for low‐risk differentiated thyroid cancer
    Alexander J. Papachristos, Anthony Glover, Mark S. Sywak, Stan B. Sidhu
    ANZ Journal of Surgery.2021; 91(9): 1704.     CrossRef
  • Lactate Dehydrogenase A as a Potential New Biomarker for Thyroid Cancer
    Eun Jeong Ban, Daham Kim, Jin Kyong Kim, Sang-Wook Kang, Jandee Lee, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung, Kunhong Kim
    Endocrinology and Metabolism.2021; 36(1): 96.     CrossRef
  • Taraxasterol inhibits TGF-β1-induced epithelial-to-mesenchymal transition in papillary thyroid cancer cells through regulating the Wnt/β-catenin signaling
    J Zhu, X Li, S Zhang, J Liu, X Yao, Q Zhao, B Kou, P Han, X Wang, Y Bai, Z Zheng, C Xu
    Human & Experimental Toxicology.2021; 40(12_suppl): S87.     CrossRef
  • Is Delayed Papillary Thyroid Cancer Surgery Associated with Higher Mortality Risk?
    Eddy P. Lincango Naranjo, Juan P. Brito
    Clinical Thyroidology.2021; 33(9): 400.     CrossRef
  • MicroRNA-99a-3p/GRP94 axis affects metastatic progression of human papillary thyroid carcinoma by regulating ITGA2 expression and localization
    Yun Gao, Yi Pan, Tingting Wang, Ying Yao, Wenbo Yuan, Xue Zhu, Ke Wang
    Acta Biochimica et Biophysica Sinica.2021; 53(12): 1650.     CrossRef
  • Microscopic Extrathyroidal Extension Results in Increased Rate of Tumor Recurrence and Is an Independent Predictor of Patient’s Outcome in Middle Eastern Papillary Thyroid Carcinoma
    Sandeep Kumar Parvathareddy, Abdul K. Siraj, Zeeshan Qadri, Felisa DeVera, Khawar Siddiqui, Saif S. Al-Sobhi, Fouad Al-Dayel, Khawla S. Al-Kuraya
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • 80MAP17 promotes the tumorigenesis of papillary thyroid carcinoma by reducing the stability of p53
    Kun Yu, Hongjiang Lu, Yanhong Chen, Ying Xin, Zhuo Tan, Qiong Yang
    Frontiers in Bioscience-Landmark.2021;[Epub]     CrossRef
  • New paradigms in the treatment of low-risk thyroid cancer
    Firas Baidoun, Anas M. Saad, Omar Abdel-Rahman
    Expert Review of Endocrinology & Metabolism.2020; 15(4): 251.     CrossRef
  • The Impact of Transcription Factor Prospero Homeobox 1 on the Regulation of Thyroid Cancer Malignancy
    Magdalena Rudzińska, Barbara Czarnocka
    International Journal of Molecular Sciences.2020; 21(9): 3220.     CrossRef
  • Modified risk stratification based on cervical lymph node metastases following lobectomy for papillary thyroid carcinoma
    Eyun Song, Jonghwa Ahn, Dong Eun Song, Won Woong Kim, Min Ji Jeon, Tae‐Yon Sung, Tae Yong Kim, Ki Wook Chung, Won Bae Kim, Young Kee Shong, Suck Joon Hong, Yu‐Mi Lee, Won Gu Kim
    Clinical Endocrinology.2020; 92(4): 358.     CrossRef
  • Clinicopathological significance of the single nucleotide polymorphism, rs2853669 within the TERT promoter in papillary thyroid carcinoma
    Tatsuya Hirokawa, Yuu Arimasu, Tomohiro Chiba, Masachika Fujiwara, Hiroshi Kamma
    Pathology International.2020; 70(4): 217.     CrossRef
  • Diagnostic accuracy and ability to reduce unnecessary FNAC: A comparison between four Thyroid Imaging Reporting Data System (TI-RADS) versions
    Lingsze Tan, Ying Sern Tan, Suzet Tan
    Clinical Imaging.2020; 65: 133.     CrossRef
  • Amino Acid Transporters as Potential Therapeutic Targets in Thyroid Cancer
    Keisuke Enomoto, Muneki Hotomi
    Endocrinology and Metabolism.2020; 35(2): 227.     CrossRef
  • FDG PET/CT versus somatostatin receptor PET/CT in TENIS syndrome: a systematic review and meta-analysis
    Felipe Alves Mourato, Maria Amorim Almeida, Ana Emília Teixeira Brito, Aline Lopes Garcia Leal, Paulo Almeida Filho, Elba Etchebehere
    Clinical and Translational Imaging.2020; 8(5): 365.     CrossRef
  • Factors Associated with Health Behaviors in Thyroid Cancer Survivors
    Junghyun Yoon, Boyoung Park
    Journal of Cancer Prevention.2020; 25(3): 173.     CrossRef
  • Patient-Derived Papillary Thyroid Cancer Organoids for Radioactive Iodine Refractory Screening
    Luc H.J. Sondorp, Vivian M.L. Ogundipe, Andries H. Groen, Wendy Kelder, Annelies Kemper, Thera P. Links, Robert P. Coppes, Schelto Kruijff
    Cancers.2020; 12(11): 3212.     CrossRef
  • Hemithyroidectomy for Thyroid Cancer: A Review
    Noor Addasi, Abbey Fingeret, Whitney Goldner
    Medicina.2020; 56(11): 586.     CrossRef
  • Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis
    Jonghwa Ahn, Meihua Jin, Eyun Song, Min Ji Jeon, Tae Yong Kim, Jin-Sook Ryu, Won Bae Kim, Young Kee Shong, Ji Min Han, Won Gu Kim
    Endocrinology and Metabolism.2020; 35(4): 830.     CrossRef
  • Clinical Significance of Gross Invasion of Strap Muscles in Patients With 1- to 4-cm-Sized Papillary Thyroid Carcinoma Undergoing Lobectomy
    Eyun Song, Won Woong Kim, Min Ji Jeon, Tae-Yon Sung, Dong Eun Song, Tae Yong Kim, Ki Wook Chung, Won Bae Kim, Young Kee Shong, Suck Joon Hong, Yu-Mi Lee, Won Gu Kim
    Annals of Surgical Oncology.2019; 26(13): 4466.     CrossRef
  • Lobectomy Is Feasible for 1–4 cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence
    Eyun Song, Minkyu Han, Hye-Seon Oh, Won Woong Kim, Min Ji Jeon, Yu-Mi Lee, Tae Yong Kim, Ki Wook Chung, Won Bae Kim, Young Kee Shong, Suck Joon Hong, Tae-Yon Sung, Won Gu Kim
    Thyroid.2019; 29(1): 64.     CrossRef
  • Laser and radiofrequency ablations for benign and malignant thyroid tumors
    Giovanni Mauri, Nicolò Gennaro, Min Kyoung Lee, Jung Hwan Baek
    International Journal of Hyperthermia.2019; 36(2): 13.     CrossRef
  • US-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: Efficacy and Safety in a Large Population
    Hyun Kyung Lim, Se Jin Cho, Jung Hwan Baek, Kang Dae Lee, Chang Woo Son, Jung Min Son, Seon Mi Baek
    Korean Journal of Radiology.2019; 20(12): 1653.     CrossRef
  • Utility of Early Postoperative Unstimulated Thyroglobulin in Influencing Decision Making in Patients with Papillary Thyroid Carcinoma
    Alexandria D. McDow, Cynthia M. Shumway, Susan C. Pitt, David F. Schneider, Rebecca S. Sippel, Kristin L. Long
    Annals of Surgical Oncology.2019; 26(12): 4002.     CrossRef
  • Extent of Surgery for Low-Risk Differentiated Thyroid Cancer
    Alexandria D. McDow, Susan C. Pitt
    Surgical Clinics of North America.2019; 99(4): 599.     CrossRef
Close layer
Original Article
Clinical Study
Disease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea: A Multicenter Cohort Study
Min Ji Jeon, Won Gu Kim, Tae Hyuk Kim, Hee Kyung Kim, Bo Hyun Kim, Hyon-Seung Yi, Eun Sook Kim, Hosu Kim, Young Nam Kim, Eun Heui Kim, Tae Yong Kim, Sun Wook Kim, Ho-Cheol Kang, Jae Hoon Chung, Young Kee Shong, Won Bae Kim
Endocrinol Metab. 2017;32(4):434-441.   Published online November 22, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.4.434
  • 9,844 View
  • 67 Download
  • 31 Web of Science
  • 30 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   
Background

Little is known regarding disease-specific mortality of differentiated thyroid cancer (DTC) patients and its risk factors in Korea.

Methods

We retrospectively reviewed a large multi-center cohort of thyroid cancer from six Korean hospitals and included 8,058 DTC patients who underwent initial surgery between 1996 and 2005.

Results

Mean age of patients at diagnosis was 46.2±12.3 years; 87% were females. Most patients had papillary thyroid cancer (PTC; 97%) and underwent total thyroidectomy (85%). Mean size of the primary tumor was 1.6±1.0 cm. Approximately 40% of patients had cervical lymph node (LN) metastases and 1.3% had synchronous distant metastases. During 11.3 years of follow-up, 150 disease-specific mortalities (1.9%) occurred; the 10-year disease-specific survival (DSS) rate was 98%. According to the year of diagnosis, the number of disease-specific mortality was not different. However, the rate of disease-specific mortality decreased during the study period (from 7.7% to 0.7%). Older age (≥45 years) at diagnosis, male, follicular thyroid cancer (FTC) versus PTC, larger tumor size (>2 cm), presence of extrathyroidal extension (ETE), lateral cervical LN metastasis, distant metastasis and tumor node metastasis (TNM) stage were independent risk factors of disease-specific mortality of DTC patients.

Conclusion

The rate of disease-specific mortality of Korean DTC patients was 1.9%; the 10-year DSS rate was 98% during 1996 to 2005. Older age at diagnosis, male, FTC, larger tumor size, presence of ETE, lateral cervical LN metastasis, distant metastasis, and TNM stages were significant risk factors of disease-specific mortality of Korean DTC patients.

Citations

Citations to this article as recorded by  
  • Prognosis and surgical outcomes of isthmusectomy for cN0 solitary Low-Risk papillary thyroid microcarcinoma in the isthmus
    Feng Zhu, QiJun Zhang, Shuai Dong, XiaoJun Xie, YiJun Wu
    Endocrine.2026;[Epub]     CrossRef
  • Rectum, Penile, Brain and Bladder, Consecutive Rare Distant Metastasis in Two Patients With Papillary Thyroid Carcinoma: Case Reports
    Douk Kwon, Won Woong Kim, Byung-Chang Kim, Yu-mi Lee, Ki-Wook Chung, Tae-Yon Sung
    Journal of Endocrine Surgery.2025; 25(3): 109.     CrossRef
  • Laterocervical Lymph Node Metastases in Papillary Thyroid Carcinoma: Predictive Factors for Recurrence and Oncological Outcome
    Andrea Migliorelli, Marianna Manuelli, Agnese Maria Tringali, Claudio Moretti, Virginia Corazzi, Matteo Geminiani, Andrea Ciorba, Francesco Stomeo, Stefano Pelucchi, Chiara Bianchini
    Journal of Personalized Medicine.2025; 15(10): 496.     CrossRef
  • Impact of Tumor Size on Prognosis in Differentiated Thyroid Cancer with Gross Extrathyroidal Extension to Strap Muscles: Redefining T3b
    Joonseon Park, Solji An, Ja Seong Bae, Kwangsoon Kim, Jeong Soo Kim
    Cancers.2024; 16(14): 2577.     CrossRef
  • Log odds of negative lymph nodes/T stage ratio (LONT): A new prognostic tool for differentiated thyroid cancer without metastases in patients aged 55 and older
    Xuezhen Wang, Yufan Wu, Xiaoxia Li, Jinsheng Hong, Mingwei Zhang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • The association between vitamin D supplementation and the long-term prognosis of differentiated thyroid cancer patients: a retrospective observational cohort study with propensity score matching
    Jong-hyuk Ahn, Hoonsung Choi, Su-jin Kim, Sun Wook Cho, Kyu Eun Lee, Do Joon Park, Young Joo Park
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Linear association between radioactive iodine dose and second primary malignancy risk in thyroid cancer
    Kyeong Jin Kim, Kyoung Jin Kim, Jimi Choi, Nam Hoon Kim, Sin Gon Kim
    JNCI: Journal of the National Cancer Institute.2023; 115(6): 695.     CrossRef
  • Outcomes of Advanced Medullary Thyroid Carcinoma in the Era of Targeted Therapy
    Nicholas L. Kesby, Alexander J. Papachristos, Matti Gild, Ahmad Aniss, Mark S. Sywak, Roderick Clifton-Bligh, Stan B. Sidhu, Anthony R. Glover
    Annals of Surgical Oncology.2022; 29(1): 64.     CrossRef
  • Clinical Implication of Mutifocality for Risk of Recurrence in Patients With Papillary Thyroid Carcinoma
    Kwangsoon Kim, Ja Seong Bae, Jeong Soo Kim
    Journal of Endocrine Surgery.2022; 22(1): 10.     CrossRef
  • Clinical Factors Predictive of Lymph Node Metastasis in Thyroid Cancer Patients: A Multivariate Analysis
    Hui Zheng, Victoria Lai, Jana Lu, Jin K Kang, Jiling Chou, Kenneth D Burman, Leonard Wartofsky, Jennifer E Rosen
    Journal of the American College of Surgeons.2022; 234(4): 691.     CrossRef
  • Minimal extrathyroidal extension is associated with lymph node metastasis in single papillary thyroid microcarcinoma: a retrospective analysis of 814 patients
    Ra-Yeong Song, Hee Sung Kim, Kyung Ho Kang
    World Journal of Surgical Oncology.2022;[Epub]     CrossRef
  • Central Lymph Node Ratio Predicts Recurrence in Patients with N1b Papillary Thyroid Carcinoma
    Il Ku Kang, Kwangsoon Kim, Joonseon Park, Ja Seong Bae, Jeong Soo Kim
    Cancers.2022; 14(15): 3677.     CrossRef
  • Characterization of the CpG island methylator phenotype subclass in papillary thyroid carcinoma
    Pengfei Gu, Yu Zeng, Weike Ma, Wei Zhang, Yu Liu, Fengli Guo, Xianhui Ruan, Jiadong Chi, Xiangqian Zheng, Ming Gao
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • MicroRNA Profile for Diagnostic and Prognostic Biomarkers in Thyroid Cancer
    Jong-Lyul Park, Seon-Kyu Kim, Sora Jeon, Chan-Kwon Jung, Yong-Sung Kim
    Cancers.2021; 13(4): 632.     CrossRef
  • Lactate Dehydrogenase A as a Potential New Biomarker for Thyroid Cancer
    Eun Jeong Ban, Daham Kim, Jin Kyong Kim, Sang-Wook Kang, Jandee Lee, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung, Kunhong Kim
    Endocrinology and Metabolism.2021; 36(1): 96.     CrossRef
  • Male sex is not an independent risk factor for recurrence of differentiated thyroid cancer: a propensity score-matching study
    Joonseon Park, Kwangsoon Kim, Dong-Jun Lim, Ja Seong Bae, Jeong Soo Kim
    Scientific Reports.2021;[Epub]     CrossRef
  • A Newly Developed Pancreatic Adenocarcinoma in a Patient with Advanced Thyroid Cancer under Long-Term Sorafenib Use
    Min Ji Kim, Han-Sang Baek, Sung Hak Lee, Dong-Jun Lim
    International Journal of Thyroidology.2021; 14(2): 175.     CrossRef
  • Modified risk stratification based on cervical lymph node metastases following lobectomy for papillary thyroid carcinoma
    Eyun Song, Jonghwa Ahn, Dong Eun Song, Won Woong Kim, Min Ji Jeon, Tae‐Yon Sung, Tae Yong Kim, Ki Wook Chung, Won Bae Kim, Young Kee Shong, Suck Joon Hong, Yu‐Mi Lee, Won Gu Kim
    Clinical Endocrinology.2020; 92(4): 358.     CrossRef
  • Long-term scintigraphic and clinical follow up in patients with differentiated thyroid cancer and iodine avid bone metastases
    Omnia Mohamed Talaat, Ismail Mohamed Ali, Sherif Maher Abolyazid, Bader Abdelmaksoud, Ibrahim Mansour Nasr
    Nuclear Medicine Communications.2020; 41(4): 327.     CrossRef
  • Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans
    Sue Youn Kim, Taeeun Kim, Kwangsoon Kim, Ja Seong Bae, Jeong Soo Kim, Chan Kwon Jung
    Journal of Pathology and Translational Medicine.2020; 54(4): 310.     CrossRef
  • Clinical Implication of World Health Organization Classification in Patients with Follicular Thyroid Carcinoma in South Korea: A Multicenter Cohort Study
    Meihua Jin, Eun Sook Kim, Bo Hyun Kim, Hee Kyung Kim, Hyon-Seung Yi, Min Ji Jeon, Tae Yong Kim, Ho-Cheol Kang, Won Bae Kim, Young Kee Shong, Mijin Kim, Won Gu Kim
    Endocrinology and Metabolism.2020; 35(3): 618.     CrossRef
  • The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice
    Krzysztof Kaliszewski, Dorota Diakowska, Łukasz Nowak, Beata Wojtczak, Jerzy Rudnicki
    BMC Cancer.2020;[Epub]     CrossRef
  • Lobectomy Is Feasible for 1–4 cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence
    Eyun Song, Minkyu Han, Hye-Seon Oh, Won Woong Kim, Min Ji Jeon, Yu-Mi Lee, Tae Yong Kim, Ki Wook Chung, Won Bae Kim, Young Kee Shong, Suck Joon Hong, Tae-Yon Sung, Won Gu Kim
    Thyroid.2019; 29(1): 64.     CrossRef
  • The binary presence or absence of lymph node metastasis or extrathyroidal extension is not associated with survival in papillary thyroid cancers: Implications for staging systems
    Hyun-Soo Zhang, Eun-Kyung Lee, Yuh-Seog Jung, Byung-Ho Nam, Boyoung Park
    Cancer Epidemiology.2019; 63: 101589.     CrossRef
  • Risk of Adverse Obstetric Outcomes and the Abnormal Growth of Offspring in Women with a History of Thyroid Cancer
    Geum Joon Cho, So-youn Kim, Hoi Chang Lee, Kyu-Min Lee, Sung Won Han, Min-Jeong Oh, Teresa K. Woodruff
    Thyroid.2019; 29(6): 879.     CrossRef
  • Changes in Serum Thyroglobulin Levels After Lobectomy in Patients with Low-Risk Papillary Thyroid Cancer
    Suyeon Park, Min Ji Jeon, Hye-Seon Oh, Yu-Mi Lee, Tae-Yon Sung, Minkyu Han, Ji Min Han, Tae Yong Kim, Ki-Wook Chung, Won Bae Kim, Young Kee Shong, Won Gu Kim
    Thyroid®.2018; 28(8): 997.     CrossRef
  • Clinical Outcomes of Differentiated Thyroid Cancer Patients with Local Recurrence or Distant Metastasis Detected in Old Age
    Ji Min Han, Ji Cheol Bae, Hye In Kim, Sam Kwon, Min Ji Jeon, Won Gu Kim, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Endocrinology and Metabolism.2018; 33(4): 459.     CrossRef
  • Prognosis of Differentiated Thyroid Carcinoma with Initial Distant Metastasis: A Multicenter Study in Korea
    Hosu Kim, Hye In Kim, Sun Wook Kim, Jaehoon Jung, Min Ji Jeon, Won Gu Kim, Tae Yong Kim, Hee Kyung Kim, Ho-Cheol Kang, Ji Min Han, Yoon Young Cho, Tae Hyuk Kim, Jae Hoon Chung
    Endocrinology and Metabolism.2018; 33(2): 287.     CrossRef
  • Decreasing Disease-Specific Mortality of Differentiated Thyroid Cancer in Korea: A Multicenter Cohort Study
    Min Ji Jeon, Hee Kyung Kim, Eun Heui Kim, Eun Sook Kim, Hyon-Seung Yi, Tae Yong Kim, Ho-Cheol Kang, Young Kee Shong, Won Bae Kim, Bo Hyun Kim, Won Gu Kim
    Thyroid.2018; 28(9): 1121.     CrossRef
  • Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea
    Hye-Seon Oh, Jeonghoon Ha, Hye In Kim, Tae Hyuk Kim, Won Gu Kim, Dong-Jun Lim, Tae Yong Kim, Sun Wook Kim, Won Bae Kim, Young Kee Shong, Jae Hoon Chung, Jung Hwan Baek
    Thyroid.2018; 28(12): 1587.     CrossRef
Close layer
Review Article
Calcium and Cardiovascular Disease
Ian R. Reid, Sarah M. Birstow, Mark J. Bolland
Endocrinol Metab. 2017;32(3):339-349.   Published online September 18, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.3.339
  • 26,178 View
  • 260 Download
  • 87 Web of Science
  • 89 Crossref
AbstractAbstract PDFPubReader   

Circulating calcium is a risk factor for vascular disease, a conclusion arising from prospective studies involving hundreds of thousands of participants and extending over periods of up to 30 years. These associations may be partially mediated by other cardiovascular risk factors such as circulating lipid levels, blood pressure, and body mass index, but there appears to be a residual independent effect of serum calcium. Polymorphisms of the calcium-sensing receptor associated with small elevations of serum calcium are also associated with cardiovascular disease, suggesting that calcium plays a causative role. Trials of calcium supplements in patients on dialysis and those with less severe renal failure demonstrate increased mortality and/or acceleration of vascular disease, and meta-analyses of trials in those without overt renal disease suggest a similar adverse effect. Interpretation of the latter trials is complicated by a significant interaction between baseline use of calcium supplements and the effect of randomisation to calcium in the largest trial. Restriction of analysis to those who are calcium-naive demonstrates a consistent adverse effect. Observational studies of dietary calcium do not demonstrate a consistent adverse effect on cardiovascular health, though very high or very low intakes may be deleterious. Thus, obtaining calcium from the diet rather than supplements is to be encouraged.

Citations

Citations to this article as recorded by  
  • MTHFR 677C/T gene polymorphism and dietary habits: effects on trace element levels, amino acids, and biochemical parameters
    Tatjana Orct, Jelena Kovačić, Ines Peremin, Zorana Kljaković-Gašpić, Daria Pašalić, Ankica Sekovanić, Adrijana Dorotić, Blanka Tariba Lovaković, Andreja Jurič, Alica Pizent, Fran Crnjac, Lora Dukić, Marko Gerić, Ivone Jakaša, Goran Gajski
    Frontiers in Nutrition.2026;[Epub]     CrossRef
  • Age‐related decline in NCKX4‐mediated calcium clearance accelerates aortic remodelling and drives early vascular ageing
    Guilherme H. Souza Bomfim, Kesava Asam, Nish Patel, Anna Zou, Kristen Rosenberg, Erna Mitaishvili, Talita Aguiar, Emmanuel Zorn, Ravichandran Ramasamy, Bradley Aouizerat, Rodrigo S. Lacruz
    The Journal of Physiology.2026;[Epub]     CrossRef
  • Singular case report of familial hypocalciuric hypercalcemia: a rare diagnosis of hypercalcemia in the older people
    Etienne Ojardias, Mélanie Leman, Ludovic Lafaie, Philippe Oriol, Paul Calmels, Thomas Celarier
    The Aging Male.2025;[Epub]     CrossRef
  • Recent developments, challenges, and prospects of dietary omega-3 PUFA-fortified foods: Focusing on their effects on cardiovascular diseases
    Yongjin Wang, Gangcheng Wu, Yandan Wang, Abdur Rehman, Le Yu, Hui Zhang, Qingzhe Jin, Hafiz Ansar Rasul Suleria, Xingguo Wang
    Food Chemistry.2025; 470: 142498.     CrossRef
  • Association between admission serum calcium levels and in‑hospital mortality in acute myocardial infarction patients with cardiovascular-kidney-metabolic syndrome
    Jing Xu, Shuai Yu, Jian Huang, Li Geng, Yumiao Wei, Xin Li, Xin Gong
    Endocrine.2025; 89(1): 232.     CrossRef
  • Clinical outcomes and safety of combined calcitriol and bisphosphonates in treating postmenopausal osteoporosis: a retrospective cohort study
    Xu Zhou, Hui Long, Jui-Hua Wang, Zhen Huang, Liping Cao
    Journal of Orthopaedic Surgery and Research.2025;[Epub]     CrossRef
  • The characterization of blue shark (Prionace glauca) cartilage potential as nature-derived drug material
    T Agustin, H. Nursyam, M. Firdaus, M. Rifa’i, I. D. Ekaputri, Mahmiah
    IOP Conference Series: Earth and Environmental Science.2025; 1473(1): 012049.     CrossRef
  • Calcium Ion Sensors with Unrivaled Stability and Selectivity Using a Bilayer Approach with Ionically Imprinted Nanocomposites
    Antonio Ruiz-Gonzalez, Roohi Chhabra, Xun Cao, Yizhong Huang, Andrew Davenport, Kwang-Leong Choy
    Nanomaterials.2025; 15(10): 741.     CrossRef
  • Hair Calcium Levels in Relation to Coronary Artery Disease Severity and Systemic Inflammation Markers: A Pilot Study
    Ewelina A. Dziedzic, Aleksandra Czernicka, Jakub S. Gąsior, Anna Szamreta-Siwicka, Beata Wodejko-Kucharska, Paweł Maciński, Anna Arbaszewska, Konrad Adler, Andrzej Osiecki, Wacław Kochman
    Journal of Clinical Medicine.2025; 14(13): 4537.     CrossRef
  • Impact of Thrombolytic Therapy on Electrolyte Imbalance in Acute Myocardial Infarction
    M. Mageshwari, Gowtham Muthaiyan, Niranjan Gopal, Kuzhandai Velu Venkatapathy
    Journal of Datta Meghe Institute of Medical Sciences University.2025; 20(2): 255.     CrossRef
  • Liposomal Delivery of Allolobophora caliginosa Coelomic Fluid Attenuates Myocardial Infarction by Suppressing Oxidative Damage, Inflammation, and Apoptosis
    Asmaa E. Farouk, Sohair R. Fahmy, Amel M. Soliman, Sherif Abdelaziz Ibrahim, Shimaa A. Sadek
    Applied Biochemistry and Biotechnology.2025; 197(9): 6202.     CrossRef
  • The effect of calcium supplements on troponin variables in athletes and their association with bone diseases : Implications for myocardial health
    Muntadher Jaber, Sada Ghalib Taher, Riyadh Rashid Hameed, Sajjad Mohammed Zorah, Doha Jehad Mohammad, Adyan Nafea Abbas, Falah Herez Madhloom Alrabea, Samer Kareem Hanoon
    Journal of Research in Pharmacy.2025; 29(5): 1890.     CrossRef
  • The interplay of serum cations, insulin resistance, and atherogenic indices in predicting depression in hypothyroid patients
    Sahira Qasim Al-Baldawi, Hussein Kadhem Al-Hakeim, Habib Hamam, Ikram Khémiri
    Biotechnology Reports.2025; 48: e00932.     CrossRef
  • Cardiovascular and Cerebrovascular Outcomes With Vitamin D Supplementation: A Systematic Review and Meta-Analysis
    Jishanth Mattumpuram, Muhammad Talha Maniya, Sabeeh Khawar Faruqui, Aymen Ahmed, Vikash Jaiswal, Sreedevi Pallath Harshakumar
    Current Problems in Cardiology.2024; 49(1): 102119.     CrossRef
  • Association of Genotypes of ANGPTL3 with Vitamin D and Calcium Concentration in Cardiovascular Disease
    Malihe Aghasizadeh, Mahmoud Ghanei, Sahar Ghoflchi, Parisa Asadian-sohan, Mohammad Haghani, Tooba Kazemi, Habibollah Esmaily, Amir Avan, Gordon A. Ferns, Ebrahim Miri-Moghaddam, Majid Ghayour-Mobarhan
    Biochemical Genetics.2024; 62(4): 2482.     CrossRef
  • 43Ca MAS-DNP NMR of Frozen Solutions for the Investigation of Calcium Ion Complexation
    Tristan Georges, Romain Chèvre, Samuel F. Cousin, Christel Gervais, Pierre Thureau, Giulia Mollica, Thierry Azaïs
    ACS Omega.2024; 9(4): 4881.     CrossRef
  • Association between Daily Dietary Calcium Intake and the Risk of Cardiovascular Disease (CVD) in Postmenopausal Korean Women
    Jae Kyung Lee, Thi Minh Chau Tran, Euna Choi, Jinkyung Baek, Hae-Rim Kim, Heeyon Kim, Bo Hyon Yun, Seok Kyo Seo
    Nutrients.2024; 16(7): 1043.     CrossRef
  • Osteosarcopenic adiposity (OSA) phenotype and its connection with cardiometabolic disorders: Is there a cause-and-effect?
    Jasminka Z. Ilich, Biljana Pokimica, Danijela Ristić-Medić, Snjezana Petrović, Aleksandra Arsić, Nadja Vasiljević, Vesna Vučić, Owen J. Kelly
    Ageing Research Reviews.2024; 98: 102326.     CrossRef
  • Associations of Dietary Calcium and Phosphorus With Vascular and Valvular Calcification
    Yume Nohara-Shitama, Yejin Mok, Shoshana H. Ballew, Casey M. Rebholz, Matthew J. Budoff, Cheryl Anderson, Junichi Ishigami, Michael J. Blaha, Kunihiro Matsushita
    JACC: Advances.2024; 3(7): 100993.     CrossRef
  • Dietary Minerals and Incident Cardiovascular Outcomes among Never-Smokers in a Danish Case–Cohort Study
    Victoria Fruh, Tesleem Babalola, Clara Sears, Gregory A. Wellenius, Thomas F. Webster, Koren K. Mann, James Harrington, Anne Tjønneland, Ole Raaschou-Nielsen, Birgit Claus Henn, Jaymie R. Meliker
    International Journal of Environmental Research and Public Health.2024; 21(7): 932.     CrossRef
  • Preparation of wheat protein peptides-calcium chelate by the ultrasound method: Structural characteristics and bioactivity
    Mingyi Zhang, Yinchen Hou, Aimei Liao, Xinyang Chen, Zhen Wang, Penghui Zhao, Long Pan, Jihong Huang
    Food Bioscience.2024; 61: 104848.     CrossRef
  • Perioperative Modulation of Left Ventricular Systolic Performance: A Retrospective Study on Ionized Calcium and Vitamin D in Cardiac Surgery Patients
    Adrian Ștef, Constantin Bodolea, Ioana Corina Bocșan, Alexandru Achim, Nadina Tintiuc, Raluca Maria Pop, Aurelia Georgeta Solomonean, Alexandru Manea, Anca Dana Buzoianu
    Journal of Personalized Medicine.2024; 14(8): 850.     CrossRef
  • Emerging Trends in Sports Cardiology: The Role of Micronutrients in Cardiovascular Health and Performance
    Biswajit Sharma, Kishore Mukhopadhyay
    Journal of Sports Medicine and Therapy.2024; 9(3): 073.     CrossRef
  • Serum total calcium levels as a non-linear predictor of in-hospital mortality in heart failure patients: insights from a retrospective cohort study
    Jing Song, Guojuan Xu, Jing Song, Guojuan Xu
    BMC Cardiovascular Disorders.2024;[Epub]     CrossRef
  • Risk Assessment of the Calcium in the Drinking Water Supplies in Babylon Governorate, Middle of Iraq
    Hussein Hamid E. Al-Husseini
    Kerbala Journal for Engineering Sciences.2024; 4(3): 178.     CrossRef
  • Case Series Analysis of Chronic Venous Insufficiency Patients to Determine Associated Arthrosis
    Malay Patel, Roy Varghese, Manjusha Rajarshi
    Indian Journal of Surgery.2023; 85(S1): 106.     CrossRef
  • Prevalence of asteroid hyalosis and systemic risk factors in United States adults
    Ryan Duong, Xiaoyu Cai, Naveen Ambati, Yevgeniy Shildkrot, Rebecca Sieburth
    Eye.2023; 37(8): 1678.     CrossRef
  • L-shaped association of serum calcium with all-cause and CVD mortality in the US adults: A population-based prospective cohort study
    Xinran Hou, Jie Hu, Zhuoyi Liu, E. Wang, Qulian Guo, Zhong Zhang, Zongbin Song
    Frontiers in Nutrition.2023;[Epub]     CrossRef
  • The genetic correlation and causal association between key factors that influence vascular calcification and cardiovascular disease incidence
    Xiaolin Ni, Lei Liu, Yao Yao, Chi Zhang, Huabin Su, Yuan Lv, Rongqiao Li, Liang Sun, Qi Zhou, Xiaoquan Zhu, Ze Yang, Zuoguan Chen, Wei He, Huolan Zhu, Shenqi Zhang, Caiyou Hu, Huiping Yuan
    Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
  • The association of long-term calcium and dairy products intake in adolescence with carotid intima media thickness and metabolic syndrome in early adulthood: Tehran Lipid and Glucose Study
    Assa AkbarySedigh, Golaleh Asghari, Maryam Mahdavi, Parvin Mirmiran, Majid Valizadeh, Fereidoun Azizi
    Nutrition & Metabolism.2023;[Epub]     CrossRef
  • Effect Modification of Kidney Function on the Non-linear Association Between Serum Calcium Levels and Cardiovascular Mortality in Korean Adults
    Jung-Ho Yang, Sun-Seog Kweon, Young-Hoon Lee, Seong-Woo Choi, So-Yeon Ryu, Hae-Sung Nam, Hye-Yeon Kim, Min-Ho Shin
    Journal of Preventive Medicine and Public Health.2023; 56(3): 282.     CrossRef
  • The Relationship between Mortality from Cardiovascular Diseases and Total Drinking Water Hardness: Systematic Review with Meta-Analysis
    Aleksandra Bykowska-Derda, Marcin Spychala, Magdalena Czlapka-Matyasik, Mariusz Sojka, Jerzy Bykowski, Mariusz Ptak
    Foods.2023; 12(17): 3255.     CrossRef
  • Association Between Calcium Supplementation and the Risk of Cardiovascular Disease and Stroke: A Systematic Review and Meta-Analysis
    Ming Gin Sim, Yao Neng Teo, Yao Hao Teo, Nicholas L. Syn, Tony Y.W. Li, Leonard L.L. Yeo, William K.F. Kong, Benjamin Y.Q. Tan, James W. Yip, Raymond C.C. Wong, Kian Keong Poh, Tiong-Cheng Yeo, Vijay Kumar Sharma, Ping Chai, Mark Y. Chan, Ching-Hui Sia
    Heart, Lung and Circulation.2023; 32(10): 1230.     CrossRef
  • Omega-3 long-chain polyunsaturated fatty acids: Metabolism and health implications
    Imad Khan, Mudassar Hussain, Bangzhi Jiang, Lei Zheng, Yuechao Pan, Jijie Hu, Adil Khan, Azqa Ashraf, Xiaoqiang Zou
    Progress in Lipid Research.2023; 92: 101255.     CrossRef
  • RETRACTED: The role of chromium supplementation in cardiovascular risk factors: A comprehensive reviews of putative molecular mechanisms
    Dhiaa lattef Gossa Al-Saadde, Ali Murtaza Haider, Arsalan Ali, Ebraheem Abdu Musad Saleh, Abduladheem Turki Jalil, Furqan M. Abdulelah, Rosario Mireya Romero-Parra, Nahla A. Tayyib, Andrés Alexis Ramírez-Coronel, Ameer S. Alkhayyat
    Heliyon.2023; 9(9): e19826.     CrossRef
  • Calcium as an essential macronutrient: benefits and risks for cardiovascular and other body systems
    A.V. Gostry, R.A. Bekker, Yu.V. Bykov
    Russian Journal of Preventive Medicine.2023; 26(10): 109.     CrossRef
  • Bone-friendly lifestyle and the role of calcium or vitamin D supplementation
    I. R. Reid
    Climacteric.2022; 25(1): 37.     CrossRef
  • Cardiovascular risks associated with calcium supplementation in patients with osteoporosis: a nationwide cohort study
    Kyoung Jin Kim, Min Sun Kim, Namki Hong, Jae Hyun Bae, Kyeong Jin Kim, Nam Hoon Kim, Yumie Rhee, Juneyoung Lee, Sin Gon Kim
    European Heart Journal - Cardiovascular Pharmacotherapy.2022; 8(6): 568.     CrossRef
  • Cyclic voltammetric determination of calcium in water in the presence of natural organic matter (humic acid) and Cu (II) at gold electrode's surface
    Olayemi J. Fakayode, Thabo T.I. Nkambule
    Food Chemistry Advances.2022; 1: 100012.     CrossRef
  • Low serum concentration of zinc, selenium, calcium, potassium and high serum concentration of iron, sodium are associated with myocardial infarction
    S. M. Naim Uddin, Md. Zahedur Rahaman, Thanmin Jarana Thammi, Mohammad Rashedul Islam, Md. Iftikhar Uddin Masud, Md. Giash Uddin, Mohammad Safiqul Islam
    Aging and Health Research.2022; 2(1): 100063.     CrossRef
  • Organelle-specific blue-emitting two-photon probes for calcium ions: Combination with green-emitting two-photon probe for simultaneous detection of proton ions
    Seung Taek Hong, Mun Seok Kim, Bo Ra Kim, Eun Jeong Lee, Yeo Uk Yoon, Kyu Cheol Paik, Man So Han, Eun Sun Kim, Bong Rae Cho
    Talanta.2022; 244: 123408.     CrossRef
  • Plasma Calcium and Phosphorus Levels and Cardiovascular Disease Risks in Egyptian Type 2 Diabetic Patients
    Sahar Al-Okbi, Seham Sabry, Enas S. K. Al-Siedy, Shaimaa Elsayed
    Open Access Macedonian Journal of Medical Sciences.2022; 10(A): 502.     CrossRef
  • The Incidence of Serum Calcium Elevation due to Adrenal Insufficiency After Unilateral Adrenalectomy
    Woochul Kim, Jee-Hye Choi, Ja Kyung Lee, Chang Ho Ahn, Hyeong Won Yu, June Young Choi
    Journal of Endocrine Surgery.2022; 22(1): 18.     CrossRef
  • Calcium Supplementation, Risk of Cardiovascular Diseases, and Mortality: A Real-World Study of the Korean National Health Insurance Service Data
    Jae-Min Park, Bora Lee, Young-Sang Kim, Kyung-Won Hong, Yon Chul Park, Dong Hyeok Shin, Yonghwan Kim, Kunhee Han, Kwangyoon Kim, Junghwa Shin, Mina Kim, Bom-Taeck Kim
    Nutrients.2022; 14(12): 2538.     CrossRef
  • Physical Fitness and Dietary Intake Improve Mental Health in Chinese Adolescence Aged 12–13
    Wenjie Liang, Jian Fu, Xin Tian, Jiaxue Tian, Yu Yang, Wencui Fan, Zijuan Du, Zheyu Jin
    Frontiers in Integrative Neuroscience.2022;[Epub]     CrossRef
  • EXTENSIVE EXPERTISE IN ENDOCRINOLOGY: Osteoporosis management
    Ian R Reid
    European Journal of Endocrinology.2022; 187(4): R65.     CrossRef
  • Evaluation of the Increase in Serum Calcium Levels After Unilateral Adrenalectomy
    Mehmet Üstün, Korhan Tuncer
    Cureus.2022;[Epub]     CrossRef
  • Comparing the Evidence from Observational Studies and Randomized Controlled Trials for Nonskeletal Health Effects of Vitamin D
    William B. Grant, Barbara J. Boucher, Fatme Al Anouti, Stefan Pilz
    Nutrients.2022; 14(18): 3811.     CrossRef
  • Phenotypic plasticity of vascular smooth muscle cells in vascular calcification: Role of mitochondria
    Yan Zhong Liu, Zong Xiang Li, Lin Lin Zhang, Dan Wang, Yi Ping Liu
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Association between serum calcium level and in-hospital mortality in patients with acute myocardial infarction: a retrospective cohort study
    Dingfeng Fang, Haibo Chen
    Scientific Reports.2022;[Epub]     CrossRef
  • Calcium and vitamin D supplements for the treatment and prevention of osteoporosis. Should it be widely used?
    Yuliya A. Kaminarskaya
    Clinical nutrition and metabolism.2022; 3(3): 167.     CrossRef
  • Calcium Signalling in Heart and Vessels: Role of Calmodulin and Downstream Calmodulin-Dependent Protein Kinases
    Sofia Beghi, Malgorzata Furmanik, Armand Jaminon, Rogier Veltrop, Nikolas Rapp, Kanin Wichapong, Elham Bidar, Annamaria Buschini, Leon J. Schurgers
    International Journal of Molecular Sciences.2022; 23(24): 16139.     CrossRef
  • Childhood and long-term dietary calcium intake and adult cardiovascular risk in a population with high calcium intake
    Feitong Wu, Katja Pahkala, Markus Juonala, Suvi P. Rovio, Matthew A. Sabin, Tapani Rönnemaa, Kylie J. Smith, Antti Jula, Terho Lehtimäki, Nina Hutri-Kähönen, Mika Kähönen, Tomi Laitinen, Jorma S.A. Viikari, Olli T. Raitakari, Costan G. Magnussen
    Clinical Nutrition.2021; 40(4): 1926.     CrossRef
  • Collagen networks within 3D PEG hydrogels support valvular interstitial cell matrix mineralization
    Megan E. Schroeder, Andrea Gonzalez Rodriguez, Kelly F. Speckl, Cierra J. Walker, Firaol S. Midekssa, Joseph C. Grim, Robert M. Weiss, Kristi S. Anseth
    Acta Biomaterialia.2021; 119: 197.     CrossRef
  • Effects of High-Impact Weight-Bearing Exercise on Bone Mineral Density and Bone Metabolism in Middle-Aged Premenopausal Women: A Randomized Controlled Trial
    Sung-Woo Kim, Myong-Won Seo, Hyun-Chul Jung, Jong-Kook Song
    Applied Sciences.2021; 11(2): 846.     CrossRef
  • Higher Intakes of Potassium and Magnesium, but Not Lower Sodium, Reduce Cardiovascular Risk in the Framingham Offspring Study
    R. Taylor Pickering, M. Loring Bradlee, Martha R. Singer, Lynn L. Moore
    Nutrients.2021; 13(1): 269.     CrossRef
  • Low serum calcium is associated with higher long-term mortality in myocardial infarction patients from a population-based registry
    Timo Schmitz, Christian Thilo, Jakob Linseisen, Margit Heier, Annette Peters, Bernhard Kuch, Christa Meisinger
    Scientific Reports.2021;[Epub]     CrossRef
  • Edible Insects versus Meat—Nutritional Comparison: Knowledge of Their Composition Is the Key to Good Health
    Agnieszka Orkusz
    Nutrients.2021; 13(4): 1207.     CrossRef
  • The Role of Essential Oils and Their Main Compounds in the Management of Cardiovascular Disease Risk Factors
    Jorge M. Alves-Silva, Mónica Zuzarte, Henrique Girão, Lígia Salgueiro
    Molecules.2021; 26(12): 3506.     CrossRef
  • Polymorphism rs7214723 in CAMKK1: a new genetic variant associated with cardiovascular diseases
    Sofia Beghi, Francesca Cavaliere, Matteo Manfredini, Sandro Ferrarese, Claudio Corazzari, Cesare Beghi, Annamaria Buschini
    Bioscience Reports.2021;[Epub]     CrossRef
  • The Role of Serum Calcium Levels in Pediatric Dyslipidemia: Are There Any?
    Yaguang Peng, Lixin Hu, Xiaolu Nie, Siyu Cai, Ruohua Yan, Yali Liu, Yanying Cai, Wenqi Song, Xiaoxia Peng
    Frontiers in Pediatrics.2021;[Epub]     CrossRef
  • The impact of serum 25-hydroxyvitamin D, calcium, and parathyroid hormone levels on the risk of coronary artery disease in patients with diabetes: a Mendelian randomization study
    Songzan Chen, Fangkun Yang, Tian Xu, Yao Wang, Kaijie Zhang, Guosheng Fu, Wenbin Zhang
    Nutrition Journal.2021;[Epub]     CrossRef
  • Temporal Relationship Between Changes in Serum Calcium and Hypercholesteremia and Its Impact on Future Brachial-Ankle Pulse Wave Velocity Levels
    Xing Meng, Tianshu Han, Wenbo Jiang, Fengli Dong, Hongxue Sun, Wei Wei, Yageng Yan
    Frontiers in Nutrition.2021;[Epub]     CrossRef
  • The Evidence and Controversy Between Dietary Calcium Intake and Calcium Supplementation and the Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Cohort Studies and Randomized Controlled Trials
    Chao Yang, Xiangling Shi, Hui Xia, Xian Yang, Hechun Liu, Da Pan, Guiju Sun
    Journal of the American College of Nutrition.2020; 39(4): 352.     CrossRef
  • Association between the cumulative exposure to bisphosphonates and hospitalization for atherosclerotic cardiovascular events: A population-based study
    Manuela Casula, Elena Olmastroni, Federica Galimberti, Elena Tragni, Giovanni Corrao, Lorenza Scotti, Alberico L. Catapano
    Atherosclerosis.2020; 301: 1.     CrossRef
  • Calcium and/or Vitamin D Supplementation for the Prevention of Fragility Fractures: Who Needs It?
    Ian R Reid, Mark J Bolland
    Nutrients.2020; 12(4): 1011.     CrossRef
  • Oxalates, urinary stones and risk of cardiovascular diseases
    Ahmed Arafa, Ehab S. Eshak, Hiroyasu Iso
    Medical Hypotheses.2020; 137: 109570.     CrossRef
  • A dual signal on-off fluorescent nanosensor for the simultaneous detection of copper and creatinine
    Resmi V. Nair, Parvathy Radhakrishna Pillai Suma, Ramapurath S. Jayasree
    Materials Science and Engineering: C.2020; 109: 110569.     CrossRef
  • Soy isoflavones interact with calcium and contribute to blood pressure homeostasis in women: a randomized, double-blind, placebo controlled trial
    Lee-Jane W. Lu, Nai-Wei Chen, Fatima Nayeem, Manubai Nagamani, Karl E. Anderson
    European Journal of Nutrition.2020; 59(6): 2369.     CrossRef
  • Associations between diet and mental health using the 12-item General Health Questionnaire: cross-sectional and prospective analyses from the Japan Multi-Institutional Collaborative Cohort Study
    Naoki Choda, Kenji Wakai, Mariko Naito, Nahomi Imaeda, Chiho Goto, Kenta Maruyama, Yuka Kadomatsu, Mineko Tsukamoto, Tae Sasakabe, Yoko Kubo, Rieko Okada, Sayo Kawai, Takashi Tamura, Asahi Hishida, Kenji Takeuchi, Atsuyoshi Mori, Nobuyuki Hamajima
    Nutrition Journal.2020;[Epub]     CrossRef
  • Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trials
    Silvia Fogacci, Federica Fogacci, Maciej Banach, Erin D. Michos, Adrian V. Hernandez, Gregory Y.H. Lip, Michael J. Blaha, Peter P. Toth, Claudio Borghi, Arrigo F.G. Cicero
    Clinical Nutrition.2020; 39(6): 1742.     CrossRef
  • Establishing Benefit from Vitamin D Supplementation — Adherence to Defined Criteria and Targeting of High-Risk Groups Essential?
    Siobhán McGettigan, P. Mulkerrin, P.M. O'Shea, S.T. O'Keeffe, E.C. Mulkerrin
    The Journal of nutrition, health and aging.2020; 24(8): 827.     CrossRef
  • Nutritional Quality and Health Effects of Low Environmental Impact Diets: The “Seguimiento Universidad de Navarra” (SUN) Cohort
    Ujué Fresán, Winston J. Craig, Miguel A. Martínez-González, Maira Bes-Rastrollo
    Nutrients.2020; 12(8): 2385.     CrossRef
  • Beyond Fish Oil Supplementation: The Effects of Alternative Plant Sources of Omega-3 Polyunsaturated Fatty Acids upon Lipid Indexes and Cardiometabolic Biomarkers—An Overview
    Heitor O. Santos, James C. Price, Allain A. Bueno
    Nutrients.2020; 12(10): 3159.     CrossRef
  • Oxidative stress by Ca2+ overload is critical for phosphate-induced vascular calcification
    Nhung Thi Nguyen, Tuyet Thi Nguyen, Dat Da Ly, Jing-Bo Xia, Xu-Feng Qi, In-Kyu Lee, Seung-Kuy Cha, Kyu-Sang Park
    American Journal of Physiology-Heart and Circulatory Physiology.2020; 319(6): H1302.     CrossRef
  • A Naringin- and Icariin-Contained Herbal Formula, Gushukang, Ameliorated Aged Osteoporosis of Aged Mice with High Calcium Intake
    Xiao-Li Li, Fei Xu, Fu-Hui Lin, Lian-Zhong Ai, Yong-Jian Zhao, Xiao-Lei Bi, Li Sui, Yan Zhang
    The American Journal of Chinese Medicine.2020; 48(07): 1671.     CrossRef
  • Gushukang exerts osteopreserve effects by regulating vitamin D and calcium metabolism in ovariectomized mice
    Xiao-Li Li, Liang Wang, Xiao-Lei Bi, Bing-Bing Chen, Yan Zhang
    Journal of Bone and Mineral Metabolism.2019; 37(2): 224.     CrossRef
  • Genetic predisposition to increased serum calcium, bone mineral density, and fracture risk in individuals with normal calcium levels: mendelian randomisation study
    Agustin Cerani, Sirui Zhou, Vincenzo Forgetta, John A Morris, Katerina Trajanoska, Fernando Rivadeneira, Susanna C Larsson, Karl Michaëlsson, J Brent Richards
    BMJ.2019; : l4410.     CrossRef
  • Protective Effects of Phenylpropanoids and Phenylpropanoid-rich Essential Oils on the Cardiovascular System
    Jorge M. Alves-Silva, Mónica Zuzarte, Carla Marques, Henrique Girão, Lígia Salgueiro
    Mini-Reviews in Medicinal Chemistry.2019; 19(17): 1459.     CrossRef
  • Borderline high serum calcium levels are associated with arterial stiffness and 10‐year cardiovascular disease risk determined by Framingham risk score
    Byoungjin Park, Yong‐Jae Lee
    The Journal of Clinical Hypertension.2019; 21(5): 668.     CrossRef
  • Effects of IGF-1 on the Cardiovascular System
    Milan Obradovic, Sonja Zafirovic, Sanja Soskic, Julijana Stanimirovic, Andreja Trpkovic, Danimir Jevremovic, Esma R. Isenovic
    Current Pharmaceutical Design.2019; 25(35): 3715.     CrossRef
  • Associations between serum calcium, 25(OH)D level and bone mineral density in older adults
    Minbo Liu, Xiaocong Yao, Zhongxin Zhu
    Journal of Orthopaedic Surgery and Research.2019;[Epub]     CrossRef
  • Controversies in medicine: the role of calcium and vitamin D supplements in adults
    Ian R Reid, Mark J Bolland
    Medical Journal of Australia.2019; 211(10): 468.     CrossRef
  • Structural insight into TRPV5 channel function and modulation
    Shangyu Dang, Mark K. van Goor, Daniel Asarnow, YongQiang Wang, David Julius, Yifan Cheng, Jenny van der Wijst
    Proceedings of the National Academy of Sciences.2019; 116(18): 8869.     CrossRef
  • Serum calcium levels independently predict in-hospital mortality in patients with acute myocardial infarction
    A. Shiyovich, Y. Plakht, H. Gilutz
    Nutrition, Metabolism and Cardiovascular Diseases.2018; 28(5): 510.     CrossRef
  • Primary Bone Marrow B-Cell Lymphoma Undetected by Multiple Imaging Modalities That Initially Presented with Hypercalcemia
    Jin Sae Yoo, Juwon Kim, Hyeong Ju Kwon, Jung Soo Lim
    Case Reports in Endocrinology.2018; 2018: 1.     CrossRef
  • Dietary Micronutrient and Mineral Intake in the Mediterranean Healthy Eating, Ageing, and Lifestyle (MEAL) Study
    Dora Castiglione, Armando Platania, Alessandra Conti, Mariagiovanna Falla, Maurizio D’Urso, Marina Marranzano
    Antioxidants.2018; 7(7): 79.     CrossRef
  • Calcium fluxes at the bone/plasma interface: Acute effects of parathyroid hormone (PTH) and targeted deletion of PTH/PTH-related peptide (PTHrP) receptor in the osteocytes
    Christopher Dedic, Tin Shing Hung, Alan M. Shipley, Akira Maeda, Thomas Gardella, Andrew L. Miller, Paola Divieti Pajevic, Joseph G. Kunkel, Alessandro Rubinacci
    Bone.2018; 116: 135.     CrossRef
  • Effects of Altered Calcium Metabolism on Cardiac Parameters in Primary Aldosteronism
    Jung Soo Lim, Namki Hong, Sungha Park, Sung Il Park, Young Taik Oh, Min Heui Yu, Pil Yong Lim, Yumie Rhee
    Endocrinology and Metabolism.2018; 33(4): 485.     CrossRef
Close layer
Original Articles
Utility of the Visceral Adiposity Index and Hypertriglyceridemic Waist Phenotype for Predicting Incident Hypertension
Mohsen Janghorbani, Mohammad Reza Salamat, Ashraf Aminorroaya, Masoud Amini
Endocrinol Metab. 2017;32(2):221-229.   Published online May 19, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.2.221
  • 8,352 View
  • 57 Download
  • 27 Web of Science
  • 28 Crossref
AbstractAbstract PDFPubReader   
Background

The aim of this study was to assess the utility of the visceral adiposity index (VAI) and the hypertriglyceridemic waist (HTGW) phenotype as possible hypertension (HTN) predictors in a high-risk population without diabetes and HTN.

Methods

Incident HTN over a 7-year follow-up was assessed among 1,375 first-degree non-diabetic and non-hypertensive relatives of consecutive patients with type 2 diabetes who were 30 to 70 years of age. HTN was defined as a blood pressure reading ≥140/90 mm Hg or the use of antihypertensive medications. We examined the incidence of HTN across VAI quintiles and four groups defined according to baseline fasting serum triglyceride (TG) levels and waist circumference (WC).

Results

The VAI and the HTGW phenotype at baseline were related to an increased risk for HTN. In comparison with the lowest VAI quintile, the highest VAI quintile showed a significant associated with HTN in an age- and gender-adjusted model (odds ratio [OR], 1.65; 95% confidence interval [CI], 1.07 to 2.55). Those with HTGW were 2.3 times (OR, 2.27; 95% CI, 1.54 to 3.35) more likely to develop HTN than those with a normal WC and normal TG levels.

Conclusion

Greater VAI values weakly predicted HTN, whereas the HTGW phenotype was a stronger predictor of incident HTN in an Iranian high-risk population.

Citations

Citations to this article as recorded by  
  • Hypertriglyceridemic waist phenotype in relation to diabetes mellitus and cardiovascular diseases in the Indonesian and Korean populations: evidence from two national surveys
    Fathimah S. Sigit, Sinyoung Cho, Farid Kurniawan, Hye-Ryeong Jeon, Ratu Ayu Dewi Sartika, Dicky L. Tahapary, Hyuktae Kwon
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Food Insecurity Associated With Higher Odds of Hypertriglyceridemic Waist Phenotype in Women: A Cross‐Sectional Study
    Paria Jadidi, Atieh Mirzababaei, Faezeh Abaj, Azadeh Dehghani, Neda Valisoltani, Moloud Ghorbani, Cain C. T. Clark, Khadijeh Mirzaei
    Food Science & Nutrition.2025;[Epub]     CrossRef
  • Predictive ability of the Chinese visceral adiposity index for incident hypertension in working-aged Koreans
    Ju Young Jung, Chang-Mo Oh, Hyun chul Jo, Sung Keun Park
    Epidemiology and Health.2024; 46: e2024034.     CrossRef
  • Association of the visceral adiposity index with arterial stiffness in elderly Chinese population
    Yifan Fan, Zhe Wang, Xiaotao Zhao, Shouling Wu, Hongjie Chi
    The American Journal of the Medical Sciences.2023; 365(3): 279.     CrossRef
  • Visceral and subcutaneous fat, muscle mass, and liver volume as noninvasive predictors of the progress of non-alcoholic fatty liver disease
    Omar M. Mahmoud, Gehad Abd Elaziz Mahmoud, Haisam Atta, Wael A. Abbas, Hanan M. Ahmed, Mohamed A. A. Abozaid
    Egyptian Journal of Radiology and Nuclear Medicine.2023;[Epub]     CrossRef
  • Association between Hypertriglyceridemic-Waist Phenotype and Metabolic Abnormalities in Hypertensive Adults
    Kyung-A SHIN, Myung Shin KANG
    Korean Journal of Clinical Laboratory Science.2023; 55(2): 113.     CrossRef
  • Association of Hyper-Triglyceridemic Waist Phenotype and Diabetic Vascular Complication in the Chinese Population
    Kun Li, Bin Cao, Jing Ke, Longyan Yang, Dong Zhao
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 2233.     CrossRef
  • The relationship between hypertriglyceridemic wait-to-height ratio and hypertension–diabetes comorbidity among older adult
    Ping Zhang, Yangyang Xiong, Menghan Chen, Huaide Zhang, Nan Sun, Fan Wu, Jiayu Yang, Yongcheng Ren
    Frontiers in Public Health.2023;[Epub]     CrossRef
  • Association of hypertriglyceridemic waist phenotype with non-alcoholic fatty liver disease: a cross-sectional study in a Chinese population
    Yan Xuan, Ping Gao, Ying Shen, Sujie Wang, Xi Gu, Dou Tang, Xun Wang, FanFan Zhu, Leiqun Lu, Ling Chen
    Hormones.2022; 21(3): 437.     CrossRef
  • The Association Between Hypertriglyceridemic-Waist Phenotype and Chronic Kidney Disease in Patients with Type 2 Diabetes: A Cross-Sectional METAL Study
    Yan Xuan, Wen Zhang, Yuying Wang, Bin Wang, Yi Chen, Fangzhen Xia, Kun Zhang, Qing Li, Ningjian Wang, Yingli Lu
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1885.     CrossRef
  • Chinese Visceral Adiposity Index Is More Closely Associated With Hypertension and Prehypertension Than Traditional Adiposity Indices in Chinese Population: Results From the REACTION Study
    Binqi Li, Jie Wang, Xin Zhou, Yang Liu, Weiqing Wang, Zhengnan Gao, Xulei Tang, Li Yan, Qin Wan, Zuojie Luo, Guijun Qin, Lulu Chen, Guang Ning, Yiming Mu
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Association between hypertriglyceridemic-waist phenotype and cardiovascular disease: A cohort study and meta-analysis
    Xiaowei Zheng, Xiao Ren, Minglan Jiang, Longyang Han
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • The association between visceral adiposity index and leukocyte telomere length in adults: results from National Health and Nutrition Examination Survey
    Yifan Fan, Yulin Guo, Jiuchang Zhong, Hongjie Chi, Xiaotao Zhao, Pixiong Su, Jie Gao, Mulei Chen
    Aging Clinical and Experimental Research.2022; 34(9): 2177.     CrossRef
  • Hypertriglyceridemic-waist phenotype is strongly associated with cardiovascular risk factor clustering in Chinese adolescents
    Rongrong Cai, Jinyu Zhou, Ling Bai, Yangyang Dong, Wenqing Ding
    Scientific Reports.2022;[Epub]     CrossRef
  • Visceral adiposity index and atherogenic index of plasma as useful predictors of risk of cardiovascular diseases: evidence from a cohort study in Iran
    Behrooz Hamzeh, Yahya Pasdar, Narmin Mirzaei, Roya Safari Faramani, Farid Najafi, Ebrahim Shakiba, Mitra Darbandi
    Lipids in Health and Disease.2021;[Epub]     CrossRef
  • Visceral adiposity index is positively associated with blood pressure: A systematic review
    Nathália Nogueira Leite, Bruna Clemente Cota, Ana Raquel Ernesto Manuel Gotine, Daniela Mayumi Usuda Prado Rocha, Patrícia Feliciano Pereira, Helen Hermana Miranda Hermsdorff
    Obesity Research & Clinical Practice.2021; 15(6): 546.     CrossRef
  • The hypertriglyceridemic-waist phenotype as a valuable and integrative mirror of metabolic syndrome traits
    Begoña de Cuevillas, Ismael Alvarez-Alvarez, Jose I. Riezu-Boj, Santiago Navas-Carretero, J. Alfredo Martinez
    Scientific Reports.2021;[Epub]     CrossRef
  • Association of Hypertriglyceridemic Waist Phenotype with Obstructive Sleep Apnea: A Cross-Sectional Study
    Meizhen Gu, Weijun Huang, Xinyi Li, Yupu Liu, Fan Wang, Chao Fang, Ting Chen
    Nature and Science of Sleep.2021; Volume 13: 2165.     CrossRef
  • The Visceral Adipose Index in Relation to Incidence of Hypertension in Chinese Adults: China Health and Nutrition Survey (CHNS)
    Yong Xue, Qun Shen, Chang Li, Zijian Dai, Tingchao He
    Nutrients.2020; 12(3): 805.     CrossRef
  • Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis
    Chan-Hee Jung, Eun-Jung Rhee, Hyemi Kwon, Yoosoo Chang, Seungho Ryu, Won-Young Lee
    Endocrinology and Metabolism.2020; 35(1): 165.     CrossRef
  • Severity of the metabolic syndrome as a predictor of prediabetes and type 2 diabetes in first degree relatives of type 2 diabetic patients: A 15-year prospective cohort study
    Rokhsareh Meamar, Masoud Amini, Ashraf Aminorroaya, Maryam Nasri, Majid Abyar, Awat Feizi
    World Journal of Diabetes.2020; 11(5): 202.     CrossRef
  • Association between Visceral Adiposity Index and hypertension among Chinese Adults: a nationwide cross-sectional study in the China Health and Nutrition Survey
    Jing Yang, Hongxia Li, Lianhua Han, Lei Zhang, Yafeng Zhou
    Blood Pressure Monitoring.2020; 25(5): 271.     CrossRef
  • Hypertriglyceridemic Waist Phenotype and Lipid Accumulation Product: Two Comprehensive Obese Indicators of Waist Circumference and Triglyceride to Predict Type 2 Diabetes Mellitus in Chinese Population
    Minrui Xu, Mingtao Huang, Deren Qiang, Jianxin Gu, Yong Li, Yingzi Pan, Xingjuan Yao, Wenchao Xu, Yuan Tao, Yihong Zhou, Hongxia Ma, Ulrike Rothe
    Journal of Diabetes Research.2020; 2020: 1.     CrossRef
  • Association of the hypertriglyceridemic waist phenotype and severity of acute pancreatitis
    Yanbing Ding, Min Zhang, Lisheng Wang, Tao Yin, Ningzhi Wang, Jian Wu, Jiehua Zhi, Weiwei Chen, Keyan Wu, Weijuan Gong, Weiming Xiao, Zhenglei Xu, Guotao Lu
    Lipids in Health and Disease.2019;[Epub]     CrossRef
  • Association between the Hypertriglyceridemic Waist Phenotype and Prediabetes in Chinese Adults Aged 40 Years and Older
    Kun Zhao, Shan-Shan Yang, Hai-Bin Wang, Kang Chen, Zhao-Hui Lu, Yi-Ming Mu
    Journal of Diabetes Research.2018; 2018: 1.     CrossRef
  • Sex-specific relationship between visceral fat index and dyslipidemia in Chinese rural adults: The Henan Rural Cohort Study
    Zhongyan Tian, Yuqian Li, Zhenxing Mao, Songcheng Yu, Yanhua Wang, Xiaotian Liu, Runqi Tu, Haiqing Zhang, Xinling Qian, Xia Zhang, Lulu Zhang, Jingzhi Zhao, Lei Yin, Chongjian Wang
    Preventive Medicine.2018; 116: 104.     CrossRef
  • Response: Utility of the Visceral Adiposity Index and Hypertriglyceridemic Waist Phenotype for Predicting Incident Hypertension (Endocrinol Metab 2017;32:221-9, Mohsen Janghorbani et al.)
    Mohsen Janghorbani
    Endocrinology and Metabolism.2017; 32(4): 485.     CrossRef
  • Letter: Utility of the Visceral Adiposity Index and Hypertriglyceridemic Waist Phenotype for Predicting Incident Hypertension (Endocrinol Metab 2017;32:221-9, Mohsen Janghorbani et al.)
    Eun-Jung Rhee
    Endocrinology and Metabolism.2017; 32(3): 396.     CrossRef
Close layer
Clinical Study
Urinary Albumin Excretion Reflects Cardiovascular Risk in Postmenopausal Women without Diabetes: The 2011 to 2013 Korean National Health and Nutrition Examination Survey
Hee Jung Ahn, Do Sik Moon, Da Yeong Kang, Jung In Lee, Da Young Kim, Jin Hwa Kim, Sang Yong Kim, Hak Yeon Bae
Endocrinol Metab. 2016;31(4):537-546.   Published online November 3, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.4.537
  • 6,656 View
  • 34 Download
  • 3 Web of Science
  • 4 Crossref
AbstractAbstract PDFPubReader   
Background

The objective of the current study was to determine whether there was an association between urinary albumin excretion and cardiovascular disease (CVD) risk by estimating the Framingham Risk Score (FRS) in postmenopausal women without diabetes.

Methods

This study was based on data from the Korea National Health and Nutrition Examination Survey, which was conducted by the Korean Ministry of Health and Welfare in 2011 to 2013. Data on 2,316 postmenopausal women from a total of 24,594 participants was included in the analysis.

Results

The mean FRS was significantly different in each of the urinary albumin to creatinine ratio (UACR) subgroups, and it increased with UACR. The FRS was 12.69±0.12 in the optimal group, 14.30±0.19 in the intermediate normal group, 14.62±0.26 in the high normal group, and 15.86±0.36 in the microalbuminuria group. After fully adjusting for potential confounding factors, high normal levels and microalbuminuria were significantly associated with the highest tertile of FRS ([odds ratio (OR), 1.642; 95% confidence interval (CI), 1.124 to 2.400] and [OR, 3.385; 95% CI, 2.088 to 5.488], respectively) compared with the optimal subgroup. High normal levels and microalbuminuria were also significantly associated with a ≥10% 10-year risk of CVD ([OR, 1.853; 95% CI, 1.122 to 3.060] and [OR, 2.831; 95% CI, 1.327 to 6.037], respectively) after adjusting for potential confounding covariates.

Conclusion

Urinary albumin excretion reflects CVD risk in postmenopausal women without diabetes, and high normal levels and microalbuminuria were independently associated with a higher risk of CVD.

Citations

Citations to this article as recorded by  
  • Association between urinary albumin creatinine ratio and cardiovascular disease
    Yoo Jin Kim, Sang Won Hwang, Taesic Lee, Jun Young Lee, Young Uh, Gulali Aktas
    PLOS ONE.2023; 18(3): e0283083.     CrossRef
  • Relationship between Hypertension and the Declining Renal Function in Korean Adults
    Jun Ho Lee
    The Korean Journal of Clinical Laboratory Science.2021; 53(1): 32.     CrossRef
  • Significance of Obstetrical History with Future Cardiovascular Disease Risk
    Emmanuel Bassily, Cameron Bell, Sean Verma, Nidhi Patel, Aarti Patel
    The American Journal of Medicine.2019; 132(5): 567.     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
Close layer
Review Article
Endocrine Risk Factors for Cognitive Impairment
Jae Hoon Moon
Endocrinol Metab. 2016;31(2):185-192.   Published online April 25, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.2.185
  • 8,474 View
  • 62 Download
  • 27 Web of Science
  • 27 Crossref
AbstractAbstract PDFPubReader   

Cognitive impairment, including Alzheimer's disease and other kinds of dementia, is a major health problem in older adults worldwide. Although numerous investigators have attempted to develop effective treatment modalities or drugs, there is no reasonably efficacious strategy for preventing or recovering from cognitive impairment. Therefore, modifiable risk factors for cognitive impairment have received attention, and the growing literature of metabolic risk factors for cognitive impairment has expanded from epidemiology to molecular pathogenesis and therapeutic management. This review focuses on the epidemiological evidence for the association between cognitive impairment and several endocrine risk factors, including insulin resistance, dyslipidemia, thyroid dysfunction, vitamin D deficiency, and subclinical atherosclerosis. Researches suggesting possible mechanisms for this association are reviewed. The research investigating modifiable endocrine risk factors for cognitive impairment provides clues for understanding the pathogenesis of cognitive impairment and developing novel treatment modalities. However, so far, interventional studies investigating the beneficial effect of the "modification" of these "modifiable risk factors" on cognitive impairment have reported variable results. Therefore, well-designed, randomized prospective interventional studies are needed.

Citations

Citations to this article as recorded by  
  • Long-term adverse effects of modern Wilms tumour therapies: implications for monitoring
    Filippo Spreafico, Giovanna Gattuso, Marta G. Podda, Olga Nigro, Valeria Colombo, Sabina Vennarini, Antonio Mastrangelo, Francesca Filippi, Giovanni Montini, Maura Massimino, Monica Terenziani
    Nature Reviews Urology.2026;[Epub]     CrossRef
  • Assessment of Clinical and Neurological Alterations Before Radiation Therapy in Children With Malignant Brain Tumours
    M. Lecchi, A. Erbetta, P. Grampa, C. Cavatorta, S. Meroni, A. Nigri, F. Spreafico, E. Pecori, M.C. Oprandi, V. Biassoni, E. Schiavello, D. Peruzzo, R. Laureanti, L. Mainardi, S. Vennarini, G. Poggi, O. Nigro, P. Verderio, E. Pignoli, M. Massimino
    Clinical Oncology.2025; 43: 103872.     CrossRef
  • Gut-brain nexus: Mapping multimodal links to neurodegeneration at biobank scale
    Mohammad Shafieinouri, Samantha Hong, Paul Suhwan Lee, Spencer M. Grant, Marzieh Khani, Anant Dadu, Artur F. Schumacher Schuh, Mary B. Makarious, Rodrigo Sandon, Emily Simmonds, Hirotaka Iwaki, Gracelyn Hill, Cornelis Blauwendraat, Valentina Escott-Price,
    Science Advances.2025;[Epub]     CrossRef
  • Vitamin D and focal brain atrophy in PD with non-dementia: a VBM study
    Yingying Xu, Erlei Wang, Qilin Zhang, Jing Liu, Weifeng Luo
    Frontiers in Human Neuroscience.2024;[Epub]     CrossRef
  • Association between the neutrophil to lymphocyte ratio and mild cognitive impairment in patients with type 2 diabetes
    Zi-Wei Yu, Ying Wang, Xin Li, Xue-Wei Tong, Yi-Tong Zhang, Xin-Yuan Gao
    Aging Clinical and Experimental Research.2023; 35(6): 1339.     CrossRef
  • Cognitive status and its risk factors in patients with hypertension and diabetes in a low‐income rural area of China: A cross‐sectional study
    Yuyan Guo, Ruifeng Liang, Jingjuan Ren, Liting Cheng, Mengqin Wang, Huilin Chai, Xiaoyu Cheng, Yaowen Yang, Yajuan Sun, Jiantao Li, Shuhong Zhao, Wenjing Hou, Jianhua Zhang, Feng Liu, Rong Wang, Qiao Niu, Hongmei Yu, Shoulin Yang, Jianying Bai, Hongmei Zh
    International Journal of Geriatric Psychiatry.2023;[Epub]     CrossRef
  • Insulin Resistance and Glucose Metabolism during Infection
    Borros Arneth
    Endocrines.2023; 4(4): 685.     CrossRef
  • Relationship between serum lipids and depression: A cross sectional survey among adults in Haryana, India
    Rubina Mulchandani, Tanica Lyngdoh, Ria Nangia, Sukriti Singh, Sandeep Grover, JS Thakur
    Indian Journal of Psychiatry.2023; 65(1): 61.     CrossRef
  • Corresponding risk factors between cognitive impairment and type 1 diabetes mellitus: A narrative review
    Chen-Yang Jin, Shi-Wen Yu, Jun-Ting Yin, Xiao-Ying Yuan, Xu-Gang Wang
    Heliyon.2022; 8(8): e10073.     CrossRef
  • Cerebrospinal fluid heart fatty acid‐binding protein as a predictive biomarker of neurodegeneration in Alzheimer’s disease
    Lu Pan, Ya-Nan Ou, Lin Tan, Lan Tan, Jin-Tai Yu
    Brain Science Advances.2021; 7(1): 44.     CrossRef
  • Endocrine dysfunction and cognitive impairment
    Valeria CALSOLARO, Marina BOTTARI, Giulia COPPINI, Bianca LEMMI, Fabio MONZANI
    Minerva Endocrinology.2021;[Epub]     CrossRef
  • Effect of hypothyroidism on cognitive status: Evidence from stroop task
    Shilpi Goyal, Abhinav Dixit, Neelam Vaney, SV Madhu
    Indian Journal of Medical Specialities.2020; 11(1): 34.     CrossRef
  • Statin use and safety concerns: an overview of the past, present, and the future
    Rubina Mulchandani, Tanica Lyngdoh, Ashish Kumar Kakkar
    Expert Opinion on Drug Safety.2020; 19(8): 1011.     CrossRef
  • Neurocognitive impairment in type 2 diabetes mellitus
    Marianna Karvani, P. Simos, S. Stavrakaki, D. Kapoukranidou
    Hormones.2019; 18(4): 523.     CrossRef
  • TDP-43 proteinopathy in aging: Associations with risk-associated gene variants and with brain parenchymal thyroid hormone levels
    Peter T. Nelson, Zsombor Gal, Wang-Xia Wang, Dana M. Niedowicz, Sergey C. Artiushin, Samuel Wycoff, Angela Wei, Gregory A. Jicha, David W. Fardo
    Neurobiology of Disease.2019; 125: 67.     CrossRef
  • Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults
    Willa D. Brenowitz, Fang Han, Walter A. Kukull, Peter T. Nelson
    Neurobiology of Aging.2018; 62: 64.     CrossRef
  • Translating molecular advances in Down syndrome and Fragile X syndrome into therapies
    Victor Faundez, Ilario De Toma, Barbara Bardoni, Renata Bartesaghi, Dean Nizetic, Rafael de la Torre, Roi Cohen Kadosh, Yann Herault, Mara Dierssen, Marie-Claude Potier, Stylianos Antonarakis, Renata Bartesaghi, Andrea Contestabile, Tonnie Coppus, Peter D
    European Neuropsychopharmacology.2018; 28(6): 675.     CrossRef
  • Associations between waist circumference, metabolic risk and executive function in adolescents: A cross-sectional mediation analysis
    Anna Bugge, Sören Möller, Daniel R. Westfall, Jakob Tarp, Anne K. Gejl, Niels Wedderkopp, Charles H. Hillman, Ying-Mei Feng
    PLOS ONE.2018; 13(6): e0199281.     CrossRef
  • BsmI polymorphism in the vitamin D receptor gene is associated with 25-hydroxy vitamin D levels in individuals with cognitive decline
    Ana Carolina R. de Oliveira, Carolina A. Magalhães, Cristina M. G. Loures, Vanessa G. Fraga, Leonardo C. de Souza, Henrique C. Guimarães, Marco T. G. Cintra, Maria A. Bicalho, Maira C. R. Sousa, Josianne N. Silveira, Ieda F. O. Silva, Paulo Caramelli, Mar
    Arquivos de Neuro-Psiquiatria.2018; 76(11): 760.     CrossRef
  • Traumatic brain injury: sex, gender and intersecting vulnerabilities
    Tatyana Mollayeva, Shirin Mollayeva, Angela Colantonio
    Nature Reviews Neurology.2018; 14(12): 711.     CrossRef
  • Determinants of poor cognitive function using A-IQCODE among Lebanese older adults: a cross-sectional study
    Ibrahim R. Bou-Orm, Assem M. Khamis, Monique Chaaya
    Aging & Mental Health.2018; 22(6): 844.     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
  • Alcohol consumption and gastric cancer risk: a meta-analysis of prospective cohort studies
    Xue Han, Li Xiao, Yao Yu, Yu Chen, Hai-Hua Shu
    Oncotarget.2017; 8(47): 83237.     CrossRef
  • Functional capacity and obesity reflect the cognitive performance of older adults living in long‐term care facilities
    Karine Gonçalves Damascena, Cristiane Batisti Ferreira, Pâmela dos Santos Teixeira, Bibiano Madrid, Alexandre Gonçalves, Cláudio Córdova, Otávio de Toledo Nóbrega, Aparecido Pimentel Ferreira
    Psychogeriatrics.2017; 17(6): 439.     CrossRef
  • Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease
    Therese S Salameh, Elizabeth M Rhea, William A Banks, Angela J Hanson
    Experimental Biology and Medicine.2016; 241(15): 1676.     CrossRef
  • Role of the Orexin System on the Hypothalamus-Pituitary-Thyroid Axis
    Antonietta Messina, Carolina De Fusco, Vincenzo Monda, Maria Esposito, Fiorenzo Moscatelli, Anna Valenzano, Marco Carotenuto, Emanuela Viggiano, Sergio Chieffi, Vincenzo De Luca, Giuseppe Cibelli, Marcellino Monda, Giovanni Messina
    Frontiers in Neural Circuits.2016;[Epub]     CrossRef
  • Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging
    Peter T. Nelson, Yuriko Katsumata, Kwangsik Nho, Sergey C. Artiushin, Gregory A. Jicha, Wang-Xia Wang, Erin L. Abner, Andrew J. Saykin, Walter A. Kukull, David W. Fardo
    Acta Neuropathologica.2016; 132(6): 841.     CrossRef
Close layer
Original Articles
Clinical Study
The Relationship between 10-Year Cardiovascular Risk Calculated Using the Pooled Cohort Equation and the Severity of Non-Alcoholic Fatty Liver Disease
Jeong In Lee, Min Chul Kim, Byung Sub Moon, Young Seok Song, Eun Na Han, Hyo Sun Lee, Yoonjeong Son, Jihyun Kim, Eun Jin Han, Hye-Jeong Park, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee
Endocrinol Metab. 2016;31(1):86-92.   Published online March 16, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.1.86
  • 8,074 View
  • 48 Download
  • 22 Web of Science
  • 24 Crossref
AbstractAbstract PDFPubReader   
Background

We investigated the association between the severity of non-alcoholic fatty liver disease (NAFLD) and the estimated 10-year risk of cardiovascular disease (CVD) calculated by Pooled Cohort Equation (PCE) and Framingham risk score (FRS).

Methods

A total of 15,913 participants (mean age, 46.3 years) in a health screening program were selected for analysis. The presence and severity of fatty liver was assessed by abdominal ultrasonogram. Subjects who drank alcohol more than three times a week were excluded from the study.

Results

Among the participants, 57.6% had no NAFLD, 35.4% had grade I, 6.5% had grade II, and 0.5% had grade III NAFLD. Mean estimated 10-year CVD risk was 2.59%, 3.93%, 4.68%, and 5.23% calculated using the PCE (P for trend <0.01) and 4.55%, 6.39%, 7.33%, and 7.13% calculated using FRS, according to NAFLD severity from none to severe (P for trend <0.01). The odds ratio for ≥7.5% estimated CVD risk calculated using the PCE showed a higher correlation with increasing severity of NAFLD even after adjustment for conventional CVD risk factors (1.52, 2.56, 3.35 vs. the no NAFLD group as a reference, P<0.01) compared with calculated risk using FRS (1.65, 1.62, 1.72 vs. no NAFLD group as a reference, P<0.01).

Conclusion

In our study of apparently healthy Korean adults, increasing severity of NAFLD showed a higher correlation with estimated 10-year CVD risk when calculated using the PCE than when calculated using FRS.

Citations

Citations to this article as recorded by  
  • Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective
    Inha Jung, Dae-Jeong Koo, Won-Young Lee
    Diabetes & Metabolism Journal.2024; 48(3): 327.     CrossRef
  • Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases
    Dana Kablawi, Faisal Aljohani, Chiara Saroli Palumbo, Sophie Restellini, Alain Bitton, Gary Wild, Waqqas Afif, Peter L Lakatos, Talat Bessissow, Giada Sebastiani
    Crohn's & Colitis 360.2023;[Epub]     CrossRef
  • Low Relative Handgrip Strength Is Associated with a High Risk of Non-Alcoholic Fatty Liver Disease in Italian Adults: A Retrospective Cohort Study
    Samantha Maurotti, Roberta Pujia, Elisa Mazza, Maria Francesca Pileggi, Franco Arturi, Maria Grazia Tarsitano, Tiziana Montalcini, Arturo Pujia, Yvelise Ferro
    Applied Sciences.2023; 13(22): 12489.     CrossRef
  • Fatty Liver Disease: Diagnosis and Stratification
    Yedidya Saiman, Andres Duarte-Rojo, Mary E. Rinella
    Annual Review of Medicine.2022; 73(1): 529.     CrossRef
  • “Dangerous liaisons: NAFLD and liver fibrosis increase cardiovascular risk in HIV”
    Adriana Cervo, Giada Sebastiani, Jovana Milic, Thomas Krahn, Sergio Mazzola, Salvatore Petta, Antonio Cascio, Giovanni Guaraldi, Giovanni Mazzola
    HIV Medicine.2022; 23(8): 911.     CrossRef
  • Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes
    Nong Li, Huiwen Tan, Aixia Xie, Cheng Li, Xuan Fu, Weiting Xang, Amina Kirim, Xuefang Huang
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • The Relation Between Non-alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease
    Seyed Moayed Alavian, Hosein Zadi
    Multidisciplinary Cardiovascular Annals.2022;[Epub]     CrossRef
  • Risk factors for cardiovascular disease among individuals with hepatic steatosis
    Julia Karády, Maros Ferencik, Thomas Mayrhofer, Nandini M. Meyersohn, Daniel O. Bittner, Pedro V. Staziaki, Balint Szilveszter, Travis R. Hallett, Michael T. Lu, Stefan B. Puchner, Tracey G. Simon, Borek Foldyna, Geoffrey S. Ginsburg, Robert W. McGarrah,
    Hepatology Communications.2022; 6(12): 3406.     CrossRef
  • Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity
    Mohammad E. Khamseh, Mojtaba Malek, Rowshanak Abbasi, Hoda Taheri, Maryam Lahouti, Fariba Alaei-Shahmiri
    Metabolic Syndrome and Related Disorders.2021; 19(3): 167.     CrossRef
  • Interplay between non‐alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population
    Grazia Pennisi, Vito Di Marco, Carola Buscemi, Giovanni Mazzola, Cristiana Randazzo, Federica Spatola, Antonio Craxì, Silvio Buscemi, Salvatore Petta
    Journal of Gastroenterology and Hepatology.2021; 36(9): 2389.     CrossRef
  • Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts
    Jiwon Kim, Minyoung Lee, Soo Yeon Kim, Ji-Hye Kim, Ji Sun Nam, Sung Wan Chun, Se Eun Park, Kwang Joon Kim, Yong-ho Lee, Joo Young Nam, Eun Seok Kang
    Endocrinology and Metabolism.2021; 36(4): 823.     CrossRef
  • Coronary Artery Disease is More Severe in Patients with Non-Alcoholic Steatohepatitis than Fatty Liver
    Toshihiro Niikura, Kento Imajo, Anna Ozaki, Takashi Kobayashi, Michihiro Iwaki, Yasushi Honda, Takaomi Kessoku, Yuji Ogawa, Masato Yoneda, Hiroyuki Kirikoshi, Satoru Saito, Atsushi Nakajima
    Diagnostics.2020; 10(3): 129.     CrossRef
  • Cardiovascular Disease in Nonalcoholic Steatohepatitis: Screening and Management
    Hersh Shroff, Lisa B. VanWagner
    Current Hepatology Reports.2020; 19(3): 315.     CrossRef
  • Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults
    Sang Bae Lee, Min Kyung Kim, Shinae Kang, Kahui Park, Jung Hye Kim, Su Jung Baik, Ji Sun Nam, Chul Woo Ahn, Jong Suk Park
    Endocrinology and Metabolism.2019; 34(2): 179.     CrossRef
  • Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease
    Pegah Golabi, Natsu Fukui, James Paik, Mehmet Sayiner, Alita Mishra, Zobair M. Younossi
    Hepatology Communications.2019; 3(8): 1050.     CrossRef
  • Lower hand grip strength in older adults with non-alcoholic fatty liver disease: a nationwide population-based study
    Beom-Jun Kim, Seong Hee Ahn, Seung Hun Lee, Seongbin Hong, Mark W. Hamrick, Carlos M. Isales, Jung-Min Koh
    Aging.2019; 11(13): 4547.     CrossRef
  • Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency
    Ga Eun Nam, Soon Young Hwang, Hye Soo Chung, Ju Hee Choi, Hyun Jung Lee, Nam Hoon Kim, Hye Jin Yoo, Ji-A Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Kyung Mook Choi
    International Journal of Endocrinology.2018; 2018: 1.     CrossRef
  • Implication of liver enzymes on incident cardiovascular diseases and mortality: A nationwide population-based cohort study
    Kyung Mook Choi, Kyungdo Han, Sanghyun Park, Hye Soo Chung, Nam Hoon Kim, Hye Jin Yoo, Ji-A Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Yong Gyu Park, Seon Mee Kim
    Scientific Reports.2018;[Epub]     CrossRef
  • Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance
    Mariana Verdelho Machado
    GE - Portuguese Journal of Gastroenterology.2017; 24(4): 157.     CrossRef
  • Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case‐control study
    Gyuri Kim, Suk‐Yong Jang, Eugene Han, Yong‐ho Lee, Se‐young Park, Chung Mo Nam, Eun Seok Kang
    International Journal of Cancer.2017; 140(4): 798.     CrossRef
  • Clinical Characteristics of Non-Alcoholic Fatty Liver Disease Based on Analyses from the Kangbuk Samsung Health Study
    Eun-Jung Rhee
    The Journal of Korean Diabetes.2017; 18(2): 81.     CrossRef
  • Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation
    Jihyun Kim, Da Young Lee, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee, Susanne Kaser
    PLOS ONE.2017; 12(7): e0180118.     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
  • Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases
    Eugene Han, Yong-ho Lee
    Diabetes & Metabolism Journal.2017; 41(6): 430.     CrossRef
Close layer
Obesity and Metabolism
Factors Associated with Glycemic Variability in Patients with Type 2 Diabetes: Focus on Oral Hypoglycemic Agents and Cardiovascular Risk Factors
Soyeon Yoo, Sang-Ouk Chin, Sang-Ah Lee, Gwanpyo Koh
Endocrinol Metab. 2015;30(3):352-360.   Published online August 4, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.3.352
  • 6,810 View
  • 53 Download
  • 12 Web of Science
  • 12 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   
Background

The role of glycemic variability (GV) in development of cardiovascular diseases remains controversial, and factors that determine glucose fluctuation in patients with diabetes are unknown. We investigated relationships between GV indices, kinds of oral hypoglycemic agents (OHAs), and cardiovascular risk factors in patients with type 2 diabetes mellitus (T2DM).

Methods

We analyzed 209 patients with T2DM. The GV index (standard deviation [SD] and mean absolute glucose change [MAG]) were calculated from 7-point self-monitoring of blood glucose profiles. The patients were classified into four groups according to whether they take OHAs known as GV-lowering (A) and GV-increasing (B): 1 (A only), 2 (neither), 3 (both A and B), and 4 (B only). The 10-year risk for atherosclerotic cardiovascular disease (ASCVD) was calculated using the Pooled Cohort Equations.

Results

GV indices were significantly higher in patients taking sulfonylureas (SUs), but lower in those taking dipeptidyl peptidase-4 inhibitors. In hierarchical regression analysis, the use of SUs remained independent correlates of the SD (β=0.209, P=0.009) and MAG (β=0.214, P=0.011). In four OHA groups, GV indices increased progressively from group 1 to group 4. However, these did not differ according to quartiles of 10-year ASCVD risk.

Conclusion

GV indices correlated significantly with the use of OHAs, particularly SU, and differed significantly according to combination of OHAs. However, cardiovascular risk factors and 10-year ASCVD risk were not related to GV indices. These findings suggest that GV is largely determined by properties of OHAs and not to cardiovascular complications in patients with T2DM.

Citations

Citations to this article as recorded by  
  • Comparative Effectiveness of Oral Hypoglycemic Agents for Glycemic Control and Glycemic Variability in Patients with Type 2 Diabetes Mellitus: Using Flash Glucose Monitoring
    Poongothai Venkatachalapathy, Karthik Kumar Dos Alagarswamy Mohandoss, Murali Munisamy, Mohan Sellappan
    Current Diabetes Reviews.2025;[Epub]     CrossRef
  • Combined assessment of stress hyperglycemia ratio and glycemic variability to predict all-cause mortality in critically ill patients with atherosclerotic cardiovascular diseases across different glucose metabolic states: an observational cohort study with
    Fuxu Wang, Yu Guo, Yuru Tang, Shuangmei Zhao, Kaige Xuan, Zhi Mao, Ruogu Lu, Rongyao Hou, Xiaoyan Zhu
    Cardiovascular Diabetology.2025;[Epub]     CrossRef
  • Glycemic Variability and Gut Microbiota Metabolic Patterns: A Novel Perspective on Diabetic Complications
    Yongjie Xu, Di Chen, Huiru Yang, Yiqiong Zhang, Changyudong Huang, Yinxue Zhong, Haizhi Li, Liying Zhu, Chengcheng Li, Rui Yan, Mi Liu, Wei Pan
    Food Science & Nutrition.2025;[Epub]     CrossRef
  • Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort observational study
    Yun‐Ru Lai, Wen‐Chan Chiu, Chih‐Cheng Huang, Ben‐Chung Cheng, I‐Hsun Yu, Chia‐Te Kung, Ting Yin Lin, Hui Ching Chiang, Chun‐En Aurea Kuo, Cheng‐Hsien Lu
    Journal of Diabetes Investigation.2024; 15(3): 326.     CrossRef
  • Influence of dipeptidyl peptidase-4 inhibitors on glycemic variability in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
    Shangyu Chai, Ruya Zhang, Ye Zhang, Richard David Carr, Yiman Zheng, Swapnil Rajpathak, Miao Yu
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Glycemic Variability in Subjects with Diabetes and Hypogonadism during Testosterone Replacement Treatment: A Pilot Study
    Giuseppe Defeudis, Ernesto Maddaloni, Giovanni Rossini, Alfonso Maria Di Tommaso, Rossella Mazzilli, Paolo Di Palma, Paolo Pozzilli, Nicola Napoli
    Journal of Clinical Medicine.2022; 11(18): 5333.     CrossRef
  • New Insights into the Role of Visit-to-Visit Glycemic Variability and Blood Pressure Variability in Cardiovascular Disease Risk
    Jin J. Zhou, Daniel S. Nuyujukian, Peter D. Reaven
    Current Cardiology Reports.2021;[Epub]     CrossRef
  • Prevalence of glycemic variability and factors associated with the glycemic arrays among end-stage kidney disease patients on chronic hemodialysis
    Abdul Hanif Khan Yusof Khan, Nor Fadhlina Zakaria, Muhammad Adil Zainal Abidin, Nor Azmi Kamaruddin
    Medicine.2021; 100(30): e26729.     CrossRef
  • Dipeptidyl-Peptidase-IV Inhibitors, Imigliptin and Alogliptin, Improve Beta-Cell Function in Type 2 Diabetes
    Xu Liu, Yang Liu, Hongzhong Liu, Haiyan Li, Jianhong Yang, Pei Hu, Xinhua Xiao, Dongyang Liu
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • HbA 1C variability and hypoglycemia hospitalization in adults with type 1 and type 2 diabetes: A nested case-control study
    Victor W. Zhong, Juhaeri Juhaeri, Stephen R. Cole, Christina M. Shay, Penny Gordon-Larsen, Evangelos Kontopantelis, Elizabeth J. Mayer-Davis
    Journal of Diabetes and its Complications.2018; 32(2): 203.     CrossRef
  • Glucose fluctuation and the resultant endothelial injury are correlated with pancreatic β cell dysfunction in patients with coronary artery disease
    Makoto Murata, Hitoshi Adachi, Shigeru Oshima, Masahiko Kurabayashi
    Diabetes Research and Clinical Practice.2017; 131: 107.     CrossRef
  • Efficacy of lifestyle interventions in patients with type 2 diabetes: A systematic review and meta-analysis
    Xiao-Li Huang, Jian-Hua Pan, Dan Chen, Jing Chen, Fang Chen, Tao-Tao Hu
    European Journal of Internal Medicine.2016; 27: 37.     CrossRef
Close layer
Obesity and Metabolism
Associations between Dietary Acid-Base Load and Cardiometabolic Risk Factors in Adults: The Tehran Lipid and Glucose Study
Zahra Bahadoran, Parvin Mirmiran, Hadise Khosravi, Fereidoun Azizi
Endocrinol Metab. 2015;30(2):201-207.   Published online June 30, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.2.201
  • 6,611 View
  • 37 Download
  • 42 Web of Science
  • 40 Crossref
AbstractAbstract PDFPubReader   
Background

In this study we investigated the associations of dietary acid-base load, identified by potential renal acid load (PRAL) and protein to potassium (Pro:K) ratio, with cardiometabolic risk factors in Tehranian adults.

Methods

A cross-sectional study was conducted within the framework of the fourth phase of the Tehran Lipid and Glucose Study (2009 to 2011) on 5,620 men and women aged 19 to 70 years. Dietary data were collected by a trained dietitian using a validated, 147-food item, semi-quantitative food frequency questionnaire, and dietary PRAL and Pro:K ratio were calculated. Multiple linear regression models with adjustment for potential confounding variables were used to evaluate the associations of dietary acid-base load with anthropometric measures, blood pressure, serum triglycerides, high density lipoprotein cholesterol (HDL-C), serum creatinine, and fasting blood glucose.

Results

The mean±SD age of the participants was 39.8±12.8 years and 54% of participants were women. Mean±SD PRAL was -22.0±29.1; mean PRAL was -15.6 in men and -26.8 in women. Dietary PRAL was associated with weight (β=0.098, P<0.001), waist circumference (β=0.062, P<0.01), serum triglycerides (β=0.143, P<0.01), HDL-C (β=-0.11, P<0.01), diastolic blood pressure (β=0.062, P<0.01), and serum creatinine (β=0.142, P<0.001). Pro:K ratio was associated with weight (β=0.055, P<0.001), waist circumference (β=0.04, P<0.01), serum HDL-C (β=-0.06, P<0.01), serum triglycerides (β=0.03, P<0.05), diastolic blood pressure (β=0.026, P<0.05), and serum creatinine (β=0.07, P<0.01).

Conclusion

A more acidic dietary acid-base load may be a risk factor for the development of metabolic disorders.

Citations

Citations to this article as recorded by  
  • Carbohydrate Intake and Its Association With Dietary Acid Load in U.S. Adults: Results From a Cross-Sectional Study
    Maximilian A. Storz, Alvaro L. Ronco
    American Journal of Lifestyle Medicine.2025; 19(5): 711.     CrossRef
  • Relationship between TyG-BMI index and glycemic index with diet quality, anthropometric indices, and blood pressure in patients with metabolic syndrome
    Paria Moulavi, Afsane Ahmadi, Seyed Jalil Masoumi, Morteza Zare, Mahdi Honardoust, Rahil Ranjbar
    Medicine.2025; 104(3): e41276.     CrossRef
  • Dietary Acid Load and Human Health: A Systematic Review and Meta-analysis of Observational Studies
    Maryam Abbastabar, Zahra Mohammadi-Pirouz, Shabnam Omidvar, Afsaneh Bakhtiari, Francesca L Crowe, Mahdi Sepidarkish
    Nutrition Reviews.2025; 83(9): 1641.     CrossRef
  • The association between dietary acid load and indices of insulin resistance
    Niloufar Abdollahpour, Najmeh Seifi, Alireza Abbas Abad Arabi, Negar Sadat Sanei Shahri, Ali Ferasati, Hanieh Keikhay Moghadam, Habibollah Esmaily, Gordon A. Ferns, Majid Ghayour-Mobarhan
    Scientific Reports.2025;[Epub]     CrossRef
  • Dietary Acid Load and the Risk of All-Cause Mortality: A Systematic Review and Meta-Analysis of Observational Studies
    Fatemeh Hajizadeh-Sharafabad, Sara Shojaei-Zarghani, Elham Sharifi-Zahabi, Nastaran Najafi, Mohammad Reza Pashaei
    Nutrition Reviews.2025;[Epub]     CrossRef
  • The association between dietary acid load and Kidney/Liver function in morbidly obese bariatric candidates
    Yasamin Hozhabr Kalali, Ali Nikparast, Fatemeh S. Hosseini, Seyed Ali Keshavarz, Hastimansooreh Ansar
    BMC Nutrition.2025;[Epub]     CrossRef
  • A high dietary acid load can potentially exacerbate cardiometabolic risk factors: An updated systematic review and meta-analysis of observational studies
    Shamim Dolati, Soha Razmjouei, Mohammad Alizadeh, Amir Hossein Faghfouri, Amir Hossein Moridpour
    Nutrition, Metabolism and Cardiovascular Diseases.2024; 34(3): 569.     CrossRef
  • High dietary acid load predicts severity of autoimmune skin disease: a cross-sectional study
    Maryam Fallah, Banafsheh Jafari Azad, Anahita Najafi, Zahra Esmaeily, Kamran Balighi, Maryam Daneshpazhooh, Soraiya Ebrahimpour-Koujan
    Scientific Reports.2024;[Epub]     CrossRef
  • Dietary acid load and cardiovascular diseases
    Nursel Sahın, Ugur Gunsen
    Critical Reviews in Food Science and Nutrition.2023; 63(28): 9033.     CrossRef
  • Health Inequities in the USA: a Role for Dietary Acid Load? Results from the National Health and Nutrition Examination Surveys
    Maximilian Andreas Storz
    Journal of Racial and Ethnic Health Disparities.2023; 10(6): 2851.     CrossRef
  • Dietary acid load is associated with waist circumference in university students with low adherence to the Mediterranean diet: The potential role of ultra-processed foods
    Paraskevi Detopoulou, Vassilios Dedes, Ioanna Pylarinou, Dimitra Syka, Konstantinos Tzirogiannis, Georgios I. Panoutsopoulos
    Clinical Nutrition ESPEN.2023; 56: 43.     CrossRef
  • Dietary acid load and its interaction with CETP TaqB1 polymorphisms on lipid profile among patients with Type 2 diabetes mellitus
    Faezeh Abaj, Zahra Esmaeily, Zeinab Naeini, Ehsan Alvandi, Masoumeh Rafiee, Fariba Koohdani
    BMC Endocrine Disorders.2023;[Epub]     CrossRef
  • A Nutrigenetic Approach to Investigate ApoB EcoR1 Polymorphism-Dietary Acid Load Interactions on Lipid and Anthropometric-Related Outcomes in Adults with Dyslipidemic Type 2 Diabetes
    Zeinab Naeini, Faezeh Abaj, Zahra Esmaeily, Ehsan Alvandi, Masoumeh Rafiee, Fariba Koohdani
    Lifestyle Genomics.2023; 16(1): 61.     CrossRef
  • Interaction of dietary acid load and general and central obesity with muscle strength and skeletal muscle mass
    Saba Mohammadpour, Parivash Ghorbaninejad, Mahshid Shahavandi, Sakineh Shab-Bidar
    Clinical Nutrition ESPEN.2022; 48: 361.     CrossRef
  • Dietary acid load modifies the effects of ApoA2–265 T > C polymorphism on lipid profile and serum leptin and ghrelin levels among type 2 diabetic patients
    Faezeh Abaj, Zahra Esmaeily, Zeinab Naeini, Masoumeh Rafiee, Fariba Koohdani
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • The association between dietary acid load and adiposity measures among children and adolescents
    Nasim Sorraya, Arman Arab, Shokoofeh Talebi
    BMC Pediatrics.2022;[Epub]     CrossRef
  • Metabolic status is not related to dietary acid load in polycystic ovary syndrome
    Tülay OMMA, Fatmanur Hümeyra ZENGİN, Süheyla AYDOĞMUŞ, Cavit ÇULHA
    Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi.2022; 55(2): 111.     CrossRef
  • EVALUATION OF THE RELATIONSHİP BETWEEN QUALITY OF LIFE AND DIETARY ACID LOAD IN OBESE WOMEN
    Nurefşan KONYALIGİL, Betül ÇİÇEK, Tuba TEKİN, Meltem ÜNLÜSAVURAN SÖNMEZ
    Karya Journal of Health Science.2022; 3(2): 145.     CrossRef
  • The association between dietary acid load and body composition in physical education students aged 18–25 years
    Maryam Mansordehghan, Elnaz Daneshzad, Vahid Basirat, Bahram Pourghassem Gargari, Tohid Rouzitalab
    Journal of Health, Population and Nutrition.2022;[Epub]     CrossRef
  • Association of dietary acid load with anthropometric indices in children and adolescents
    Zahra Aslani, Maryam Bahreynian, Nazli Namazi, Nitin Shivappa, James R. Hébert, Hamid Asayesh, Mohammad Esmaeil Motlagh, Mohammad Ali Pourmirzaei, Amir Kasaeian, Armita Mahdavi-Gorabi, Mostafa Qorbani, Roya Kelishadi
    Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity.2021; 26(2): 555.     CrossRef
  • Dietary acid load, kidney function and risk of chronic kidney disease: A systematic review and meta-analysis of observational studies
    Manije Darooghegi Mofrad, Elnaz Daneshzad, Leila Azadbakht
    International Journal for Vitamin and Nutrition Research.2021; 91(3-4): 343.     CrossRef
  • The association between dietary acid load with cardiometabolic risk factors and inflammatory markers amongst elderly men: A cross‐sectional study
    Alireza Jafari, Mahtab Ghanbari, Hossein Shahinfar, Nick Bellissimo, Leila Azadbakht
    International Journal of Clinical Practice.2021;[Epub]     CrossRef
  • Dietary Acid Load and Its Interaction with IGF1 (rs35767 and rs7136446) and IL6 (rs1800796) Polymorphisms on Metabolic Traits among Postmenopausal Women
    Sook Yee Lim, Yoke Mun Chan, Vasudevan Ramachandran, Zalilah Mohd Shariff, Yit Siew Chin, Manohar Arumugam
    Nutrients.2021; 13(7): 2161.     CrossRef
  • Associations between dietary acid load and obesity among Iranian women
    Somaye Fatahi, Mostafa Qorbani, Pamela J. Surkan, Leila Azadbakht
    Journal of Cardiovascular and Thoracic Research.2021; 13(4): 285.     CrossRef
  • Higher dietary acid load is not associated with risk of breast cancer in Iranian women
    Maryam Safabakhsh, Hossein Imani, Mehdi Yaseri, Ramesh Omranipour, Sakineh Shab‐Bidar
    Cancer Reports.2020;[Epub]     CrossRef
  • Dietary acid load, blood pressure, fasting blood sugar and biomarkers of insulin resistance among adults: Findings from an updated systematic review and meta‐analysis
    Parvin Dehghan, Mahdieh Abbasalizad Farhangi
    International Journal of Clinical Practice.2020;[Epub]     CrossRef
  • Ameliorating Chronic Kidney Disease Using a Whole Food Plant-Based Diet
    Kathleen E. Adair, Rodney G. Bowden
    Nutrients.2020; 12(4): 1007.     CrossRef
  • Positive association between dietary acid load and future insulin resistance risk: findings from the Korean Genome and Epidemiology Study
    Kyung Won Lee, Dayeon Shin
    Nutrition Journal.2020;[Epub]     CrossRef
  • Dietary Acid Load and Cardiometabolic Risk Factors—A Narrative Review
    Joanna Ostrowska, Justyna Janiszewska, Dorota Szostak-Węgierek
    Nutrients.2020; 12(11): 3419.     CrossRef
  • Dietary acid load and cardiometabolic risk factors: a systematic review and meta-analysis of observational studies
    Elnaz Daneshzad, Fahimeh Haghighatdoost, Leila Azadbakht
    Public Health Nutrition.2019; 22(15): 2823.     CrossRef
  • The Associations of Dietary Acid Load with Insulin Resistance and Type 2 Diabetes: A Systematic Review of Existing Human Studies
    Hadi Emamat, Hadith Tangestani, Zahra Bahadoran, Sajjad Khalili-Moghadam, Parvin Mirmiran
    Recent Patents on Food, Nutrition & Agriculture.2019; 10(1): 27.     CrossRef
  • Association of dietary acid load with cardiovascular risk factors and the prevalence of metabolic syndrome in Iranian women: A cross-sectional study
    Hadis Mozaffari, Nazli Namazi, Bagher Larijani, Nick Bellissimo, Leila Azadbakht
    Nutrition.2019; 67-68: 110570.     CrossRef
  • Higher dietary acid load potentially increases serum triglyceride and obesity prevalence in adults: An updated systematic review and meta-analysis
    Mahdieh Abbasalizad Farhangi, Leila Nikniaz, Zeinab Nikniaz, Raffaele Serra
    PLOS ONE.2019; 14(5): e0216547.     CrossRef
  • Dietary acid load significantly predicts 10-years survival in patients underwent coronary artery bypass grafting (CABG) surgery
    Mahdieh Abbasalizad Farhangi, Mahdi Vajdi, Mahdi Najafi, Raffaele Serra
    PLOS ONE.2019; 14(10): e0223830.     CrossRef
  • Higher dietary acid load is associated with higher likelihood of peripheral arterial disease among American adults
    Mohsen Mazidi, Dimitri P. Mikhailidis, Maciej Banach
    Journal of Diabetes and its Complications.2018; 32(6): 565.     CrossRef
  • Nutrition and Cardio-Metabolic Risk Factors: 20 Years of the Tehran Lipid and Glucose Study Findings
    Firoozeh Hosseini-Esfahani, Somaye Hosseinipour, Golaleh Asghari, Zahra Bahadoran, Nazanin Moslehi, Mahdieh Golzarand, Hanieh Ejtahed, Parvin Mirmiran, Fereidoun Azizi
    International Journal of Endocrinology and Metabolism.2018;[Epub]     CrossRef
  • Higher dietary acid load is weakly associated with higher adiposity measures and blood pressure in Japanese adults: The National Health and Nutrition Survey
    Kentaro Murakami, M. Barbara E. Livingstone, Hitomi Okubo, Satoshi Sasaki
    Nutrition Research.2017; 44: 67.     CrossRef
  • Accuracy and precision of estimation equations to predict net endogenous acid excretion using the Australian food database
    Benjamin H. Parmenter, Gary J. Slater, Lynda A. Frassetto
    Nutrition & Dietetics.2017; 74(3): 308.     CrossRef
  • Dietary acid load and mortality among Japanese men and women: the Japan Public Health Center–based Prospective Study
    Shamima Akter, Akiko Nanri, Tetsuya Mizoue, Mitsuhiko Noda, Norie Sawada, Shizuka Sasazuki, Shoichiro Tsugane
    The American Journal of Clinical Nutrition.2017; 106(1): 146.     CrossRef
  • Association between Dietary Acid Load and Insulin Resistance: Tehran Lipid and Glucose Study
    Sajjad Khalili Moghadam, Zahra Bahadoran, Parvin Mirmiran, Maryam Tohidi, Fereidoun Azizi
    Preventive Nutrition and Food Science.2016; 21(2): 104.     CrossRef
Close layer
Obesity and Metabolism
Helicobacter pylori Stool Antigen Levels and Serological Biomarkers of Gastric Inflammation are Associated with Cardio-Metabolic Risk Factors in Type 2 Diabetic Patients
Zahra Bahadoran, Parvin Mirmiran, Maryam Zarif-yeaganeh, Homayoun Zojaji, Fereidoun Azizi
Endocrinol Metab. 2015;30(3):280-287.   Published online May 18, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.3.280
  • 6,609 View
  • 38 Download
  • 8 Web of Science
  • 7 Crossref
AbstractAbstract PDFPubReader   
Background

Helicobacter pylori infection and subsequent gastric inflammation have been proposed as risk factors for the development of insulin resistance and cardiovascular disease. In this study we assessed the possible association of H. pylori bacterial load, and serum biomarker of gastric inflammation with cardiometabolic risk factors in diabetic patients.

Methods

In this cross-sectional study, 84 H. pylori-infected type 2 diabetic patients were assessed for anthropometrics, biochemical and clinical measurements. Pearson correlation test, linear, and logarithmic regression curve estimation models were used to assess the association of H. pylori stool antigen (HpSAg) levels, and pepsinogen I (PGI) to pepsinogen II (PGII) ratio with fasting serum glucose, insulin, serum lipid and lipoprotein parameters, malondialdehyde, high-sensitive C-reactive protein (hs-CRP), systolic and diastolic blood pressure, body weight, waist circumference and lipid accumulation product (LAP) index.

Results

The mean age of participants was 54±10 years, and 44% were men. Mean HpSAg levels and PGI/PGII ratio were 0.24±0.23 µg/mL and 9.9±9.0, respectively. Higher HpSAg as well as lower PGI/PGII was correlated with higher anthropometric measures and LAP. A significant negative correlation between PGI/PGII ratio and blood pressure (r=-0.21 and r=-0.22, systolic and diastolic, respectively, P<0.05), serum insulin (r=-0.17, P=0.05), and hs-CRP (r=-0.17, P=0.05) was observed. A significant linear association between PGI/PGII ratio with serum triglycerides (β=-0.24, P<0.05), serum high density lipoprotein cholesterol (HDL-C; β=0.43, P<0.01), and triglycerides/HDL-C ratio (β=-0.28, P<0.05) were observed.

Conclusion

Higher H. pylori bacterial load and lower PGI/PGII ratio was associated with higher levels of cardiometabolic risk factors in H. pylori infected type 2 diabetic patients.

Citations

Citations to this article as recorded by  
  • Pathogenesis of Helicobacter pylori in the gastric carcinoma: A narrative reviews
    Mulat Erkihun
    The Microbe.2026; 10: 100648.     CrossRef
  • Association between Anti-Helicobacter pylori IgG seropositivity on coronary heart disease and potential pathogenesis: a Mendelian randomization study
    Jing Wang, Tianying Chang, Yiqiang Wang, Jinling Zhang, Rui Chen, Le Liu, Yingzi Cui, Hongguang Jin, Antony Bayer
    PLOS One.2025; 20(12): e0329137.     CrossRef
  • Cardiovascular and Neurological Diseases and Association with Helicobacter Pylori Infection—An Overview
    Vlad Pădureanu, Dalia Dop, Daniel Cosmin Caragea, Dumitru Rădulescu, Rodica Pădureanu, Mircea-Cătălin Forțofoiu
    Diagnostics.2024; 14(16): 1781.     CrossRef
  • Both diet and Helicobacter pylori infection contribute to atherosclerosis in pre- and postmenopausal cynomolgus monkeys
    Traci L. Testerman, Cristina Semino-Mora, Jennifer A. Cann, Beidi Qiang, Edsel A. Peña, Hui Liu, Cara H. Olsen, Haiying Chen, Susan E. Appt, Jay R. Kaplan, Thomas C. Register, D. Scott Merrell, Andre Dubois, Xianwu Cheng
    PLOS ONE.2019; 14(9): e0222001.     CrossRef
  • Associations of Helicobacter pylori infection and peptic disease with diabetic mellitus: Results from a large population-based study
    Saeda Haj, Gabriel Chodick, Rotem Refaeli, Sophy Goren, Varda Shalev, Khitam Muhsen, David M. Ojcius
    PLOS ONE.2017; 12(8): e0183687.     CrossRef
  • Helicobacter Pylori Infection Is Associated with Dyslipidemia and Increased Levels of Oxidized LDL in Type-2 Diabetes Mellitus
    Mohamed Hasan Mukhtar, Wesam Ahmed Nasif, Abdullatif Taha Babakr
    Journal of Diabetes Mellitus.2016; 06(03): 185.     CrossRef
  • Update on prevention and treatment of Helicobacter pylori infection
    Zhao-Chun Chi
    World Chinese Journal of Digestology.2016; 24(16): 2454.     CrossRef
Close layer
Review Article
Thyroid
Prevalence and Risk Factors of Subclinical Thyroid Disease
Ye An Kim, Young Joo Park
Endocrinol Metab. 2014;29(1):20-29.   Published online March 14, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.1.20
  • 16,229 View
  • 173 Download
  • 77 Web of Science
  • 78 Crossref
AbstractAbstract PDFPubReader   

Subclinical thyroid disease is defined biochemically by an abnormal thyrotropin (TSH) level and normal serum-free thyroxine level. The prevalence of this condition varies according to the reference range for TSH and geographic or demographic factors. Recently, several studies, including our community-based cohort studies, have reported on the incidence of subclinical thyroid disease in Korea. Using these studies, we reviewed the prevalence and risk factors of subclinical thyroid disease, focusing on subclinical hypothyroidism.

Citations

Citations to this article as recorded by  
  • Hyperthyroidism: a review of the African American population
    Chibuzor Joseph Onwughalu, Irebami Kolapo-Raheem, Toluwalase Emmanuel Akinfisoye, Olamide Olayinka, Kelsey Danielle Rodrigues, Inemesit Imoh Ekanem, Olawale Gabriel Ajibola
    Discover Medicine.2025;[Epub]     CrossRef
  • Radiological, cytological and histopathological correlation in patients undergoing thyroid surgery at a tertiary care hospital in western Gujarat: a cross-sectional study
    Rashmi Sorathiya, Sharvil Nimavat, Narendra Hirani, Ajeet Kumar Khilnani, Ayush Tank, Mansi Patel
    International Journal of Otorhinolaryngology and Head and Neck Surgery.2025; 11(1): 28.     CrossRef
  • Mechanistic insights into TSH-mediated macrophage mitochondrial dysfunction via TSHR signaling in metabolic disorders
    Yuhan Zhang, Hanyu Wang, Mengfei Fu, Liu Yang, Xiao Chen, Zixuan Wang, Jiaqi Liu, Hui Sun
    Free Radical Biology and Medicine.2025; 240: 783.     CrossRef
  • Subclinical hyperthyroidism
    Alasdair Cooper, Prakash Abraham
    Current Opinion in Endocrinology, Diabetes & Obesity.2025; 32(5): 175.     CrossRef
  • Heart rate variability and left atrial stiffness index by 2D speckle-tracking echocardiography in subclinical thyroid dysfunction
    Asmaa A. Hassan, Eman Samy El Shehawy, Mona S. Esmail, Gehan E. Hossam-Eldin, Radwa M. Fath Allah, Hanaa Elasayed Abozeid, Doaa Sayed Mohammed, Marwa Abdelaziz Abo Seree Yassien, Sally Abdelaziz Ahmed, Doaa Mohamed Salama, Esraa M. Aslah, Fatma M. Kotb, E
    Egyptian Journal of Radiology and Nuclear Medicine.2025;[Epub]     CrossRef
  • Appropriateness of Levothyroxine Prescription: A Multicenter Retrospective Study
    Ivan Nicolas Ayala, Cristian Soto Jacome, David Toro-Tobon, Elizabeth Golembiewski, Andrea Garcia-Bautista, Jessica Hidalgo, Sandra Cordova-Madera, Raghda Al Anbari, Jessica Sohn R, Naykky Singh Ospina, Spyridoula Maraka, Marina Joseph, Juan P Brito
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(2): e765.     CrossRef
  • Changes in thyroid function and evolution of subclinical thyroid disease in older men
    Stephanie Y. Tan, S. A. Paul Chubb, Leon Flicker, Osvaldo P. Almeida, Jonathan Golledge, Graeme J. Hankey, Bu B. Yeap
    Clinical Endocrinology.2024; 100(2): 170.     CrossRef
  • Subclinical thyroid dysfunction and the risk of incident atrial fibrillation: A systematic review and meta-analysis
    Hasveer Singh, Mariam Z. Shahid, Stephanie L. Harrison, Deirdre A. Lane, Gregory Y. H. Lip, Sunil Jit R. J. Logantha, Gaetano Santulli
    PLOS ONE.2024; 19(1): e0296413.     CrossRef
  • EMAS position statement: Thyroid disease and menopause
    Gesthimani Mintziori, Stavroula Veneti, Kris Poppe, Dimitrios G. Goulis, Eleni Armeni, C. Tamer Erel, Ivan Fistonić, Timothy Hillard, Angelica Lindén Hirschberg, Blazej Meczekalski, Nicolás Mendoza, Alfred O. Mueck, Tommaso Simoncini, Petra Stute, Dorenda
    Maturitas.2024; 185: 107991.     CrossRef
  • A Clinical Study of Thyroid Abnormalities and Autoantibodies in Patients Diagnosed With Anti-nuclear Antibody Positive Autoimmune Connective Tissue Disorders: An Observational Cross-Sectional Study
    Saimounika Adapa, Varsha R Bhatt, Govind Shiddapur, Nilesh Jagdale, Vutukuru Kalyan Kumar Reddy, Mohith Prakash Kondapalli, Sonali Agarwal, Diksha Sabharwal, Advait Jha
    Cureus.2024;[Epub]     CrossRef
  • Efficacy of Standardized Yoga Asanas as Add-on Therapy in the Management of Hypothyroidism: A Randomized, Open-label, Controlled Clinical Study
    Tanu Sharma, Bhavy Goyal, Khan Afreen Mustaq Ahmed, Guru Deo, Ishita Kaushik, Rohit Malik, Vineet Jain, Dharmander Singh, Sunil Kohli, Kailash Chandra
    International Journal of Yoga.2024; 17(2): 124.     CrossRef
  • Subclinical Hypothyroidism and Clinical Outcomes After Percutaneous Coronary Intervention: A Meta-Analysis
    Song Peng Ang, Jia Ee Chia, Vikash Jaiswal, Dhrubajyoti Bandyopadhyay, Jose Iglesias, Gautham Varun Krishna Mohan, Sudarshan Gautam, Thazin Win, Tushar Kumar, Abbas Iqbal, Tong Hong Chia, Wilbert Aronow
    Current Problems in Cardiology.2023; 48(8): 101719.     CrossRef
  • Preliminary observation of thyroid function changes in subclinical thyroid diseases
    Hua-Xin Wang, Wen-Yu Gao, Yang Yang, Yun-Feng Li, Yan Zhang, Xin-Yi Zhang, Yu-Xia Li
    Technology and Health Care.2023; 31(5): 1715.     CrossRef
  • Cardiovascular outcomes in subclinical thyroid disease: an update
    Matthew D. Ettleson
    Current Opinion in Endocrinology, Diabetes & Obesity.2023; 30(5): 218.     CrossRef
  • Effects of whole seaweed consumption on humans: current evidence from randomized-controlled intervention trials, knowledge gaps, and limitations
    João P. Trigo, Marie Palmnäs-Bédard, Mar Vall-Llosera Juanola, Ingrid Undeland
    Frontiers in Nutrition.2023;[Epub]     CrossRef
  • The correlation of lipid profile with subclinical and overt hypothyroidism: A cross-sectional study from Syria
    Fatima Tarboush, Mohammad Alsultan, Zaynab Alourfi
    Medicine.2023; 102(37): e34959.     CrossRef
  • Autoimmune thyroid status in subclinical thyroid disorders in patients attending a tertiary care center in Nepal: a hospital-based cross-sectional study
    Vijay Kumar Sharma, Apeksha Niraula, Eans Tara Tuladhar, Aseem Bhattarai, Mithileshwer Raut, Raju Kumar Dubey, Sujata Baidya, Naresh Parajuli
    BMC Endocrine Disorders.2023;[Epub]     CrossRef
  • The effect of low dose thyroid replacement therapy in patients with episodic migraine and subclinical hypothyroidism: A randomised placebo-controlled trial
    Priya Dev, T.T. Favas, Rishab Jaiswal, Mareena Cyriac, Vijaya Nath Mishra, Abhishek Pathak
    Cephalalgia.2023;[Epub]     CrossRef
  • The Role of Global Longitudinal Strain in Subclinical Hypothyroid Patients With Heart Failure
    Nismat Javed, Vibha Hayagreev, Angel DeLaCruz, Muhammad Saad, Amandeep Singh, Timothy Vittorio
    Cureus.2023;[Epub]     CrossRef
  • Relationship Between Thyroid Hormonal Status in Patients with a Hypothyroid Form of Hashimoto’s Thyroiditis and Iodine Concentrations in Drinking Water
    Olha Kasiyan, Halyna Tkachenko, Natalia Kurhaluk, Svitlana Yurchenko, Alek Manenko
    Biological Trace Element Research.2022; 200(1): 59.     CrossRef
  • Androgen deprivation therapy for prostate cancer and the risk of thyroid diseases
    Jui‐Ming Liu, Yu‐Tang Chen, Chun‐Te Wu, Wen‐Lin Hsu, Ren‐Jun Hsu
    The Prostate.2022; 82(7): 809.     CrossRef
  • Subclinical hypothyroidism in women’s health: from pre- to post-menopause
    Anna Capozzi, Giovanni Scambia, Stefano Lello
    Gynecological Endocrinology.2022; 38(5): 357.     CrossRef
  • Subclinical Hypothyroidism and Cognitive Impairment
    Jung-Min Pyun, Young Ho Park, SangYun Kim
    Journal of Alzheimer's Disease.2022; 88(2): 757.     CrossRef
  • Rosuvastatin potentiates the thyrotropin‐lowering effect of metformin in men with non‐autoimmune subclinical hypothyroidism and prediabetes
    Robert Krysiak, Karolina Kowalcze, Bogusław Okopień
    Journal of Clinical Pharmacy and Therapeutics.2022; 47(12): 2030.     CrossRef
  • Natural history of subclinical hypothyroidism and prognostic factors for the development of overt hypothyroidism: Tehran Thyroid Study (TTS)
    A. Amouzegar, M. Dehghani, H. Abdi, L. Mehran, S. Masoumi, F. Azizi
    Journal of Endocrinological Investigation.2022; 45(12): 2353.     CrossRef
  • Interplay between cardiovascular and thyroid dysfunctions: A review of clinical implications and management strategies
    Sanyal Debmalya, Ray Saumitra, Malhi Harshveer Singh
    Endocrine Regulations.2022; 56(4): 311.     CrossRef
  • Routine Measurement of Thyroid Stimulating Hormone in Patients Presenting With Third-Degree Atrioventricular Block: Do We Really Need It?
    Muhammad Faisal, Zubair Mumtaz, Abdul Mueed, Sajid Ali, Haseeb H Raza, Samra Khan, Sayeda Salma, Mustajab Mujtaba, Musa Karim, Faisal Qadir
    Cureus.2021;[Epub]     CrossRef
  • Update of hypothyroidism and its management in Unani medicine
    Md. Anzar Alam, Mohd Aleemuddin Quamri, Ghulamuddin Sofi, Shabnam Ansari
    Journal of Basic and Clinical Physiology and Pharmacology.2021; 32(2): 1.     CrossRef
  • Endemik guatrın dünü, bugünü ve yarını
    Yılmaz SEZGİN
    Turkish Journal of Family Medicine and Primary Care.2021; 15(1): 1.     CrossRef
  • Prognosis of papillary thyroid carcinoma in relation to preoperative subclinical hypothyroidism
    SY Kang, HR Ahn, HJ Youn, SH Jung
    The Annals of The Royal College of Surgeons of England.2021; 103(5): 367.     CrossRef
  • Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology
    Saeideh Aghayari Sheikh Neshin, Shima Shahjouei, Eric Koza, Isabel Friedenberg, Faezeh Khodadadi, Mirna Sabra, Firas Kobeissy, Saeed Ansari, Georgios Tsivgoulis, Jiang Li, Vida Abedi, Donna M. Wolk, Ramin Zand
    Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
  • Higher hepatic sterol-binding protein-2 gene expression and serum triglyceride level in methimazole induced subclinical hypothyroid animal model
    Marie Saghaeian Jazi, Mohammad Mostakhdem Hashemi, Abbas Nezhadebrahimi, Azadreza Mansourian
    Comparative Clinical Pathology.2021; 30(4): 627.     CrossRef
  • Subclinical Hypothyroidism: Prevalence, Health Impact, and Treatment Landscape
    Won Sang Yoo, Hyun Kyung Chung
    Endocrinology and Metabolism.2021; 36(3): 500.     CrossRef
  • Thyroid Function and Nutrient Status in the Athlete
    D. Enette Larson-Meyer, Demetre E. Gostas
    Current Sports Medicine Reports.2020; 19(2): 84.     CrossRef
  • Seasonal effects on resting energy expenditure are dependent on age and percent body fat
    Duong Duc Pham, Jeong Hun Lee, Ki Hwan Hong, Youn Joo Jung, Sung Jin Kim, Chae Hun Leem
    Clinical Nutrition.2020; 39(4): 1276.     CrossRef
  • Subclinical hypothyroidism
    Chelsea Simon, Emily Weidman-Evans, Sarah Allen
    JAAPA.2020; 33(5): 21.     CrossRef
  • Clinical and subclinical maternal hypothyroidism and their effects on neurodevelopment, behavior and cognition
    Alice Batistuzzo, Miriam Oliveira Ribeiro
    Archives of Endocrinology and Metabolism.2020; 64(1): 89.     CrossRef
  • Protective effect of a polyherbal bioactive fraction in propylthiouracil-induced thyroid toxicity in ratsby modulation of the hypothalamic–pituitary–thyroid and hypothalamic–pituitary–adrenal axes
    Sneha Singh, Vandana Panda, Sudhamani S., Payal Dande
    Toxicology Reports.2020; 7: 730.     CrossRef
  • Subclinical Hypothyroidism Affects the Long-Term Outcomes of Patients Who Undergo Coronary Artery Bypass Grafting Surgery but Not Heart Valve Surgery
    Hana Kim, Sung Hye Kong, Jae Hoon Moon, Sang Yoon Kim, Kay-Hyun Park, Jun Sung Kim, Joong Haeng Choh, Young Joo Park, Cheong Lim
    Endocrinology and Metabolism.2020; 35(2): 308.     CrossRef
  • Serum FT4 / FT3 Ratio, a Predictive Biochemical Marker for Subclinical Hypothyroidism in Patients with Chronic Kidney Disease
    Venkat Siddarth Chagamreddy, Malligai Elancheran, Murugavel K
    Journal of Evolution of Medical and Dental Sciences.2020; 9(33): 2319.     CrossRef
  • Importance of thyroid-stimulating hormone levels in liver disease
    Hyun Jin Kim
    Journal of Pediatric Endocrinology and Metabolism.2020; 33(9): 1133.     CrossRef
  • Does Hypothyroidism Increase Complications, Lengths of Stay, Readmissions, and Costs Following Primary 1- to 2-Level Lumbar Fusion?
    Rushabh M. Vakharia, Joseph O. Ehiorobo, Bilal Mahmood, Martin W. Roche, Michael A. Mont, Afshin E. Razi
    Clinical Spine Surgery: A Spine Publication.2020; 33(10): E559.     CrossRef
  • Acute psychosis in patients with subclinical hyperthyroidism
    Sohei Kimoto, Kazuhiko Yamamuro, Toshifumi Kishimoto
    Psychiatry and Clinical Neurosciences.2019; 73(6): 348.     CrossRef
  • Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review
    Francesca Reyes Domingo, Marc T. Avey, Marion Doull
    Systematic Reviews.2019;[Epub]     CrossRef
  • Association between subclinical hypothyroidism and metabolic disorders: A retrospective chart review study in an emerging university hospital
    Khaled Aldossari, Sameer Al‐Ghamdi, Jamaan Al‐Zahrani, Anwar Al Jammah, Bader Alanazi, Abdulilah Al‐Briek, Mohammad Alanazi
    Journal of Clinical Laboratory Analysis.2019;[Epub]     CrossRef
  • Investigation of Vitamin D Levels and Metabolic Parameters in Patients With Subclinical Hyperthyroidism
    Müge Keskin, Esra Ademoğlu, Arzu Or Koca, Derun Taner Ertugrul
    Ankara Medical Journal.2019;[Epub]     CrossRef
  • Reference Range and Sociodemographic Characteristics of TSH among Reproductive Age Women in Rural China
    Qiang Su, Shikun Zhang, Mei Hu, Qiaomei Wang, Na Liu, Haiping Shen, Yiping Zhang, Man Zhang
    Biological Trace Element Research.2019; 189(2): 336.     CrossRef
  • Subklinik Hipotiroiditli Çocuklarda Ağız Sağlığı Durumunun Değerlendirilmesi
    Nuray TÜLOĞLU, Tuğçe KALİÇOĞLU, Birgül KIREL
    Journal of Biotechnology and Strategic Health Research.2019; 3(3): 237.     CrossRef
  • Association High-Iodine-Containing Seaweed Soup Consumption after Birth and Subclinical Hypothyroidism in Korean Women: Korea National Health and Nutrition Examination Survey IV (2013–2015)
    Hyunsam Kim, Ha Ni Lee, Jeonghoon Ha
    International Journal of Thyroidology.2019; 12(2): 105.     CrossRef
  • Graves Disease in Central Ghana: Clinical Characteristics and Associated Factors
    Osei Sarfo-Kantanka, Fred Stephen Sarfo, Eunice Oparebea Ansah, Ishmael Kyei
    Clinical Medicine Insights: Endocrinology and Diabetes.2018;[Epub]     CrossRef
  • Sex differences in risk factors for subclinical hypothyroidism
    Jeonghoon Ha, Jeongmin Lee, Kwanhoon Jo, Dong-Jun Lim, Moo Il Kang, Bong Yun Cha, Min-Hee Kim
    Endocrine Connections.2018; 7(4): 511.     CrossRef
  • Age-sex disparities and sub-clinical hypothyroidism among patients in Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia
    Habtamu Azene Tekle, Tesfahun Molla Bobe, Efrata Girma Tufa, Fithamlak Bisetegen Solomon
    Journal of Health, Population and Nutrition.2018;[Epub]     CrossRef
  • Subclinical Hypothyroidism and the Risk of Cardiovascular Disease and All-Cause Mortality: A Meta-Analysis of Prospective Cohort Studies
    Shinje Moon, Min Joo Kim, Jae Myung Yu, Hyung Joon Yoo, Young Joo Park
    Thyroid.2018; 28(9): 1101.     CrossRef
  • Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: Data from Korean National Health and Nutrition Examination Survey IV (2013–2015)
    So Young Park, Hae In Kim, Hyun-Kyung Oh, Tae Hyuk Kim, Hye Won Jang, Jae Hoon Chung, Myung-Hee Shin, Sun Wook Kim, Sun Y Lee
    PLOS ONE.2018; 13(2): e0190738.     CrossRef
  • Helicobacter pylori-induced autoimmune thyroiditis: is the pathogenic link concluded or still a hypothesis?
    Santhanamari Thiyagarajan, Anil M.R. Saini, Jamal Alruwaili
    Reviews in Medical Microbiology.2018; 29(2): 64.     CrossRef
  • Evaluation of Thyroid Hormone Levels and Urinary Iodine Concentrations in Koreans Based on the Data from Korea National Health and Nutrition Examination Survey VI (2013 to 2015)
    Jae Hoon Chung
    Endocrinology and Metabolism.2018; 33(2): 160.     CrossRef
  • Transcriptome Network Analysis Reveals Aging-Related Mitochondrial and Proteasomal Dysfunction and Immune Activation in Human Thyroid
    Byuri Angela Cho, Seong-Keun Yoo, Young Shin Song, Su-jin Kim, Kyu Eun Lee, Minho Shong, Young Joo Park, Jeong-Sun Seo
    Thyroid.2018; 28(5): 656.     CrossRef
  • Relation of Subclinical Hypothyroidism is Associated With Cardiovascular Events and All-Cause Mortality in Adults With High Cardiovascular Risk
    Shinje Moon, Sung Hye Kong, Hoon Sung Choi, Yul Hwangbo, Moon-Kyu Lee, Jae Hoon Moon, Hak Chul Jang, Nam Han Cho, Young Joo Park
    The American Journal of Cardiology.2018; 122(4): 571.     CrossRef
  • Subclinical Hypothyroidism and Coronary Revascularization After Coronary Artery Bypass Grafting
    Sung Hye Kong, Ji Won Yoon, Sang Yoon Kim, Tae Jung Oh, Kay-Hyun Park, Joong Haeng Choh, Young Joo Park, Cheong Lim
    The American Journal of Cardiology.2018; 122(11): 1862.     CrossRef
  • A Case of Subclinical Hyperthyroidism Treatment with Herbal Medicine
    Dong-eun Jin, Seok-woo Kim, Hyeon-cheo Shin
    The Journal of Internal Korean Medicine.2018; 39(4): 831.     CrossRef
  • Cardiovascular Risk in Subclinical Hypothyroidism
    Mariana Dobrescu, Diana Păun, Daniel Grigorie, Cătălina Poiană
    Internal Medicine.2018; 15(3): 51.     CrossRef
  • Association between thyroid autoimmunity and Helicobacter pylori infection
    Yun Mi Choi, Tae Yong Kim, Eui Young Kim, Eun Kyung Jang, Min Ji Jeon, Won Gu Kim, Young Kee Shong, Won Bae Kim
    The Korean Journal of Internal Medicine.2017; 32(2): 309.     CrossRef
  • Effect of Marijuana Use on Thyroid Function and Autoimmunity
    Sonali Malhotra, Rubina A. Heptulla, Peter Homel, Roja Motaghedi
    Thyroid.2017; 27(2): 167.     CrossRef
  • Insidious danger in childhood era's: subclinical hypothyroidism
    Ayşegül Alpcan, Ayça Törel Ergür, Serkan Tursun
    Ortadoğu Tıp Dergisi.2017; 9(1): 34.     CrossRef
  • Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015
    Won Gu Kim, Won Bae Kim, Gyeongji Woo, Hyejin Kim, Yumi Cho, Tae Yong Kim, Sun Wook Kim, Myung-Hee Shin, Jin Woo Park, Hai-Lin Park, Kyungwon Oh, Jae Hoon Chung
    Endocrinology and Metabolism.2017; 32(1): 106.     CrossRef
  • Thyroid diseases and risk of non-thyroidal pathology
    R I Glushakov, E V Kozyrko, I V Sobolev, S A Ermolova, O V Vlaseva, A A Kuzin, N I Tapilskaya
    Kazan medical journal.2017; 98(1): 77.     CrossRef
  • Hipertiroidismo
    M. Toni, J. Pineda, E. Anda, J.C. Galofré
    Medicine - Programa de Formación Médica Continuada Acreditado.2016; 12(13): 731.     CrossRef
  • Subclinical Hypothyroidism in Childhood Cancer Survivors
    Hyun Joo Lee, Seung Min Hahn, Song Lee Jin, Yoon Jung Shin, Sun Hee Kim, Yoon Sun Lee, Hyo Sun Kim, Chuhl Joo Lyu, Jung Woo Han
    Yonsei Medical Journal.2016; 57(4): 915.     CrossRef
  • Comparison of universal screening with targeted high-risk case finding for diagnosis of thyroid disorders
    Sima Nazarpour, Fahimeh Ramezani Tehrani, Masoumeh Simbar, Maryam Tohidi, Hamid AlaviMajd, Fereidoun Azizi
    European Journal of Endocrinology.2016; 174(1): 77.     CrossRef
  • Association of low baseline free thyroxin levels with progression of coronary artery calcification over 4 years in euthyroid subjects: the Kangbuk Samsung Health Study
    Hye‐Jeong Park, Jihyun Kim, Eun Jin Han, Se Eun Park, Cheol‐Young Park, Won‐Young Lee, Ki‐Won Oh, Sung‐Woo Park, Eun‐Jung Rhee
    Clinical Endocrinology.2016; 84(6): 889.     CrossRef
  • Distinct Features of Nonthyroidal Illness in Critically Ill Patients With Infectious Diseases
    Woo Kyung Lee, Sena Hwang, Daham Kim, Seul Gi Lee, Seonhyang Jeong, Mi-Youn Seol, Hyunji Kim, Cheol Ryong Ku, Dong Yeop Shin, Woong Youn Chung, Eun Jig Lee, Jandee Lee, Young Suk Jo
    Medicine.2016; 95(14): e3346.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
  • Reference interval for thyrotropin in a ultrasonography screened Korean population
    Mijin Kim, Tae Yong Kim, Soo Han Kim, Yunkyoung Lee, Su-yeon Park, Hyung-don Kim, Hyemi Kwon, Yun Mi Choi, Eun Kyung Jang, Min Ji Jeon, Won Gu Kim, Young Kee Shong, Won Bae Kim
    The Korean Journal of Internal Medicine.2015; 30(3): 335.     CrossRef
  • Incidence and Prevalence of Overt Hypothyroidism and Causative Diseases in Korea as Determined Using Claims Data Provided by the Health Insurance Review and Assessment Service
    Gi Hyeon Seo, Jae Hoon Chung
    Endocrinology and Metabolism.2015; 30(3): 288.     CrossRef
  • Subclinical Hypothyroidism and Cardiovascular Disease
    Sunghwan Suh, Duk Kyu Kim
    Endocrinology and Metabolism.2015; 30(3): 246.     CrossRef
  • Bone Health and Clinical Results after Hip Fracture Surgery in Patients with Subclinical Hypothyroidism
    Ki-Choul Kim, Young-Kyun Lee, You Jin Lee, Yong-Chan Ha, Kyung-Hoi Koo
    Journal of Bone Metabolism.2014; 21(3): 213.     CrossRef
  • Subclinical Thyroid Dysfunction in the Elderly
    Ki Dong Ko
    Journal of the Korean Geriatrics Society.2014; 18(3): 111.     CrossRef
  • Subclinical hypothyroidism in addition to common risk scores for prediction of cardiovascular disease: a 10-year community-based cohort study
    Tae Hyuk Kim, Hoon Sung Choi, Ji Cheol Bae, Jae Hoon Moon, Hyung-Kwan Kim, Sung Hee Choi, Soo Lim, Do Joon Park, Kyong Soo Park, Hak Chul Jang, Moon-Kyu Lee, Nam H Cho, Young Joo Park
    European Journal of Endocrinology.2014; 171(5): 649.     CrossRef
Close layer
Namgok Lecture 2013
Obesity and Metabolism
Ectopic Fat Assessment Focusing on Cardiometabolic and Renal Risk
Soo Lim
Endocrinol Metab. 2014;29(1):1-4.   Published online March 14, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.1.1
  • 7,467 View
  • 74 Download
  • 44 Web of Science
  • 42 Crossref
AbstractAbstract PDFPubReader   

It is well known that people with high levels of body fat are at higher risk for developing diabetes mellitus, kidney disease, and cardiovascular disorders. Since individuals who are slightly overweight, or even individuals of normal weight, can vary in body fat distribution, their metabolic profiles and the degree of association of these profiles with cardiometabolic risk factors may differ. Fat distribution might be more of a predictive factor for cardiorenometabolic risk than obesity itself, which has led researchers to investigate whether ectopic fat accumulation may partially account for the development of cardiorenometabolic disorders. In addition to visceral obesity, fat can accumulate in the liver and muscle, and these intrahepatic and intramuscular lipid stores are associated with insulin resistance and adverse metabolic phenotypes. More recently, pericardial fat, perivascular fat, and perirenal fat were found to be associated with coronary atherosclerosis, cardiovascular diseases, and kidney damage, respectively. Thus, regional fat distribution may play a key role in understanding the development of cardiorenometabolic diseases in nonobese people.

Citations

Citations to this article as recorded by  
  • Pharmacological inhibition of G protein-coupled receptor kinase 5 decreases high-fat diet-induced hepatic steatosis in mice
    Mary E. Seramur, Sandy Sink, Tony E. Reeves, Leah C. Solberg Woods, Chia-Chi Chuang Key
    Biochemical and Biophysical Research Communications.2026; 795: 153078.     CrossRef
  • Validation of the 2024 European Association for the Study of Obesity diagnostic criteria: A comprehensive assessment of obesity‐related mortality risks
    Xiao‐Yue Liu, San‐Yu Ge, Chen‐An Liu, Bing Yin, Zhao‐Ting Bu, Xin Zheng, Yue Chen, Xiang‐Rui Li, Han‐Ping Shi
    Diabetes, Obesity and Metabolism.2025; 27(5): 2405.     CrossRef
  • Association Between Abdominal Obesity, Body Mass Index, and Hypertension in India: Evidence From a Large Nationally Representative Data
    Rajat Das Gupta, Mohammad Rifat Haider, Simanta Roy, Mohammad Rashidul Hashan, Amrit Baral, Nowrin Tamanna, Ananna Mazumder, Shams Shabab Haider, Biplab Datta
    The Journal of Clinical Hypertension.2025;[Epub]     CrossRef
  • Renal stiffness measured by shear wave elastography and its relationship with perirenal fat in patients with chronic kidney disease
    Yiming Li, Yongzhan Liu, Lili Gao, Chuan Tian
    Journal of Clinical Ultrasound.2024; 52(1): 3.     CrossRef
  • Ameliorated lipid distribution in prediabetes - Effects of 12 weeks traditional Chinese YiJinJing exercise plus TheraBand: A randomized controlled trial
    Sha-sha Wang, Mu Cui, Jing-yuan Li, Huai-ming Zhang, Xiang-yun Liu, Jia Han
    Journal of Exercise Science & Fitness.2024; 22(4): 438.     CrossRef
  • New Perspectives on Obesity-Associated Nephropathy from Pathophysiology to Therapeutics: Revealing the Promise of GLP-1 RA Therapy
    Linan Ren, Feng Ju, Siyuan Liu, Yunjia Cai, Xiaokun Gang, Guixia Wang
    Drug Design, Development and Therapy.2024; Volume 18: 4257.     CrossRef
  • Metabolic Syndrome, Kidney-Related Adiposity, and Kidney Microcirculation: Unraveling the Damage
    Kyu Won Jang, Jin Hur, Dong Won Lee, Seo Rin Kim
    Biomedicines.2024; 12(12): 2706.     CrossRef
  • Characterization of Green and Yellow Papaya (Carica papaya) for Anti-Diabetic Activity in Liver and Myoblast Cells and Wound-Healing Activity in Fibroblast Cells
    Haiwen Li, Obaid Ullah Beg, Ahmed Reza Rafie, Sadia Kanwal, Alexandra Ovalle-Cisneros, Milton Omar Faison, Rafat Ali Siddiqui
    Nutrients.2023; 15(8): 1929.     CrossRef
  • Association between fatty liver index and risk of end-stage renal disease stratified by kidney function in patients with type 2 diabetes: A nationwide population-based study
    Goh Eun Chung, Kyungdo Han, Kyu-Na Lee, Jung Ho Bae, Sun Young Yang, Su-Yeon Choi, Jeong Yoon Yim, Nam Ju Heo
    Diabetes & Metabolism.2023; 49(4): 101454.     CrossRef
  • Perirenal Fat as a New Independent Prognostic Factor in Patients With Surgically Treated Clear Cell Renal Cell Carcinoma
    Yiqing Du, Wenbo Yang, Huixin Liu, Caipeng Qin, Xu Tang, Tao Xu
    Clinical Genitourinary Cancer.2022; 20(1): e75.     CrossRef
  • The Influence of Obesity and Metabolic Health on Vascular Health
    Eun-Jung Rhee
    Endocrinology and Metabolism.2022; 37(1): 1.     CrossRef
  • Obesity‐related glomerulopathy: Current approaches and future perspectives
    José Ignacio Martínez‐Montoro, Enrique Morales, Isabel Cornejo‐Pareja, Francisco J. Tinahones, José Carlos Fernández‐García
    Obesity Reviews.2022;[Epub]     CrossRef
  • Neck circumference and waist circumference associated with cardiovascular events in type 2 diabetes (Beijing Community Diabetes Study 23)
    Guang-Ran Yang, Ming-Xia Yuan, Gang Wan, Xue-Lian Zhang, Han-Jing Fu, Shen-Yuan Yuan, Liang-Xiang Zhu, Rong-Rong Xie, Jian-Dong Zhang, Yu-Ling Li, Yan-Hua Sun, Qin-Fang Dai, Da-Yong Gao, Xue-Li Cui, Jian-Qin Gao, Zi-Ming Wang, Ying-Jun Chen, Yong-Jin Li,
    Scientific Reports.2021;[Epub]     CrossRef
  • LKB1 Regulates Goat Intramuscular Adipogenesis Through Focal Adhesion Pathway
    Yan Xiong, Yuxue Wang, Qing Xu, An Li, Yongqi Yue, Yan Ma, Yaqiu Lin
    Frontiers in Physiology.2021;[Epub]     CrossRef
  • Serum Uric Acid and Diabetes: From Pathophysiology to Cardiovascular Disease
    Niki Katsiki, George D. Dimitriadis, Dimitri P. Mikhailidis
    Current Pharmaceutical Design.2021; 27(16): 1941.     CrossRef
  • Is Epidural Fat Affected by Peripheric or Visceral Adipose Tissue? A Radiologic View
    Nilüfer AYLANÇ, Mustafa REŞORLU, Gürhan ADAM
    Konuralp Tıp Dergisi.2019; 11(1): 41.     CrossRef
  • Perirenal Adiposity and Other Excessive Intra- and Peri-Organ Fat Depots: What Is the Connection?
    Niki Katsiki, George Dimitriadis, Dimitri P. Mikhailidis
    Angiology.2019; 70(7): 581.     CrossRef
  • Letter: Association of Z-Score of the Log-Transformed A Body Shape Index with Cardiovascular Disease in People Who Are Obese but Metabolically Healthy: The Korea National Health and Nutrition Examination Survey 2007-2010 (J Obes Metab Syndr 2018;27:158-65
    Eun-Jung Rhee
    Journal of Obesity & Metabolic Syndrome.2019; 28(2): 139.     CrossRef
  • Determinants of Bone Mass and Insulin Resistance in Korean Postmenopausal Women: Muscle Area, Strength, or Composition?
    Hye-Sun Park, Jung Soo Lim, Sung-Kil Lim
    Yonsei Medical Journal.2019; 60(8): 742.     CrossRef
  • FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease
    Yuya Seko, Kohta Yano, Aya Takahashi, Shinya Okishio, Seita Kataoka, Keiichiroh Okuda, Naoki Mizuno, Masashi Takemura, Hiroyoshi Taketani, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Takeshi Okanoue, Yoshito Itoh
    International Journal of Molecular Sciences.2019; 21(1): 171.     CrossRef
  • Being Metabolically Healthy, the Most Responsible Factor for Vascular Health
    Eun-Jung Rhee
    Diabetes & Metabolism Journal.2018; 42(1): 19.     CrossRef
  • The persistence of fatty liver has a differential impact on the development of diabetes: The Kangbuk Samsung Health Study
    Ji Cheol Bae, Ji Min Han, Jung Hwan Cho, Hyemi Kwon, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sam Kwon, Sung-Woo Park, Eun Jung Rhee
    Diabetes Research and Clinical Practice.2018; 135: 1.     CrossRef
  • Changes of renal sinus fat and renal parenchymal fat during an 18-month randomized weight loss trial
    Hila Zelicha, Dan Schwarzfuchs, Ilan Shelef, Yftach Gepner, Gal Tsaban, Lilac Tene, Anat Yaskolka Meir, Avital Bilitzky, Oded Komy, Noa Cohen, Nitzan Bril, Michal Rein, Dana Serfaty, Shira Kenigsbuch, Yoash Chassidim, Benjamin Sarusi, Joachim Thiery, Uta
    Clinical Nutrition.2018; 37(4): 1145.     CrossRef
  • Association between abdominal obesity and increased risk for the development of hypertension regardless of physical activity: A nationwide population‐based study
    Eun‐Jung Rhee, Jung‐Hwan Cho, Hyemi Kwon, Se‐Eun Park, Jin‐Hyung Jung, Kyung‐Do Han, Yong‐Gyu Park, Hye Soon Park, Yang‐Hyun Kim, Soon‐Jib Yoo, Won‐Young Lee
    The Journal of Clinical Hypertension.2018; 20(10): 1417.     CrossRef
  • Mesenchymal stem cells in obesity: insights for translational applications
    Kenichi Matsushita, Victor J Dzau
    Laboratory Investigation.2017; 97(10): 1158.     CrossRef
  • Additive effect of non-alcoholic fatty liver disease on the development of diabetes in individuals with metabolic syndrome
    Ji Cheol Bae, Soo Kyoung Kim, Ji Min Han, Sam Kwon, Da Young Lee, Jihyun Kim, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun Jung Rhee
    Diabetes Research and Clinical Practice.2017; 129: 136.     CrossRef
  • Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study
    Dong Hyun Sinn, Danbee Kang, Hye Ryoun Jang, Seonhye Gu, Soo Jin Cho, Seung Woon Paik, Seungho Ryu, Yoosoo Chang, Mariana Lazo, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
    Journal of Hepatology.2017; 67(6): 1274.     CrossRef
  • Mesenchymal Stem Cells and Metabolic Syndrome: Current Understanding and Potential Clinical Implications
    Kenichi Matsushita, Paulo J. Oliveira
    Stem Cells International.2016;[Epub]     CrossRef
  • LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort
    Ji Cheol Bae, Ji Min Han, Sam Kwon, Jae Hwan Jee, Tae Yang Yu, Moon Kyu Lee, Jae Hyeon Kim
    Atherosclerosis.2016; 251: 170.     CrossRef
  • Sirtuin 3 (SIRT3) Regulates α-Smooth Muscle Actin (α-SMA) Production through the Succinate Dehydrogenase-G Protein-coupled Receptor 91 (GPR91) Pathway in Hepatic Stellate Cells
    Ying Hui Li, Dae Hee Choi, Eun Hye Lee, Su Ryeon Seo, Seungkoo Lee, Eun-Hee Cho
    Journal of Biological Chemistry.2016; 291(19): 10277.     CrossRef
  • Deletion of angiotensin II type 2 receptor accelerates adipogenesis in murine mesenchymal stem cells via Wnt10b/beta-catenin signaling
    Kenichi Matsushita, Yaojiong Wu, Richard E Pratt, Victor J Dzau
    Laboratory Investigation.2016; 96(8): 909.     CrossRef
  • Increased risk of subclinical atherosclerosis associated with high visceral adiposity index in apparently healthy Korean adults: the Kangbuk Samsung Health Study
    Hye-Jeong Park, Jihyun Kim, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee
    Annals of Medicine.2016; 48(6): 410.     CrossRef
  • The Roles of Adipokines, Proinflammatory Cytokines, and Adipose Tissue Macrophages in Obesity-Associated Insulin Resistance in Modest Obesity and Early Metabolic Dysfunction
    Yea Eun Kang, Ji Min Kim, Kyong Hye Joung, Ju Hee Lee, Bo Ram You, Min Jeong Choi, Min Jeong Ryu, Young Bok Ko, Min A. Lee, Junguee Lee, Bon Jeong Ku, Minho Shong, Ki Hwan Lee, Hyun Jin Kim, Guillermo López Lluch
    PLOS ONE.2016; 11(4): e0154003.     CrossRef
  • Neck circumference and future cardiovascular events in a high-risk population—A prospective cohort study
    Yingnan Dai, Xiaojing Wan, Xin Li, Enze Jin, Xueqi Li
    Lipids in Health and Disease.2016;[Epub]     CrossRef
  • Anti-obesity Effects of Ethanolic Extract of Polygonatum sibiricum Rhizome in High-fat Diet-fed Mice
    Jong-Hee Ko, Woo-Jin Jeon, Hyuk-Sang Kwon, Seung-Woo Yeon, Jae-Hoon Kang
    Korean Journal of Food Science and Technology.2015; 47(4): 499.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
  • Anti-diabetic efficacy of KICG1338, a novel glycogen synthase kinase-3β inhibitor, and its molecular characterization in animal models of type 2 diabetes and insulin resistance
    Kyoung Min Kim, Kuy-Sook Lee, Gha Young Lee, Hyunjin Jin, Eunice Sung Durrance, Ho Seon Park, Sung Hee Choi, Kyong Soo Park, Young-Bum Kim, Hak Chul Jang, Soo Lim
    Molecular and Cellular Endocrinology.2015; 409: 1.     CrossRef
  • Effects ofPolygonatum sibiricumrhizome ethanol extract in high-fat diet-fed mice
    Jong-Hee Ko, Hyuk-Sang Kwon, Jong-Min Yoon, Jong-Su Yoo, Hyeon-Soo Jang, Ji-Young Kim, Seung-Woo Yeon, Jae-Hoon Kang
    Pharmaceutical Biology.2015; 53(4): 563.     CrossRef
  • Lactisole inhibits the glucose-sensing receptor T1R3 expressed in mouse pancreatic β-cells
    Kunihisa Hamano, Yuko Nakagawa, Yoshiaki Ohtsu, Longfei Li, Johan Medina, Yuji Tanaka, Katsuyoshi Masuda, Mitsuhisa Komatsu, Itaru Kojima
    Journal of Endocrinology.2015; 226(1): 57.     CrossRef
  • Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial
    Ji Cheol Bae, Won Young Lee, Kun Ho Yoon, Joong Yeol Park, Hyun Sik Son, Kyung Ah Han, Kwan Woo Lee, Jeong Taek Woo, Young Cheol Ju, Won Jae Lee, Yoon Young Cho, Moon-Kyu Lee
    Diabetes Care.2015; 38(7): 1245.     CrossRef
  • Letter: The Risk Factors of Sarcopenia among Korean Elderly Men: Based on 2009 Korean National Health and Nutrition Examination Survey Data (Korean J Obes 2014;23:23-31)
    Ho Cheol Hong
    The Korean Journal of Obesity.2014; 23(2): 136.     CrossRef
  • The association between ectopic fat in the pancreas and subclinical atherosclerosis in type 2 diabetes
    Mee Kyoung Kim, Hyun Ji Chun, Jin Hee Park, Dong Myung Yeo, Ki-Hyun Baek, Ki-Ho Song, Dong Jin Chung, Hyuk-Sang Kwon
    Diabetes Research and Clinical Practice.2014; 106(3): 590.     CrossRef
Close layer
Original Articles
Obesity and Metabolism
Variation in Serum Creatinine Level Is Correlated to Risk of Type 2 Diabetes
Jun Sung Moon, Ji Eun Lee, Ji Sung Yoon
Endocrinol Metab. 2013;28(3):207-213.   Published online September 13, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.3.207
  • 10,803 View
  • 80 Download
  • 23 Crossref
AbstractAbstract PDFPubReader   
Background

Skeletal muscle is well established as a major target organ of insulin action, and is associated with the pathogenesis of type 2 diabetes. Therefore, we attempted to determine whether a variation in serum creatinine is related to the development of type 2 diabetes and other risk factors for diabetes.

Methods

A total of 2,676 nondiabetic subjects with stable and normal renal function (estimated glomerular filtration rate >60 mL/min/1.73 m2) were followed up for approximately 4.5 years. New onset diabetes was defined as fasting plasma glucose (FPG) ≥7.0 mmol/L, glycated hemoglobin (HbA1c) ≥6.5%, or subjects taking antidiabetic agents. Variation of serum creatinine (ΔCre) was defined as a difference between follow-up and baseline creatinine. In subgroup analysis, body composition was examined by bioelectric impedance analysis method.

Results

A total of 106 subjects were diagnosed with new-onset diabetes during the follow-up period. Baseline serum creatinine was not different between the new-onset diabetes and no diabetes groups. Negative ΔCre (ΔCre <0) showed an association with increased risk of type 2 diabetes after adjusting for age, sex, body mass index, systolic blood pressure, FPG, HbA1c, triglyceride, high density lipoprotein cholesterol, and γ-glutamyl transpeptidase (odds ratio, 1.885; 95% confidence interval, 1.127 to 3.153). Serum creatinine level demonstrated positive correlation with muscle mass and negative correlation with percentage of body fat in body composition analysis.

Conclusion

Serum creatinine reflected body muscle mass and the decrease of serum creatinine might be regarded as a risk factor for type 2 diabetes.

Citations

Citations to this article as recorded by  
  • Associations between dose–response of serum creatinine and type 2 diabetes mellitus risk: consistent and robust evidence from a systematic review and meta-analysis
    Vu Thi Minh Phuong, Vu Thi Quynh Chi, Nguyen Di Khanh, Tran Quang Duc, Ngo Huy Hoang
    Expert Review of Endocrinology & Metabolism.2025; 20(2): 153.     CrossRef
  • Association between serum albumin to creatinine ratio and non-alcoholic fatty liver disease: a longitudinal cohort study in non-obese Chinese individuals
    Weitao Wu, Donghai Wu, Fanglan Chen, Shihua Ding, Ying Ying, Dayong Sun, Haofei Hu
    BMC Gastroenterology.2025;[Epub]     CrossRef
  • Plasma Insulin Predicts Early Amyloid-β Pathology Changes in Alzheimer’s Disease
    Yu-Han Chen, Zhi-Bo Wang, Xi-Peng Liu, Zhi-Qi Mao
    Journal of Alzheimer's Disease.2024; 100(1): 321.     CrossRef
  • Exploring Risk Factors of Type 2 Diabetes Mellitus Using Decision Tree and Random Forest Models: Baseline Data From Kharameh Cohort Study
    Maryam Jalali, Hamid Reza Niazkar, Masoumeh Ghoddusi Johari, Amir Hossein Saem, Abbas Rezaianzadeh
    Epidemiology and Health System Journal.2024; 11(3): 128.     CrossRef
  • Low serum creatinine, a surrogate marker of muscle mass, correlates with insulin sensitivity in nonhuman primates
    Uddhav K. Chaudhari, Barbara C. Hansen
    Journal of Medical Primatology.2023; 52(2): 100.     CrossRef
  • Identification of Novel Biomarkers of Spinal Muscular Atrophy and Therapeutic Response by Proteomic and Metabolomic Profiling of Human Biological Fluid Samples
    Megi Meneri, Elena Abati, Delia Gagliardi, Irene Faravelli, Valeria Parente, Antonia Ratti, Federico Verde, Nicola Ticozzi, Giacomo P. Comi, Linda Ottoboni, Stefania Corti
    Biomedicines.2023; 11(5): 1254.     CrossRef
  • Association of serum creatinine levels and risk of type 2 diabetes mellitus in Korea: a case control study
    Do Kyeong Song, Young Sun Hong, Yeon-Ah Sung, Hyejin Lee
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • Impact of Female Sex on the Susceptibility to Hypernatremia Among Older Community-Dwelling Individuals in Japan
    Sho Tanaka, Midori Fujishiro, Kazuhiro Imatake, Yasuyuki Suzuki, Hisamitsu Ishihara, Shigemasa Tani
    International Journal of General Medicine.2022; Volume 15: 777.     CrossRef
  • Ameliorative Effect of Oxytocin on FBN1 and PEPCK Gene Expression, and Behavioral Patterns in Rats' Obesity-Induced Diabetes
    Asmaa Elnagar, Khalifa El-Dawy, Hussein I. El-Belbasi, Ibrahim F. Rehan, Hamdy Embark, Zeinab Al-Amgad, Obeid Shanab, Elsayed Mickdam, Gaber E. Batiha, Salman Alamery, Samer S. Fouad, Simona Cavalu, Mohammed Youssef
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • Time to doubling of serum creatinine in patients with diabetes in Ethiopian University Hospital: Retrospective follow-up study
    Adeladlew Kassie Netere, Ashenafi Kibret Sendekie, Donovan Anthony McGrowder
    PLOS ONE.2022; 17(9): e0274495.     CrossRef
  • Deep Learning for Integrated Analysis of Insulin Resistance with Multi-Omics Data
    Eunchong Huang, Sarah Kim, TaeJin Ahn
    Journal of Personalized Medicine.2021; 11(2): 128.     CrossRef
  • Arsenic Secondary Methylation Capacity Is Inversely Associated with Arsenic Exposure-Related Muscle Mass Reduction
    Md. Khalequzzaman Sarker, Selim Reza Tony, Abu Eabrahim Siddique, Md. Rezaul Karim, Nazmul Haque, Zohurul Islam, Md. Shofikul Islam, Moriom Khatun, Jahidul Islam, Shakhawoat Hossain, Zahangir Alam Saud, Hideki Miyataka, Daigo Sumi, Aaron Barchowsky, Seiic
    International Journal of Environmental Research and Public Health.2021; 18(18): 9730.     CrossRef
  • Creatinine to Body Weight Ratio Is Associated with Incident Diabetes: Population-Based Cohort Study
    Yoshitaka Hashimoto, Takuro Okamura, Masahide Hamaguchi, Akihiro Obora, Takao Kojima, Michiaki Fukui
    Journal of Clinical Medicine.2020; 9(1): 227.     CrossRef
  • ¿Debemos prestar más atención a la creatinina baja?
    Carlos A. Amado Diago, José A. Amado Señaris
    Endocrinología, Diabetes y Nutrición.2020; 67(7): 486.     CrossRef
  • Arsenic exposure-related hyperglycemia is linked to insulin resistance with concomitant reduction of skeletal muscle mass
    Victor Mondal, Zubaer Hosen, Faruk Hossen, Abu Eabrahim Siddique, Selim Reza Tony, Zohurul Islam, Md. Shofikul Islam, Shakhawoat Hossain, Khairul Islam, Md. Khalequzzaman Sarker, M.M. Hasibuzzaman, Ling-Zhi Liu, Bing-Hua Jiang, Md Mominul Hoque, Zahangir
    Environment International.2020; 143: 105890.     CrossRef
  • Noninvasive assessment of abdominal adipose tissues and quantification of hepatic and pancreatic fat fractions in type 2 diabetes mellitus
    Manoj Kumar Sarma, Andres Saucedo, Christine Hema Darwin, Ely Richard Felker, Kavya Umachandran, Daniel Kohanghadosh, Edward Xu, Steve Raman, Michael Albert Thomas
    Magnetic Resonance Imaging.2020; 72: 95.     CrossRef
  • Should we pay more attention to low creatinine levels?
    Carlos A. Amado Diago, José A. Amado Señaris
    Endocrinología, Diabetes y Nutrición (English ed.).2020; 67(7): 486.     CrossRef
  • Acute Effect of the Timing of Resistance Exercise and Nutrient Intake on Muscle Protein Breakdown
    Wataru Kume, Jun Yasuda, Takeshi Hashimoto
    Nutrients.2020; 12(4): 1177.     CrossRef
  • Serum creatinine levels and risk of incident type 2 diabetes mellitus or dysglycemia in middle-aged Japanese men: a retrospective cohort study
    Mamoru Takeuchi, Hironori Imano, Isao Muraki, Yuji Shimizu, Mina Hayama-Terada, Akihiko Kitamura, Takeo Okada, Masahiko Kiyama, Hiroyasu Iso
    BMJ Open Diabetes Research & Care.2018; 6(1): e000492.     CrossRef
  • Assessment of kidney dysfunction with cystatin C- and creatinine-based estimated glomerular filtration rate and predicting type 2 diabetes: Toranomon Hospital Health Management Center Study 21
    Yoriko Heianza, Shigeko Hara, Kazumi Saito, Hiroshi Tsuji, Shiro Tanaka, Satoru Kodama, Tetsuro Kobayashi, Yasuji Arase, Hirohito Sone
    Diabetes Research and Clinical Practice.2016; 113: 60.     CrossRef
  • Profiling human blood serum metabolites by nuclear magnetic resonance spectroscopy: a comprehensive tool for the evaluation of hemodialysis efficiency
    Marika Kromke, Martina Palomino-Schätzlein, Horst Mayer, Stefan Pfeffer, Antonio Pineda-Lucena, Burkhard Luy, Martin Hausberg, Claudia Muhle-Goll
    Translational Research.2016; 171: 71.     CrossRef
  • Safety evaluation of the consumption of high dose milk fat globule membrane in healthy adults: a double-blind, randomized controlled trial with parallel group design
    Sayaka Hari, Ryuji Ochiai, Yasushi Shioya, Yoshihisa Katsuragi
    Bioscience, Biotechnology, and Biochemistry.2015; 79(7): 1172.     CrossRef
  • Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
    Won-Young Lee
    Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
Close layer
Obesity and Metabolism
Hemoglobin A1c Is Positively Correlated with Framingham Risk Score in Older, Apparently Healthy Nondiabetic Korean Adults
Ji Hye Shin, Ji In Kang, Yun Jung, Young Min Choi, Hyun Jung Park, Jung Hae So, Jin Hwa Kim, Sang Yong Kim, Hak Yeon Bae
Endocrinol Metab. 2013;28(2):103-109.   Published online June 18, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.2.103
  • 6,664 View
  • 35 Download
  • 7 Web of Science
  • 9 Crossref
AbstractAbstract PDFPubReader   
Background

Several studies have suggested that elevated levels of hemoglobin A1c (HbA1c) are associated with cardiovascular disease (CVD) in nondiabetic individuals. However, it is unclear whether HbA1c levels can serve as a simple screening marker for increased CVD risk in nondiabetic individuals. Our objective was to evaluate the relationship between HbA1c levels and CVD risk using the Framingham risk score (FRS) in older, apparently healthy nondiabetic Korean adults.

Methods

We retrospectively studied 2,879 Korean adults between the ages of 40 and 79 who underwent voluntary health check-ups at the Health Promotion Center of our hospital from July 2009 to June 2011. Subjects were subdivided based on their HbA1c levels into four groups: tertiles within the HbA1c normal tolerance range and a group for subjects with an increased risk for diabetes (IRD).

Results

The mean FRS for the upper tertile (9.6±3.8) group was significantly higher than that of the middle tertile (8.4±4.0) and lower tertile (7.6±3.8) groups. In addition, FRS was highest in the IRD group (10.5±3.7). Multiple linear regression analysis demonstrated that HbA1c levels exhibited a significant positive correlation with FRS when adjusted for confounding variables in all subjects (β±standard error [SE], 0.018±0.002; R2, 0.131), women (β±SE, 0.023±0.003; R2, 0.170), and men (β±SE, 0.016±0.004; R2, 0.109).

Conclusion

HbA1c levels were positively correlated with FRS in older, apparently healthy nondiabetic Korean adults. We propose that HbA1c levels may reflect CVD risk in nondiabetic individuals.

Citations

Citations to this article as recorded by  
  • Correlation between cardiovascular risk and glycemic control among patients with diabetes
    Naomi Niari Dalimunthe, Herwindo Ahmad, Dina Arwina Dalimunthe
    MGM Journal of Medical Sciences.2024; 11(1): 44.     CrossRef
  • Framingham Risk Score Assessment in Subjects with Pre-diabetes and Diabetes: A Cross-Sectional Study in Korea
    Hyuk Sang Kwon, Kee Ho Song, Jae Myung Yu, Dong Sun Kim, Ho Sang Shon, Kyu Jeung Ahn, Sung Hee Choi, Seung Hyun Ko, Won Kim, Kyoung Hwa Lee, Il Seong Nam-Goong, Tae Sun Park
    Journal of Obesity & Metabolic Syndrome.2021; 30(3): 261.     CrossRef
  • Physician-Directed Diabetes Education without a Medication Change and Associated Patient Outcomes
    Hun-Sung Kim, Hyunah Kim, Hae-Kyung Yang, Eun Young Lee, Yoo Jin Jeong, Tong Min Kim, So Jung Yang, Seo Yeon Baik, Seung-Hwan Lee, Jae Hyoung Cho, In Young Choi, Hyeon Woo Yim, Bong-Yun Cha
    Diabetes & Metabolism Journal.2017; 41(3): 187.     CrossRef
  • Randomized, Open-Label, Parallel Group Study to Evaluate the Effect of Internet-Based Glucose Management System on Subjects with Diabetes in China
    Hun-Sung Kim, Chenglin Sun, So Jung Yang, Lin Sun, Fei Li, In Young Choi, Jae-Hyoung Cho, Guixia Wang, Kun-Ho Yoon
    Telemedicine and e-Health.2016; 22(8): 666.     CrossRef
  • GA to HbA1C ratio, but not HbA1C is associated with cognition in Chinese nondiabetic old adults
    Yuan Zhong, Jun Jin, Chan Chan Xu, Guo Xiang Fu
    Aging & Mental Health.2015; 19(9): 853.     CrossRef
  • Relationship of Glycated Hemoglobin A1c, Coronary Artery Calcification and Insulin Resistance in Males Without Diabetes
    Chan-Hee Jung, Eun-Jung Rhee, Kyu-Jin Kim, Bo-Yeon Kim, Se Eun Park, Yoosoo Chang, Seungho Ryu, Cheol-Young Park, Ji-Oh Mok, Ki-Won Oh, Chul-Hee Kim, Sung-Woo Park, Sung-Koo Kang, Won-Young Lee
    Archives of Medical Research.2015; 46(1): 71.     CrossRef
  • Evaluation of Nutrient Intake and Food Variety in Korean Male Adults according to Framingham Risk Score
    Mi-Kyeong Choi, Yun-Jung Bae
    The Korean Journal of Food And Nutrition.2014; 27(3): 484.     CrossRef
  • Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
    Won-Young Lee
    Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
  • Suicidal ideation and suicide attempts among diabetes mellitus: The Korea National Health and Nutrition Examination Survey (KNHANES IV, V) from 2007 to 2012
    Jae Ho Chung, Kitae Moon, Do Hyung Kim, Joo-Won Min, Tae Ho Kim, Hee-Jin Hwang
    Journal of Psychosomatic Research.2014; 77(6): 457.     CrossRef
Close layer
The Changes in Atherosclerotic Markers and Adiopocytokines after Treatment with Growth Hormone for the Patients with Hypopituitarism and Growth Hormone Deficiency.
Hyun Won Shin, In Kyung Jeong, Goo Yeong Cho, Cheul Young Choi, Jong Yeop Kim, Yeong Je Chae, Min Ho Cho, Byung Wan Lee, Seong Jin Lee, Chul Young Park, Eun Gyoung Hong, Hyeon Kyu Kim, Doo Man Kim, Jae Myung Yu, Sung Hee Ihm, Moon Ki Choi, Hyung Joon Yoo, Sung Woo Park
J Korean Endocr Soc. 2006;21(6):515-525.   Published online December 1, 2006
DOI: https://doi.org/10.3803/jkes.2006.21.6.515
  • 3,244 View
  • 24 Download
  • 1 Crossref
AbstractAbstract PDF
BACKGROUND
It is known that patients with hypopituitarism have a high mortality rate due to the presence of atherosclerosis, cardiovascular diseases and stroke. The aim of this study was the effect of growth hormone (GH) on the atherosclerotic markers and the adipocytokine levels. METHOD: The study was conducted on 13 adult patients with hypopituitarism and growth hormone deficiency (GHD), and they had been stabilized after receiving hormone replacement therapy for other insufficient pituitary hormones, other than GH, for more than one year. Before treatment with GH, we compared the lipid metabolism, glucose metabolism, cardiovascular risk factors and adipocytokine levels, including adiponectin, leptin, TNF-alpha and IL-6, between the GHD patients and 13 healthy adults who were of a similar age and gender distribution. Patients with GHD were treated with 1 U/day of GH for 6 months. We measured insulin-like growth factor-I (IGF-I), blood pressure, body composition, lipid metabolism, glucose metabolism and hs-CRP, cardiac function, adiponectin, leptin, TNF-alpha and IL-6 levels, flow mediated vasodilation (FMD) and nitroglycerin mediated vasodilation (NMD) before and after GH treatment. RESULTS: The patients with hypopituitarism and GHD showed significantly higher levels of total cholesterol (P = 0.002), low-density lipoprotein cholesterol (LDL-C) (P = 0.036), hs-CRP (P = 0.0087) and leptin (P < 0.001) than did the normal healthy adults. However, there was no difference between the normal adults and the patients with GHD for the systolic and diastolic BP, the levels of apoA, apoB, fasting blood glucose(FBG) and HOMA-IR. In the subjects with GHD after treatment with GH, the level of fat mass (P = 0.0017), total cholesterol (P = 0.004), LDL-C (P = 0.001), leptin (P = 0.013), TNF-alpha (P < 0.001) and hs-CRP (P = 0.0001) were significantly reduced, while lean body mass (P = 0.0161), FFA (P = 0.049) and FMD (P = 0.0051) showed a significant increase. However, there was no significant difference in the level of the systolic and diastolic BP, LDL-C, apoA, apoB, LP (a), HOMA-IR, ejection fraction, left ventricular posterior wall, E/A ratio, intraventricular septum, NMD, intima-media thickness, adiponectin, IL-6, FBG and fasting insulin before and after GH treatment. CONCLUSION: The subjects with GHD were vulnerable to cardiovascular disease. GH therapy for 6 months had a positive effect on their various cardiovascular risk factors.

Citations

Citations to this article as recorded by  
  • Molecular Biology of Atherosclerosis
    In-Kyung Jeong
    Endocrinology and Metabolism.2010; 25(3): 166.     CrossRef
Close layer
Contributing Factors to Different Natural Courses of Posttansplantation Diabetes Mellitus in Renal Allograft Recipients.
Kyu Yeon Hur, Myoung Soo Kim, Jae Hyun Nam, Eun Seok Kang, Hyun Joo Lee, So Hun Kim, Bong Soo Cha, Chul Woo Ahn, Soon Il Kim, Yu Seun Kim, Hyun Chul Lee
J Korean Endocr Soc. 2006;21(5):373-381.   Published online October 1, 2006
DOI: https://doi.org/10.3803/jkes.2006.21.5.373
  • 3,206 View
  • 25 Download
  • 2 Crossref
AbstractAbstract PDF
BACKGROUND
New onset diabetes is a major complication after kidney transplantation. However, the natural course of posttransplantation diabetes mellitus (PTDM) remains unclear. The aim of this study was to demonstrate the detailed natural courses of PTDM according to the onset and persistency of hyperglycemia, and to investigate risk factors for development of different courses of PTDM in renal allograft recipients. METHODS: A total of 77 renal allograft recipients without previously known diabetes were enrolled and performed a serial 75 g oral glucose tolerance test at 0, 1, and 7 years after kidney transplantation. Patients were classified according to the onset and persistency of PTDM: early PTMD (E-PTDM), late PTDM (L-PTDM), persistent PTDM (P-PTDM), transient PTMD (T-PTDM), and non-PTDN (N-PTDM). RESULTS: The incidence of each group was as follows: E-PTDM, 39%; L-PTDM, 11.7%; P-PTDM, 23.4% T-PTDM, 15.6%; N-PTDM, 49.3%. Tacrolimus and female gender were associated with the development of E-PTDM. Among E-PTDM, age at transplantation was a high risk factor for the development of P-PTDM. Higher BMI at year1 was associated with the development of L-PTDM. CONCLUSION: Different risk factors were associated with various natural courses of PTDM. Since old age and female gender are not modifiable risk factors, it may be important to modify immunosuppressive therapy regimens for the prevention of E-PTDM and control of body weight for L-PTDM.

Citations

Citations to this article as recorded by  
  • Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes Mellitus
    Jaehyun Bae, Youjin Kim, Yongin Cho, Minyoung Lee, Ji-Yeon Lee, Yong-ho Lee, Byung-Wan Lee, Bong-Soo Cha, Dong Jin Joo, Kyu Ha Huh, Myoung Soo Kim, Yu Seun Kim, Eun Seok Kang
    Transplantation Proceedings.2019; 51(10): 3444.     CrossRef
  • Post-transplantation Diabetes Mellitus
    Kun-Ho Yoon
    Journal of Korean Endocrine Society.2006; 21(5): 370.     CrossRef
Close layer
Multi-country Study on the Prevalence and Clinical Features of Peripheral Arterial Disease in Type 2 Diabetic Patients Who are at High Risk for Atherosclerosis.
Sang Youl Rhee, Seungjoon Oh, Young Kil Choi, Doo Man Kim, Bong Yun Cha, Hyun Chul Lee, Seung Woo Ha, In Kyu Lee, Tae Sun Park, Min Young Chung, In Joo Kim, Moon Kyu Lee, Sung Soo Koong, Kyung Soo Park, Kyung Wan Min, Young Seol Kim
J Korean Endocr Soc. 2006;21(4):290-301.   Published online August 1, 2006
DOI: https://doi.org/10.3803/jkes.2006.21.4.290
  • 2,795 View
  • 32 Download
AbstractAbstract PDF
BACKGROUND
PAD-SEARCH (Peripheral Arterial Disease-Screening and Evaluation of diabetic patients in Asian Regions Characterized by High risk factors) is the first international study to investigate the prevalence of peripheral arterial disease (PAD) in Asian type 2 diabetic patients and to demonstrate the relationships between the putative risk factors and PAD in this population. METHODS: A total of 6,625 type 2 diabetic patients (2,873 males and 3,752 females aged 50 and older) were enrolled in PAD-SEARCH in Korea, China, Taiwan, Hong Kong, Indonesia, Thailand and Philippines from October 2003 to March 2004. The Fukuda vascular profile VS-1000(TM) was used to determine the ankle-brachial index (ABI) and the brachial-ankle pulse wave velocity (baPWV). RESULTS: The mean patient age was 63.7 +/- 8.2 years and the mean duration of diabetes was 10.3 +/- 8.0 years. 1,172 (17.7%) subjects were diagnosed as PAD by the ABI (< or = 0.9). Subjects with PAD had a significantly longer duration of diabetes or hypertension, a higher HbA1c level and a significantly lower mean BMI than did the non-PAD subjects. In terms of the lipid profiles, triglyceride was the only significant variable. Notably, the mean ABI and baPWV in the females were significantly poorer than the age matched males for the in subjects with a normal ABI. However, the mean ABI and baPWV in males were significantly poorer than those of the age matched females for the subjects with PAD. On the multivariate analysis, gender, age, BMI, smoking status, duration of diabetes and a previous history of cerebrovascular disease were identified as the independent risk factors of PAD. CONCLUSION: These findings suggest that PAD is a common complication in Asian type 2 diabetic patients. Therefore, PAD screening and treatment should be emphasized for Asian diabetic patients with high risk factors.
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP